| we O | |
| present O | |
| a O | |
| case O | |
| of O | |
| a O | |
| 77 O | |
| - O | |
| year-old O | |
| caucasian O | |
| woman O | |
| with O | |
| obstructive B-ety | |
| jaundice I-ety | |
| . O | |
| laboratory O | |
| tests O | |
| revealed O | |
| that O | |
| she O | |
| had O | |
| elevated B-ety | |
| bilirubin I-ety | |
| and I-ety | |
| liver I-ety | |
| enzyme I-ety | |
| levels I-ety | |
| . O | |
| A O | |
| computed O | |
| tomographic O | |
| scan O | |
| showed O | |
| a O | |
| homogeneous O | |
| 5 O | |
| × O | |
| 3 O | |
| - O | |
| cm O | |
| mass O | |
| obstructing O | |
| the O | |
| common O | |
| bile O | |
| duct O | |
| . O | |
| the O | |
| results O | |
| of O | |
| brush O | |
| cytology O | |
| were O | |
| consistent O | |
| with O | |
| a O | |
| bile O | |
| duct O | |
| villous B-ety | |
| papilloma I-ety | |
| . O | |
| however O | |
| , O | |
| on O | |
| the O | |
| basis O | |
| of O | |
| the O | |
| tumor's B-ety | |
| radiological O | |
| features O | |
| , O | |
| a O | |
| preliminary O | |
| diagnosis O | |
| of O | |
| extrahepatic B-ety | |
| bile I-ety | |
| duct I-ety | |
| malignant I-ety | |
| tumor I-ety | |
| was O | |
| made O | |
| . O | |
| after O | |
| discussion O | |
| among O | |
| the O | |
| multidisciplinary O | |
| team O | |
| , O | |
| a O | |
| surgical O | |
| resection O | |
| of O | |
| the O | |
| bile B-ety | |
| duct I-ety | |
| tumor I-ety | |
| was O | |
| performed O | |
| . O | |
| histopathological O | |
| examination O | |
| confirmed O | |
| a O | |
| villous B-ety | |
| adenoma I-ety | |
| . O | |
| the O | |
| patient's O | |
| postoperative O | |
| course O | |
| was O | |
| uneventful O | |
| . O | |
| A O | |
| 65 O | |
| year-old O | |
| woman O | |
| with O | |
| hypertension B-ety | |
| and O | |
| parkinson's B-ety | |
| disease I-ety | |
| presented O | |
| with O | |
| sudden O | |
| onset O | |
| severe O | |
| chest B-ety | |
| pain I-ety | |
| . O | |
| electrocardiogram O | |
| showed O | |
| ischemic O | |
| st-segment B-ety | |
| elevation I-ety | |
| in O | |
| inferior O | |
| and O | |
| lateral O | |
| leads O | |
| . O | |
| urgent O | |
| cardiac O | |
| catheterization O | |
| revealed O | |
| focal O | |
| dissections O | |
| in O | |
| four O | |
| small O | |
| caliber O | |
| coronary O | |
| arteries O | |
| in O | |
| right O | |
| and O | |
| left O | |
| coronary O | |
| systems O | |
| including O | |
| right O | |
| posterior O | |
| decending O | |
| , O | |
| posterolateral O | |
| , O | |
| obtuse O | |
| marginal O | |
| and O | |
| septal O | |
| arteries O | |
| . O | |
| angiography O | |
| demonstrated O | |
| no O | |
| significant O | |
| atherosclerotic B-ety | |
| coronary I-ety | |
| artery I-ety | |
| disease I-ety | |
| . O | |
| the O | |
| patient O | |
| was O | |
| medically O | |
| managed O | |
| with O | |
| eptifibatide O | |
| , O | |
| aspirin O | |
| , O | |
| clopidogrel O | |
| and O | |
| beta O | |
| blocker O | |
| since O | |
| dissected B-ety | |
| vessels I-ety | |
| were O | |
| not O | |
| technically O | |
| suitable O | |
| for O | |
| percutaneous O | |
| coronary O | |
| intervention O | |
| . O | |
| antiparkinson O | |
| medications O | |
| were O | |
| held O | |
| as O | |
| a O | |
| potential O | |
| cause O | |
| of O | |
| dissection O | |
| . O | |
| she O | |
| responded O | |
| well O | |
| to O | |
| medical O | |
| management O | |
| . O | |
| A O | |
| 45 O | |
| year O | |
| old O | |
| indian O | |
| female O | |
| of O | |
| nordic O | |
| origin O | |
| presented O | |
| 5 O | |
| years O | |
| back O | |
| with O | |
| a O | |
| lump B-ety | |
| in I-ety | |
| the I-ety | |
| right I-ety | |
| breast I-ety | |
| and I-ety | |
| the I-ety | |
| axilla I-ety | |
| . O | |
| she O | |
| underwent O | |
| modified O | |
| radical O | |
| mastectomy O | |
| . O | |
| histophotomicrograph O | |
| of O | |
| the O | |
| excised O | |
| breast B-ety | |
| lesion I-ety | |
| showed O | |
| a O | |
| 2.1 O | |
| cm O | |
| duct B-ety | |
| carcinoma I-ety | |
| , O | |
| positive O | |
| for O | |
| ER O | |
| and O | |
| PR O | |
| with O | |
| 1 O | |
| out O | |
| of O | |
| 25 O | |
| lymph B-ety | |
| nodes I-ety | |
| positive I-ety | |
| for I-ety | |
| metastasis I-ety | |
| . O | |
| she O | |
| received O | |
| 6 O | |
| cycles O | |
| of O | |
| chemotherapy O | |
| with O | |
| cyclophosphamide O | |
| , O | |
| epirubicin O | |
| , O | |
| and O | |
| 5 O | |
| - O | |
| fluorouracil O | |
| . O | |
| this O | |
| was O | |
| followed O | |
| by O | |
| tamoxifen O | |
| 20 O | |
| mg O | |
| per O | |
| day O | |
| for O | |
| five O | |
| years O | |
| . O | |
| she O | |
| was O | |
| doing O | |
| well O | |
| on O | |
| follow O | |
| up O | |
| until O | |
| the O | |
| completion O | |
| of O | |
| fifth O | |
| year O | |
| of O | |
| her O | |
| disease O | |
| , O | |
| when O | |
| she O | |
| presented O | |
| with O | |
| complaints O | |
| of O | |
| mild B-ety | |
| fever I-ety | |
| and O | |
| weakness B-ety | |
| . O | |
| examination O | |
| revealed O | |
| generalized B-ety | |
| lymph I-ety | |
| node I-ety | |
| enlargement I-ety | |
| along O | |
| with O | |
| hepatomegaly B-ety | |
| . O | |
| hemogram O | |
| showed O | |
| mild B-ety | |
| anemia I-ety | |
| , O | |
| normal O | |
| platelet O | |
| count O | |
| and O | |
| a O | |
| leukocyte O | |
| count O | |
| of O | |
| 1.2 O | |
| x O | |
| 10 O | |
| ( O | |
| 11 O | |
| ) O | |
| / O | |
| L O | |
| . O | |
| peripheral O | |
| blood O | |
| examination O | |
| revealed O | |
| medium O | |
| sized O | |
| lymphoid O | |
| cells O | |
| , O | |
| constituting O | |
| almost O | |
| 75% O | |
| of O | |
| total O | |
| nucleated O | |
| cell O | |
| population O | |
| . O | |
| immunophenotying O | |
| , O | |
| established O | |
| a O | |
| diagnosis O | |
| of O | |
| post O | |
| thymic O | |
| t-cell B-ety | |
| prolymphocytic I-ety | |
| leukemia I-ety | |
| . O | |
| contrast-enhanced O | |
| computed O | |
| tomography O | |
| of O | |
| the O | |
| chest O | |
| and O | |
| abdomen O | |
| was O | |
| done O | |
| which O | |
| revealed O | |
| an O | |
| anterior B-ety | |
| mediastinal I-ety | |
| mass I-ety | |
| with O | |
| destruction O | |
| of O | |
| sternum O | |
| along O | |
| with O | |
| multiple O | |
| small O | |
| nodular O | |
| shadows O | |
| in O | |
| bilateral O | |
| lung O | |
| fields O | |
| suggestive O | |
| of O | |
| lung B-ety | |
| metastasis I-ety | |
| . O | |
| fine O | |
| needle O | |
| aspiration O | |
| cytology O | |
| of O | |
| the O | |
| mass O | |
| showed O | |
| atypical O | |
| ductal O | |
| cells O | |
| with O | |
| nuclear O | |
| pleomorphism O | |
| , O | |
| which O | |
| were O | |
| positive O | |
| for O | |
| ER O | |
| , O | |
| PR O | |
| and O | |
| her2neu O | |
| protein O | |
| . O | |
| this O | |
| confirmed O | |
| a O | |
| co-existent O | |
| metastatic B-ety | |
| breast I-ety | |
| carcinoma I-ety | |
| . O | |
| she O | |
| was O | |
| started O | |
| on O | |
| chemotherapy O | |
| for O | |
| T-PLL B-ety | |
| along O | |
| with O | |
| hormonal O | |
| therapy O | |
| with O | |
| aromatase O | |
| inhibitor O | |
| . O | |
| unfortunately O | |
| , O | |
| both O | |
| her O | |
| malignancies O | |
| progressed O | |
| after O | |
| an O | |
| initial O | |
| stable O | |
| disease O | |
| of O | |
| two O | |
| months O | |
| . O | |
| A O | |
| male O | |
| , O | |
| 63 O | |
| years O | |
| old O | |
| , O | |
| complaining O | |
| about O | |
| a O | |
| "" O | |
| wound O | |
| in O | |
| the O | |
| mouth O | |
| "" O | |
| for O | |
| 6 O | |
| months O | |
| , O | |
| without O | |
| any O | |
| pain B-ety | |
| or O | |
| spontaneous O | |
| bleeding B-ety | |
| . O | |
| his O | |
| medical O | |
| history O | |
| was O | |
| free O | |
| of O | |
| disease O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| a O | |
| smoker B-ety | |
| for O | |
| 33 O | |
| years O | |
| . O | |
| intraoral O | |
| examination O | |
| revealed O | |
| a O | |
| destructive O | |
| ulcerative B-ety | |
| lesion I-ety | |
| around O | |
| the O | |
| upper O | |
| left O | |
| first O | |
| and O | |
| second O | |
| molars O | |
| that O | |
| resembled O | |
| an O | |
| oral B-ety | |
| squamous I-ety | |
| cell I-ety | |
| carcinoma I-ety | |
| . O | |
| biopsy O | |
| of O | |
| the O | |
| ulcerative B-ety | |
| lesion I-ety | |
| was O | |
| performed O | |
| and O | |
| the O | |
| microscopic O | |
| features O | |
| showed O | |
| an O | |
| inflammatory B-ety | |
| infiltrate I-ety | |
| rich O | |
| in O | |
| plasma O | |
| cells O | |
| . O | |
| based O | |
| on O | |
| this O | |
| microscopical O | |
| finding O | |
| , O | |
| the O | |
| final O | |
| diagnosis O | |
| was O | |
| periodontal B-ety | |
| disease I-ety | |
| associated O | |
| with O | |
| a O | |
| proliferative O | |
| non-neoplastic O | |
| lesion B-ety | |
| . O | |
| the O | |
| patient O | |
| was O | |
| referred O | |
| to O | |
| a O | |
| specialized O | |
| dental O | |
| surgeon O | |
| and O | |
| underwent O | |
| periodontal O | |
| therapy O | |
| including O | |
| surgical O | |
| procedures O | |
| . O | |
| after O | |
| that O | |
| , O | |
| according O | |
| to O | |
| follow-up O | |
| with O | |
| the O | |
| patient O | |
| , O | |
| there O | |
| were O | |
| no O | |
| signs O | |
| of O | |
| disease O | |
| remission O | |
| . O | |
| the O | |
| lesion B-ety | |
| increased O | |
| in O | |
| size O | |
| , O | |
| although O | |
| the O | |
| patient O | |
| did O | |
| not O | |
| complain O | |
| of O | |
| any O | |
| symptoms O | |
| . O | |
| A O | |
| second O | |
| biopsy O | |
| was O | |
| performed O | |
| and O | |
| the O | |
| microscopic O | |
| features O | |
| again O | |
| showed O | |
| a O | |
| rich O | |
| inflammatory B-ety | |
| infiltrate I-ety | |
| with O | |
| mononuclear O | |
| cells O | |
| and O | |
| histiocytic O | |
| cells O | |
| , O | |
| characterized O | |
| by O | |
| pale O | |
| histiocytes O | |
| with O | |
| lobed O | |
| nuclei O | |
| , O | |
| resembling O | |
| a O | |
| bean O | |
| . O | |
| A O | |
| varying O | |
| number O | |
| of O | |
| eosinophils O | |
| also O | |
| were O | |
| observed O | |
| , O | |
| without O | |
| any O | |
| evidence O | |
| of O | |
| atypical O | |
| cells O | |
| present O | |
| in O | |
| this O | |
| infiltrate O | |
| . O | |
| an O | |
| immunohistochemical O | |
| staining O | |
| panel O | |
| was O | |
| done O | |
| to O | |
| determine O | |
| the O | |
| nature O | |
| of O | |
| this O | |
| inflammatory B-ety | |
| infiltrate I-ety | |
| by O | |
| using O | |
| antibodies O | |
| S O | |
| - O | |
| 100 O | |
| , O | |
| cd1a O | |
| , O | |
| CD O | |
| - O | |
| 68 O | |
| and O | |
| CD45RO O | |
| that O | |
| were O | |
| positive O | |
| . O | |
| these O | |
| immunohistochemical O | |
| findings O | |
| were O | |
| fundamental O | |
| for O | |
| the O | |
| final O | |
| diagnosis O | |
| of O | |
| LCH B-ety | |
| . O | |
| the O | |
| treatment O | |
| included O | |
| surgical O | |
| extraction O | |
| of O | |
| all O | |
| superior O | |
| teeth O | |
| , O | |
| radiation O | |
| and O | |
| systemic O | |
| corticoid O | |
| therapies O | |
| . O | |
| after O | |
| 8 O | |
| years O | |
| of O | |
| treatment O | |
| , O | |
| the O | |
| patient O | |
| is O | |
| free O | |
| of O | |
| disease O | |
| . O | |
| A O | |
| 12 O | |
| - O | |
| year-old O | |
| girl O | |
| was O | |
| referred O | |
| to O | |
| department O | |
| of O | |
| oral O | |
| surgery O | |
| , O | |
| with O | |
| a O | |
| complaint O | |
| of O | |
| pain B-ety | |
| and I-ety | |
| swelling I-ety | |
| in I-ety | |
| the I-ety | |
| left I-ety | |
| of I-ety | |
| maxilla I-ety | |
| that O | |
| appeared O | |
| 3 O | |
| months O | |
| ago O | |
| . O | |
| the O | |
| swelling B-ety | |
| was O | |
| slowly O | |
| progressive O | |
| , O | |
| associated O | |
| with O | |
| pain B-ety | |
| . O | |
| however O | |
| , O | |
| the O | |
| patient O | |
| did O | |
| not O | |
| refer O | |
| any O | |
| motor O | |
| or O | |
| sensory O | |
| deficit O | |
| . O | |
| there O | |
| was O | |
| no O | |
| family O | |
| history O | |
| of O | |
| similar O | |
| swelling B-ety | |
| . O | |
| physical O | |
| examination O | |
| revealed O | |
| a O | |
| left O | |
| maxillary B-ety | |
| swelling I-ety | |
| . O | |
| there O | |
| was O | |
| no O | |
| facial B-ety | |
| palsy I-ety | |
| . O | |
| no O | |
| cervical O | |
| lymph O | |
| node O | |
| enlargement O | |
| was O | |
| seen O | |
| . O | |
| the O | |
| oral O | |
| examination O | |
| showed O | |
| a O | |
| 4 O | |
| cm O | |
| x O | |
| 5 O | |
| cm O | |
| , O | |
| tender O | |
| , O | |
| compressible O | |
| mass O | |
| in O | |
| the O | |
| left O | |
| maxilla O | |
| , O | |
| from O | |
| the O | |
| lateral O | |
| incisor O | |
| to O | |
| the O | |
| second O | |
| premolar O | |
| teeth O | |
| . O | |
| the O | |
| tumor B-ety | |
| surface O | |
| was O | |
| smooth O | |
| and O | |
| red-purple O | |
| . O | |
| several O | |
| teeth O | |
| were O | |
| involved O | |
| and O | |
| displaced O | |
| in O | |
| the O | |
| tumor B-ety | |
| mass I-ety | |
| . O | |
| we O | |
| noted O | |
| the O | |
| absence O | |
| of O | |
| canine O | |
| . O | |
| vitality O | |
| tests O | |
| proved O | |
| negative O | |
| on O | |
| the O | |
| central O | |
| and O | |
| lateral O | |
| incisor O | |
| . O | |
| hight O | |
| mobility O | |
| of O | |
| lateral O | |
| incisor O | |
| was O | |
| noted O | |
| . O | |
| orthopantomography O | |
| and O | |
| occlusal O | |
| radiography O | |
| showed O | |
| a O | |
| wide O | |
| osteolytic O | |
| area O | |
| of O | |
| the O | |
| anterior O | |
| left O | |
| maxilla O | |
| , O | |
| extending O | |
| from O | |
| the O | |
| first O | |
| permanent O | |
| molar O | |
| to O | |
| the O | |
| central O | |
| incisor O | |
| . O | |
| the O | |
| canine O | |
| was O | |
| impacted O | |
| . O | |
| no O | |
| root O | |
| resorption O | |
| was O | |
| observed O | |
| . O | |
| the O | |
| radiolucency O | |
| was O | |
| closely O | |
| related O | |
| to O | |
| maxillary O | |
| sinus O | |
| and O | |
| involving O | |
| the O | |
| nasal O | |
| cavity O | |
| . O | |
| haematological O | |
| investigations O | |
| showed O | |
| normal O | |
| serum O | |
| calcium O | |
| , O | |
| phosphorus O | |
| and O | |
| parathormone O | |
| ( O | |
| PTH O | |
| ) O | |
| levels O | |
| . O | |
| the O | |
| provisional O | |
| diagnosis O | |
| of O | |
| benign B-ety | |
| tumor I-ety | |
| of I-ety | |
| the I-ety | |
| maxilla I-ety | |
| was O | |
| made O | |
| . O | |
| the O | |
| patient O | |
| underwent O | |
| excision O | |
| and O | |
| curettage O | |
| of O | |
| the O | |
| mass O | |
| with O | |
| extraction O | |
| of O | |
| the O | |
| canine O | |
| and O | |
| lateral O | |
| incisor O | |
| tooth O | |
| . O | |
| the O | |
| wound O | |
| was O | |
| closed O | |
| with O | |
| interrupted O | |
| sutures O | |
| . O | |
| the O | |
| post-operative O | |
| histopathological O | |
| report O | |
| revealed O | |
| multinuclear O | |
| giant O | |
| cells O | |
| scattered O | |
| randomly O | |
| throughout O | |
| the O | |
| cellular O | |
| and O | |
| fibrous O | |
| vascular-rich O | |
| tissue O | |
| . O | |
| new O | |
| bone O | |
| formation O | |
| and O | |
| granulation O | |
| tissue O | |
| rich O | |
| in O | |
| mononuclear O | |
| inflammatory O | |
| cells O | |
| was O | |
| revealed O | |
| . O | |
| the O | |
| giant O | |
| cells O | |
| were O | |
| multinucleated O | |
| with O | |
| bland-appearing O | |
| nuclei O | |
| , O | |
| and O | |
| the O | |
| background O | |
| stromal O | |
| cells O | |
| displayed O | |
| no O | |
| evidence O | |
| of O | |
| atypical O | |
| mitoses O | |
| . O | |
| A O | |
| diagnosis O | |
| of O | |
| giant B-ety | |
| cell I-ety | |
| tumor I-ety | |
| was O | |
| established O | |
| . O | |
| during O | |
| a O | |
| 1 O | |
| - O | |
| year O | |
| serial O | |
| clinical O | |
| and O | |
| radiological O | |
| follow-up O | |
| , O | |
| there O | |
| was O | |
| no O | |
| evidence O | |
| of O | |
| recurrence O | |
| . O | |
| the O | |
| facial O | |
| contour O | |
| and O | |
| masticatory O | |
| function O | |
| were O | |
| well-preserved O | |
| . O | |
| A O | |
| 19 O | |
| - O | |
| year-old O | |
| healthy O | |
| man O | |
| was O | |
| admitted O | |
| to O | |
| our O | |
| cardiology O | |
| department O | |
| following O | |
| a O | |
| syncopal B-ety | |
| episode I-ety | |
| . O | |
| his O | |
| past O | |
| medical O | |
| history O | |
| was O | |
| unremarkable O | |
| . O | |
| he O | |
| no O | |
| family O | |
| history O | |
| of O | |
| heart B-ety | |
| disease I-ety | |
| or O | |
| sudden B-ety | |
| death I-ety | |
| . O | |
| two-days O | |
| prior O | |
| the O | |
| syncope B-ety | |
| , O | |
| he O | |
| developed O | |
| chest B-ety | |
| pain I-ety | |
| and O | |
| an O | |
| influenza-like B-ety | |
| illness I-ety | |
| consisting O | |
| of O | |
| fevers B-ety | |
| , O | |
| rhinorrhea B-ety | |
| , O | |
| and O | |
| sore B-ety | |
| throat I-ety | |
| . O | |
| at O | |
| the O | |
| physical O | |
| exam O | |
| , O | |
| the O | |
| patient O | |
| was O | |
| febrile B-ety | |
| at O | |
| 39 O | |
| ° O | |
| C O | |
| . O | |
| he O | |
| had O | |
| an O | |
| inflamed O | |
| throat O | |
| , O | |
| bradycardia B-ety | |
| at O | |
| cardiac O | |
| auscultation O | |
| and O | |
| there O | |
| were O | |
| no O | |
| signs O | |
| of O | |
| heart O | |
| failure O | |
| . O | |
| the O | |
| electrocardiogram O | |
| ( O | |
| EKG O | |
| ) O | |
| showed O | |
| grade O | |
| III O | |
| atrioventricular O | |
| ( O | |
| AV B-ety | |
| ) O | |
| bloc O | |
| with O | |
| a O | |
| ventricular O | |
| rate O | |
| of O | |
| 38 O | |
| beats O | |
| per O | |
| minute O | |
| . O | |
| laboratory O | |
| studies O | |
| were O | |
| remarkable O | |
| for O | |
| a O | |
| hs-troponin O | |
| level O | |
| 181ng O | |
| / O | |
| L O | |
| , O | |
| a O | |
| white O | |
| blood O | |
| cell O | |
| count O | |
| of O | |
| 14270 O | |
| / O | |
| mm³ O | |
| with O | |
| 48% O | |
| lymphocytes O | |
| , O | |
| and O | |
| elevated B-ety | |
| c-reactive I-ety | |
| protein I-ety | |
| at O | |
| 90mg O | |
| / O | |
| L O | |
| . O | |
| serum O | |
| electrolytes O | |
| , O | |
| kidney O | |
| and O | |
| liver O | |
| functions O | |
| were O | |
| within O | |
| normal O | |
| limits O | |
| . O | |
| A O | |
| chest O | |
| x-ray O | |
| showed O | |
| an O | |
| appropriate O | |
| cardiac O | |
| size O | |
| . O | |
| the O | |
| initial O | |
| transthoracic O | |
| echocardiography O | |
| ( O | |
| TTE O | |
| ) O | |
| showed O | |
| a O | |
| normal O | |
| global O | |
| left O | |
| ventricular O | |
| function O | |
| ( O | |
| left O | |
| ventricular O | |
| ejection O | |
| fraction O | |
| ( O | |
| LVEF O | |
| ) O | |
| 60% O | |
| ) O | |
| and O | |
| wall O | |
| motion O | |
| abnormalities O | |
| ( O | |
| anteroseptal O | |
| hypokinesia B-ety | |
| ) O | |
| , O | |
| with O | |
| reduced O | |
| left O | |
| ventricular O | |
| global O | |
| longitudinal O | |
| strain O | |
| ( O | |
| LV O | |
| GLS O | |
| = O | |
| - O | |
| 14.1% O | |
| ) O | |
| . O | |
| cardiac O | |
| magnetic O | |
| resonance O | |
| ( O | |
| CMR O | |
| ) O | |
| showed O | |
| increased O | |
| signal O | |
| intensity O | |
| at O | |
| the O | |
| mid-lateral O | |
| wall O | |
| on O | |
| T2 O | |
| - O | |
| weighted O | |
| images O | |
| . O | |
| late O | |
| enhancement O | |
| revealed O | |
| a O | |
| patchy O | |
| subepicardial O | |
| hyperenhancement O | |
| of O | |
| the O | |
| medio-distal O | |
| segments O | |
| of O | |
| the O | |
| anterior O | |
| and O | |
| anterolateral O | |
| walls O | |
| which O | |
| confirm O | |
| the O | |
| diagnosis O | |
| of O | |
| myocarditis B-ety | |
| . O | |
| the O | |
| patient O | |
| was O | |
| treated O | |
| with O | |
| cefotaxime O | |
| and O | |
| doxycycline O | |
| . O | |
| all O | |
| serological O | |
| tests O | |
| ( O | |
| chlamydia O | |
| , O | |
| coxiella O | |
| , O | |
| mycoplasma O | |
| , O | |
| rickettsia O | |
| , O | |
| lyme O | |
| and O | |
| bartonella O | |
| ) O | |
| obtained O | |
| during O | |
| the O | |
| hospitalization O | |
| were O | |
| negative O | |
| . O | |
| five O | |
| days O | |
| later O | |
| , O | |
| the O | |
| patient O | |
| was O | |
| asymptomatic O | |
| . O | |
| the O | |
| 24 O | |
| hours O | |
| ECG O | |
| monitoring O | |
| showed O | |
| a O | |
| sinus O | |
| rhythm O | |
| . O | |
| the O | |
| TTE O | |
| revealed O | |
| a O | |
| normal O | |
| LVEF O | |
| and O | |
| an O | |
| improvement O | |
| in O | |
| the O | |
| LVGLS O | |
| with O | |
| segmental O | |
| reduced O | |
| values O | |
| concordant O | |
| with O | |
| the O | |
| CMR O | |
| abnormalities O | |
| . O | |
| at O | |
| one-month O | |
| follow-up O | |
| the O | |
| patient O | |
| made O | |
| a O | |
| full O | |
| recovery O | |
| without O | |
| any O | |
| recurring O | |
| cardiovascular O | |
| symptoms O | |
| or O | |
| abnormal O | |
| electrocardiographic O | |
| or O | |
| echocardiographic O | |
| findings O | |
| . O | |
| A O | |
| 50 O | |
| - O | |
| years-old O | |
| woman O | |
| , O | |
| hypertensive B-ety | |
| , O | |
| hospitalized O | |
| for O | |
| a O | |
| large O | |
| cervical B-ety | |
| mass I-ety | |
| appeared O | |
| 30 O | |
| years O | |
| ago O | |
| . O | |
| in O | |
| the O | |
| family O | |
| history O | |
| , O | |
| her O | |
| mother O | |
| , O | |
| sisters O | |
| and O | |
| cousins O | |
| underwent O | |
| a O | |
| surgery O | |
| for O | |
| MNG B-ety | |
| . O | |
| despite O | |
| of O | |
| the O | |
| large O | |
| volume O | |
| of O | |
| the O | |
| mass B-ety | |
| , O | |
| the O | |
| patient O | |
| never O | |
| described O | |
| signs O | |
| of O | |
| cervical B-ety | |
| compression I-ety | |
| whatsoever O | |
| respiratory B-ety | |
| , I-ety | |
| digestive I-ety | |
| , I-ety | |
| laryngeal I-ety | |
| , I-ety | |
| vascular I-ety | |
| or I-ety | |
| neurologic I-ety | |
| signs I-ety | |
| . O | |
| she O | |
| never O | |
| suffered O | |
| from O | |
| thyroid B-ety | |
| dysfunction I-ety | |
| . O | |
| her O | |
| neck O | |
| was O | |
| deformed O | |
| by O | |
| the O | |
| voluminous O | |
| formation O | |
| classified O | |
| grade O | |
| III O | |
| according O | |
| to O | |
| the O | |
| WHO O | |
| modified O | |
| classification O | |
| . O | |
| the O | |
| mass B-ety | |
| took O | |
| the O | |
| front O | |
| and O | |
| the O | |
| two O | |
| sides O | |
| of O | |
| the O | |
| neck O | |
| . O | |
| its O | |
| surface O | |
| was O | |
| embossed O | |
| and O | |
| covered O | |
| by O | |
| a O | |
| thin O | |
| normal O | |
| skin O | |
| . O | |
| there O | |
| were O | |
| some O | |
| veins O | |
| of O | |
| the O | |
| collateral O | |
| circulation O | |
| limited O | |
| to O | |
| the O | |
| neck O | |
| . O | |
| the O | |
| goiter B-ety | |
| measured O | |
| 18 O | |
| x O | |
| 11 O | |
| cm O | |
| . O | |
| the O | |
| mass B-ety | |
| was O | |
| firm O | |
| , O | |
| painless O | |
| , O | |
| and O | |
| mobile O | |
| with O | |
| the O | |
| swallowing O | |
| movements O | |
| . O | |
| lymphadenopathy B-ety | |
| research O | |
| was O | |
| difficult O | |
| and O | |
| found O | |
| no O | |
| palpable O | |
| lymph O | |
| nodes O | |
| . O | |
| the O | |
| laboratory O | |
| tests O | |
| ( O | |
| T O | |
| 3 O | |
| , O | |
| T O | |
| 4 O | |
| and O | |
| TSH O | |
| ) O | |
| were O | |
| normal O | |
| . O | |
| thoracic O | |
| radiography O | |
| showed O | |
| a O | |
| large O | |
| cervical O | |
| opacity O | |
| roughly O | |
| round O | |
| and O | |
| strewn O | |
| with O | |
| microcalcifications B-ety | |
| associated O | |
| with O | |
| a O | |
| right O | |
| eccentricity O | |
| of O | |
| the O | |
| trachea O | |
| . O | |
| cervical O | |
| and O | |
| chest O | |
| CT O | |
| revealed O | |
| the O | |
| presence O | |
| of O | |
| a O | |
| partially O | |
| calcified O | |
| thyroid B-ety | |
| mass I-ety | |
| slightly O | |
| plunging O | |
| in O | |
| the O | |
| anterior O | |
| mediastinum O | |
| . O | |
| it O | |
| took O | |
| heterogeneously O | |
| the O | |
| contrast O | |
| and O | |
| then O | |
| evocate O | |
| a O | |
| large O | |
| MNG B-ety | |
| . O | |
| the O | |
| trachea O | |
| was O | |
| surrounded O | |
| by O | |
| the O | |
| goiter B-ety | |
| , O | |
| slightly O | |
| narrowed O | |
| and O | |
| right O | |
| deviated O | |
| as O | |
| well O | |
| as O | |
| the O | |
| lower O | |
| part O | |
| of O | |
| the O | |
| larynx O | |
| . O | |
| the O | |
| right O | |
| and O | |
| left O | |
| vascular O | |
| axes O | |
| of O | |
| the O | |
| neck O | |
| ( O | |
| carotid O | |
| artery O | |
| and O | |
| jugular O | |
| vein O | |
| ) O | |
| were O | |
| deviated O | |
| backward O | |
| . O | |
| the O | |
| patient O | |
| underwent O | |
| a O | |
| surgery O | |
| for O | |
| her O | |
| enormous O | |
| MNG B-ety | |
| slightly O | |
| plunging O | |
| in O | |
| the O | |
| mediastinum O | |
| . O | |
| endotracheal O | |
| intubation O | |
| was O | |
| relatively O | |
| easy O | |
| by O | |
| the O | |
| laryngoscope O | |
| . O | |
| the O | |
| incision O | |
| performed O | |
| was O | |
| a O | |
| kocher O | |
| cervicotomy O | |
| . O | |
| there O | |
| was O | |
| a O | |
| multinodular O | |
| , O | |
| hypervascularized O | |
| goiter O | |
| . O | |
| its O | |
| lower O | |
| end O | |
| plunges O | |
| behind O | |
| the O | |
| sternal O | |
| manubrium O | |
| . O | |
| the O | |
| larynx O | |
| was O | |
| deviated O | |
| towards O | |
| the O | |
| right O | |
| side O | |
| . O | |
| the O | |
| total O | |
| thyroidectomy O | |
| was O | |
| performed O | |
| in O | |
| two O | |
| steps O | |
| : O | |
| initially O | |
| a O | |
| right O | |
| lobo-isthmectomy O | |
| , O | |
| then O | |
| the O | |
| left O | |
| lobectomy O | |
| . O | |
| the O | |
| retrosternal O | |
| part O | |
| of O | |
| the O | |
| goiter B-ety | |
| was O | |
| released O | |
| using O | |
| the O | |
| finger O | |
| by O | |
| the O | |
| same O | |
| incision O | |
| . O | |
| both O | |
| recurrent O | |
| laryngeal O | |
| nerves O | |
| ( O | |
| RLN O | |
| ) O | |
| were O | |
| not O | |
| identified O | |
| because O | |
| of O | |
| the O | |
| hemorrhage B-ety | |
| . O | |
| one O | |
| parathyroid O | |
| gland O | |
| was O | |
| accidently O | |
| devascularized O | |
| and O | |
| was O | |
| autotransplanted O | |
| to O | |
| the O | |
| ipsilateral O | |
| sternocleidomastoid O | |
| muscle O | |
| . O | |
| the O | |
| operation O | |
| was O | |
| finished O | |
| by O | |
| double O | |
| aspiration O | |
| drainage O | |
| . O | |
| in O | |
| the O | |
| first O | |
| hours O | |
| after O | |
| surgery O | |
| , O | |
| the O | |
| patient O | |
| developed O | |
| a O | |
| large O | |
| cervical O | |
| hematoma B-ety | |
| . O | |
| she O | |
| was O | |
| readmitted O | |
| to O | |
| the O | |
| operating O | |
| room O | |
| , O | |
| and O | |
| after O | |
| evacuation O | |
| of O | |
| the O | |
| hematoma B-ety | |
| there O | |
| was O | |
| no O | |
| vessels O | |
| bleeding B-ety | |
| . O | |
| the O | |
| operation O | |
| was O | |
| completed O | |
| with O | |
| a O | |
| double O | |
| suction O | |
| drainage O | |
| . O | |
| in O | |
| the O | |
| immediate O | |
| postoperative O | |
| period O | |
| , O | |
| the O | |
| patient O | |
| developed O | |
| hemodynamic B-ety | |
| collapse I-ety | |
| requiring O | |
| the O | |
| introduction O | |
| of O | |
| dobutamine O | |
| . O | |
| after O | |
| 48 O | |
| hours O | |
| of O | |
| hemodynamic O | |
| support O | |
| , O | |
| the O | |
| blood O | |
| pressure O | |
| stabilized O | |
| and O | |
| dobutamine O | |
| was O | |
| stopped O | |
| . O | |
| histological O | |
| study O | |
| concluded O | |
| in O | |
| multinodular B-ety | |
| colloid I-ety | |
| goiter I-ety | |
| . O | |
| the O | |
| patient O | |
| was O | |
| discharged O | |
| from O | |
| the O | |
| hospital O | |
| after O | |
| 20 O | |
| days O | |
| in O | |
| good O | |
| health O | |
| . O | |
| A O | |
| 29 O | |
| - O | |
| year-old O | |
| man O | |
| was O | |
| admitted O | |
| to O | |
| our O | |
| hospital O | |
| with O | |
| an O | |
| unidentified O | |
| fever B-ety | |
| . O | |
| he O | |
| was O | |
| diagnosed O | |
| with O | |
| malignant B-ety | |
| lymphoma I-ety | |
| ( O | |
| extra-nodal B-ety | |
| NK I-ety | |
| / I-ety | |
| T I-ety | |
| cell I-ety | |
| lymphoma I-ety | |
| nasal I-ety | |
| type I-ety | |
| ) I-ety | |
| , O | |
| and O | |
| chemotherapy O | |
| was O | |
| administered O | |
| . O | |
| after O | |
| chemotherapy O | |
| , O | |
| nodular O | |
| lung B-ety | |
| shadows I-ety | |
| along O | |
| with O | |
| new O | |
| brain B-ety | |
| , I-ety | |
| cervical I-ety | |
| , I-ety | |
| and I-ety | |
| myocardial I-ety | |
| abscesses I-ety | |
| appeared O | |
| , O | |
| despite O | |
| anti-bacterial O | |
| / O | |
| fungal O | |
| therapy O | |
| . O | |
| gene O | |
| analysis O | |
| of O | |
| the O | |
| cervical O | |
| abscess O | |
| biopsy O | |
| revealed O | |
| the O | |
| presence O | |
| of O | |
| aspergillus B-ety | |
| fumigatus I-ety | |
| species O | |
| , O | |
| and O | |
| the O | |
| transesophageal O | |
| echocardiogram O | |
| showed O | |
| a O | |
| mobile O | |
| mural O | |
| vegetation B-ety | |
| in O | |
| the O | |
| left O | |
| ventricle O | |
| ( O | |
| 22 O | |
| × O | |
| 8 O | |
| mm O | |
| ) O | |
| . O | |
| he O | |
| underwent O | |
| surgical O | |
| resection O | |
| of O | |
| this O | |
| mural O | |
| vegetation B-ety | |
| . O | |
| his O | |
| postoperative O | |
| course O | |
| was O | |
| uneventful O | |
| . O | |
| he O | |
| remains O | |
| healthy O | |
| at O | |
| 28 O | |
| months O | |
| after O | |
| surgery O | |
| with O | |
| continued O | |
| oral O | |
| antifungal O | |
| therapy O | |
| . O | |
| we O | |
| present O | |
| here O | |
| a O | |
| case O | |
| of O | |
| macrophage B-ety | |
| activation I-ety | |
| syndrome I-ety | |
| associated O | |
| with O | |
| griscelli B-ety | |
| syndrome I-ety | |
| type I-ety | |
| 2 I-ety | |
| in O | |
| a O | |
| 3 O | |
| - O | |
| years-old O | |
| male O | |
| born O | |
| of O | |
| consanguineous O | |
| parentage O | |
| . O | |
| his O | |
| birth O | |
| histories O | |
| , O | |
| his O | |
| familie O | |
| social O | |
| history O | |
| and O | |
| developmental O | |
| milestones O | |
| were O | |
| unremarkable O | |
| . O | |
| he O | |
| was O | |
| born O | |
| at O | |
| full O | |
| term O | |
| with O | |
| no O | |
| antenatal O | |
| or O | |
| perinatal B-ety | |
| complications I-ety | |
| , O | |
| he O | |
| was O | |
| on O | |
| exclusively O | |
| breast-fed O | |
| , O | |
| food O | |
| diversification O | |
| was O | |
| started O | |
| at O | |
| 6 O | |
| months O | |
| old O | |
| , O | |
| his O | |
| weight O | |
| , O | |
| length O | |
| and O | |
| psychomotor O | |
| development O | |
| were O | |
| within O | |
| the O | |
| normal O | |
| range O | |
| , O | |
| the O | |
| child O | |
| was O | |
| described O | |
| as O | |
| a O | |
| good O | |
| eater O | |
| , O | |
| was O | |
| on O | |
| a O | |
| normal O | |
| diet O | |
| and O | |
| was O | |
| thriving O | |
| appropriately O | |
| . O | |
| furthermore O | |
| the O | |
| boy O | |
| presented O | |
| a O | |
| progressive O | |
| abdominal B-ety | |
| distension I-ety | |
| since O | |
| birth O | |
| , O | |
| progressive O | |
| pallor B-ety | |
| and O | |
| recurrent O | |
| episodes O | |
| of O | |
| fever B-ety | |
| since O | |
| 1 O | |
| year O | |
| of O | |
| age O | |
| . O | |
| there O | |
| was O | |
| history O | |
| of O | |
| blood O | |
| transfusions O | |
| for O | |
| last O | |
| 2 O | |
| months O | |
| . O | |
| on O | |
| the O | |
| other O | |
| side O | |
| there O | |
| was O | |
| no O | |
| history O | |
| of O | |
| jaundice B-ety | |
| , O | |
| vomiting B-ety | |
| , O | |
| urinary O | |
| or O | |
| bowel B-ety | |
| complaints I-ety | |
| , O | |
| bleeding B-ety | |
| from O | |
| any O | |
| site O | |
| or O | |
| neurological O | |
| complaints O | |
| . O | |
| on O | |
| admission O | |
| , O | |
| he O | |
| was O | |
| very O | |
| pale O | |
| with O | |
| silvery O | |
| gray O | |
| scalp O | |
| hair O | |
| , O | |
| white B-ety | |
| eyelashes I-ety | |
| , O | |
| he O | |
| was O | |
| hypotonic B-ety | |
| , O | |
| tachycardic B-ety | |
| , O | |
| fever B-ety | |
| of O | |
| 40 O | |
| ° O | |
| C O | |
| , O | |
| lymphoadenopathy B-ety | |
| and O | |
| hepato-splenomegaly B-ety | |
| . O | |
| the O | |
| blood O | |
| count O | |
| showed O | |
| pancytopenia B-ety | |
| ; O | |
| 1980 O | |
| white O | |
| blood O | |
| cells O | |
| / O | |
| µl O | |
| ( O | |
| VN O | |
| 4000 O | |
| - O | |
| 13 O | |
| 500 O | |
| / O | |
| µl O | |
| ) O | |
| , O | |
| neutrophils O | |
| 820 O | |
| / O | |
| µl O | |
| , O | |
| 910 O | |
| cells O | |
| / O | |
| µl O | |
| , O | |
| hemoglobin O | |
| ( O | |
| hb O | |
| ) O | |
| 6.3 O | |
| g O | |
| / O | |
| dl O | |
| ( O | |
| 11.5 O | |
| - O | |
| 14 O | |
| VN O | |
| , O | |
| 5 O | |
| g O | |
| / O | |
| dl O | |
| ) O | |
| , O | |
| platelets O | |
| 44 O | |
| 000 O | |
| / O | |
| µl O | |
| ( O | |
| VN O | |
| 150 O | |
| 000 O | |
| - O | |
| 400 O | |
| 000 O | |
| / O | |
| µl O | |
| ) O | |
| , O | |
| there O | |
| were O | |
| no O | |
| giant O | |
| cytoplasmic B-ety | |
| granules I-ety | |
| in O | |
| leucocytes O | |
| . O | |
| the O | |
| liver O | |
| function O | |
| tests O | |
| were O | |
| normal O | |
| expect O | |
| low B-ety | |
| albumin I-ety | |
| ( O | |
| 2.1 O | |
| mg O | |
| / O | |
| dl O | |
| ) O | |
| and O | |
| increased B-ety | |
| alkaline I-ety | |
| phosphatase I-ety | |
| ( O | |
| 1196 O | |
| mg O | |
| / O | |
| dl O | |
| ) O | |
| with O | |
| low B-ety | |
| fibrinogen I-ety | |
| ( O | |
| 1.7g O | |
| / O | |
| l O | |
| ) O | |
| . O | |
| serum O | |
| triglycerides O | |
| , O | |
| ferrintin O | |
| and O | |
| lactic O | |
| dehydrogenase O | |
| were O | |
| very O | |
| high O | |
| ; O | |
| respectively O | |
| 4.75g O | |
| / O | |
| L O | |
| ; O | |
| 2763µg O | |
| / O | |
| L O | |
| and O | |
| 597U O | |
| / O | |
| L O | |
| . O | |
| the O | |
| C O | |
| reactive O | |
| protein O | |
| ( O | |
| CRP O | |
| ) O | |
| was O | |
| elevated O | |
| at O | |
| 83mg O | |
| / O | |
| l O | |
| . O | |
| A O | |
| chest O | |
| x-ray O | |
| was O | |
| normal O | |
| while O | |
| the O | |
| abdominal O | |
| ultrasound O | |
| showed O | |
| a O | |
| hepatomegaly B-ety | |
| and O | |
| a O | |
| splenomegaly B-ety | |
| , O | |
| free O | |
| biliary O | |
| ducts O | |
| without O | |
| ascites B-ety | |
| . O | |
| because O | |
| of O | |
| hepato-splenomegaly B-ety | |
| , O | |
| pancytopenia B-ety | |
| , O | |
| hyperferritinemia B-ety | |
| and O | |
| hypofibrinogenemia B-ety | |
| the O | |
| diagnosis O | |
| of O | |
| macrophage B-ety | |
| activation I-ety | |
| syndrome I-ety | |
| was O | |
| evoked O | |
| indicating O | |
| a O | |
| bone O | |
| marrow O | |
| aspiration O | |
| that O | |
| showed O | |
| numerous O | |
| morphologically O | |
| benign O | |
| macrophages O | |
| with O | |
| haemophagocytic O | |
| activity O | |
| that O | |
| comforting O | |
| the O | |
| diagnosis O | |
| of O | |
| a O | |
| SAM B-ety | |
| according O | |
| to O | |
| ravelli O | |
| and O | |
| HLH O | |
| - O | |
| 2004 O | |
| criteria O | |
| . O | |
| blood O | |
| culture O | |
| , O | |
| urine O | |
| examination O | |
| , O | |
| malarial O | |
| serology O | |
| , O | |
| kala O | |
| azar O | |
| serology O | |
| , O | |
| viral O | |
| serologies O | |
| such O | |
| as O | |
| EBV O | |
| , O | |
| hepatitis O | |
| A O | |
| , O | |
| B O | |
| , O | |
| C O | |
| and O | |
| human O | |
| immunodeficiency O | |
| virus O | |
| HIV O | |
| , O | |
| serologies O | |
| of O | |
| rickettsia O | |
| , O | |
| syphilis O | |
| and O | |
| toxoplasmosa O | |
| were O | |
| negatives O | |
| . O | |
| serologies O | |
| of O | |
| CMV O | |
| and O | |
| rubella O | |
| showed O | |
| an O | |
| old O | |
| immunization O | |
| . O | |
| the O | |
| immunological O | |
| tests O | |
| such O | |
| as O | |
| antinuclear O | |
| antibodies O | |
| ( O | |
| ANA O | |
| ) O | |
| , O | |
| anti-lkm1 O | |
| , O | |
| anti-mitochondria O | |
| and O | |
| anti-smooth O | |
| muscle O | |
| antibodies O | |
| were O | |
| negatives O | |
| . O | |
| because O | |
| of O | |
| the O | |
| consanguineous O | |
| family O | |
| , O | |
| notion O | |
| of O | |
| recurrent B-ety | |
| infection I-ety | |
| and O | |
| the O | |
| presence O | |
| of O | |
| silvery-gray O | |
| color O | |
| of O | |
| the O | |
| hair O | |
| and O | |
| eyebrows O | |
| , O | |
| diagnosis O | |
| of O | |
| griscelli B-ety | |
| syndrome I-ety | |
| was O | |
| evoked O | |
| directing O | |
| a O | |
| light O | |
| microscopy O | |
| examination O | |
| of O | |
| the O | |
| hair O | |
| that O | |
| showed O | |
| a O | |
| large O | |
| , O | |
| irregular O | |
| clumps O | |
| of O | |
| pigments O | |
| characteristic O | |
| of O | |
| griscelli B-ety | |
| syndrome I-ety | |
| . O | |
| the O | |
| molecular O | |
| biology O | |
| showed O | |
| mutation O | |
| in O | |
| RAB27A O | |
| gene O | |
| confirming O | |
| the O | |
| diagnosis O | |
| of O | |
| a O | |
| griscelli B-ety | |
| syndrome I-ety | |
| type I-ety | |
| 2 I-ety | |
| . O | |
| the O | |
| first-line O | |
| therapy O | |
| in O | |
| management O | |
| of O | |
| macrophage B-ety | |
| activation I-ety | |
| syndrome I-ety | |
| complicating O | |
| griscelli B-ety | |
| syndrome I-ety | |
| type I-ety | |
| 2 I-ety | |
| was O | |
| based O | |
| on O | |
| the O | |
| parenteral O | |
| administration O | |
| of O | |
| high O | |
| doses O | |
| of O | |
| corticosteroids O | |
| ( O | |
| methylprednisolone O | |
| pulses O | |
| 1g O | |
| / O | |
| 0.73m O | |
| 2 O | |
| / O | |
| day O | |
| for O | |
| 3 O | |
| days O | |
| then O | |
| 60mg O | |
| / O | |
| m O | |
| 2 O | |
| ) O | |
| with O | |
| poor O | |
| response O | |
| ; O | |
| persisting O | |
| with O | |
| involvement O | |
| of O | |
| the O | |
| 3 O | |
| cell O | |
| lines O | |
| in O | |
| the O | |
| blood O | |
| count O | |
| , O | |
| elevated O | |
| ferritin O | |
| and O | |
| triglycerides O | |
| . O | |
| given O | |
| the O | |
| lack O | |
| of O | |
| response O | |
| to O | |
| steroids O | |
| , O | |
| etoposide O | |
| was O | |
| started O | |
| for O | |
| 3 O | |
| days O | |
| associated O | |
| with O | |
| cyclophosphamide O | |
| , O | |
| the O | |
| evolution O | |
| was O | |
| good O | |
| with O | |
| improvement O | |
| of O | |
| count O | |
| blood O | |
| cells O | |
| , O | |
| ferritin O | |
| was O | |
| lessening O | |
| while O | |
| the O | |
| bone O | |
| marrow O | |
| showed O | |
| decreased O | |
| numerous O | |
| of O | |
| macrophages O | |
| with O | |
| low O | |
| haemophagocytic O | |
| activity O | |
| . O | |
| on O | |
| the O | |
| other O | |
| side O | |
| the O | |
| infectious O | |
| process O | |
| was O | |
| good O | |
| managed O | |
| by O | |
| perfusion O | |
| of O | |
| antibiotics O | |
| such O | |
| as O | |
| ceftazidim O | |
| in O | |
| combination O | |
| with O | |
| aminoside O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| sent O | |
| home O | |
| with O | |
| prednisone O | |
| and O | |
| cyclosporine O | |
| , O | |
| he O | |
| was O | |
| placed O | |
| on O | |
| the O | |
| list O | |
| of O | |
| bone O | |
| marrow O | |
| transplantation O | |
| ( O | |
| BMT O | |
| ) O | |
| . O | |
| this O | |
| is O | |
| a O | |
| case O | |
| report O | |
| of O | |
| a O | |
| 59 O | |
| - O | |
| year O | |
| old O | |
| woman O | |
| with O | |
| a O | |
| 5 O | |
| - O | |
| year O | |
| clinical O | |
| history O | |
| of O | |
| perimenopausal B-ety | |
| uterine I-ety | |
| bleeding I-ety | |
| and O | |
| three O | |
| explorative O | |
| curettages O | |
| . O | |
| gynaecological O | |
| and O | |
| ultrasound O | |
| examinations O | |
| revealed O | |
| ovarian B-ety | |
| enlargement I-ety | |
| with O | |
| a O | |
| diameter O | |
| of O | |
| 50 O | |
| mm O | |
| with O | |
| hypoechoic O | |
| zones O | |
| suspected O | |
| of O | |
| benign B-ety | |
| teratoma I-ety | |
| . O | |
| the O | |
| diagnostic O | |
| test O | |
| such O | |
| as O | |
| ca O | |
| - O | |
| 125 O | |
| , O | |
| AFP O | |
| , O | |
| free-t4 O | |
| and O | |
| TSH O | |
| was O | |
| in O | |
| normal O | |
| range O | |
| . O | |
| A O | |
| smooth O | |
| , O | |
| solid O | |
| right O | |
| ovarian O | |
| 50 O | |
| an O | |
| mm-size O | |
| tumour B-ety | |
| , O | |
| as O | |
| well O | |
| as O | |
| small O | |
| amount O | |
| of O | |
| fluid O | |
| in O | |
| the O | |
| douglas O | |
| pouch O | |
| , O | |
| was O | |
| found O | |
| during O | |
| the O | |
| total O | |
| abdominal O | |
| hysterectomy O | |
| , O | |
| bilateral O | |
| salpingo-oophorectomy O | |
| and O | |
| staging O | |
| biopsy O | |
| . O | |
| the O | |
| histopathology O | |
| revealed O | |
| teratoma B-ety | |
| with O | |
| strumal B-ety | |
| carcinoid I-ety | |
| tumour I-ety | |
| IA O | |
| stage O | |
| according O | |
| to O | |
| AJCC O | |
| 2010 O | |
| of O | |
| the O | |
| right O | |
| ovary O | |
| and O | |
| negative O | |
| cytopathology O | |
| of O | |
| the O | |
| fluid O | |
| from O | |
| the O | |
| douglas O | |
| pouch O | |
| . O | |
| on O | |
| the O | |
| postoperative O | |
| 2 O | |
| - O | |
| year O | |
| control O | |
| , O | |
| the O | |
| patient O | |
| was O | |
| tumour O | |
| free O | |
| , O | |
| and O | |
| ca O | |
| - O | |
| 125 O | |
| , O | |
| free-t4 O | |
| and O | |
| TSH O | |
| were O | |
| in O | |
| normal O | |
| range O | |
| . O | |
| A O | |
| 45 O | |
| year O | |
| old O | |
| female O | |
| with O | |
| history O | |
| of O | |
| sickle B-ety | |
| cell I-ety | |
| disease I-ety | |
| presented O | |
| with O | |
| abdominal B-ety | |
| pain I-ety | |
| . O | |
| A O | |
| CT O | |
| scan O | |
| revealed O | |
| an O | |
| exophytic O | |
| renal B-ety | |
| mass I-ety | |
| measuring O | |
| 2.9cm O | |
| x O | |
| 2.0cm O | |
| x O | |
| 2.1cm O | |
| located O | |
| on O | |
| the O | |
| antero-lateral O | |
| aspect O | |
| of O | |
| her O | |
| right O | |
| kidney O | |
| and O | |
| an O | |
| unremarkable O | |
| spleen O | |
| . O | |
| she O | |
| was O | |
| evaluated O | |
| by O | |
| urology O | |
| and O | |
| a O | |
| right O | |
| partial O | |
| nephrectomy O | |
| was O | |
| planned O | |
| , O | |
| however O | |
| on O | |
| the O | |
| day O | |
| of O | |
| the O | |
| procedure O | |
| , O | |
| the O | |
| patient's O | |
| preoperative O | |
| pregnancy O | |
| test O | |
| was O | |
| positive O | |
| . O | |
| the O | |
| procedure O | |
| was O | |
| post O | |
| postponed O | |
| until O | |
| after O | |
| she O | |
| delivered O | |
| and O | |
| interval O | |
| ultrasounds O | |
| were O | |
| obtained O | |
| throughout O | |
| her O | |
| pregnancy O | |
| to O | |
| monitor O | |
| the O | |
| renal O | |
| mass O | |
| . O | |
| the O | |
| lesion B-ety | |
| increased O | |
| minimally O | |
| in O | |
| size O | |
| . O | |
| two O | |
| months O | |
| after O | |
| caesarian O | |
| section O | |
| delivery O | |
| , O | |
| patient O | |
| underwent O | |
| an O | |
| unremarkable O | |
| right O | |
| laparoscopic O | |
| partial O | |
| nephrectomy O | |
| with O | |
| individual O | |
| artery B-ety | |
| and I-ety | |
| vein I-ety | |
| vascular I-ety | |
| occlusion I-ety | |
| at O | |
| the O | |
| level O | |
| of O | |
| the O | |
| renal O | |
| hilum O | |
| . O | |
| A O | |
| superficial O | |
| liver B-ety | |
| laceration I-ety | |
| caused O | |
| by O | |
| the O | |
| veress O | |
| needle O | |
| was O | |
| noted O | |
| at O | |
| the O | |
| beginning O | |
| of O | |
| the O | |
| procedure O | |
| and O | |
| effectively O | |
| managed O | |
| using O | |
| bipolar O | |
| cautery O | |
| . O | |
| the O | |
| patient's O | |
| post-operative O | |
| course O | |
| was O | |
| notable O | |
| for O | |
| marked O | |
| thrombocytosis B-ety | |
| with O | |
| her O | |
| platelet O | |
| count O | |
| increasing O | |
| for O | |
| her O | |
| baseline O | |
| of O | |
| 300,000 O | |
| to O | |
| a O | |
| zenith O | |
| of O | |
| 1.3 O | |
| million O | |
| . O | |
| she O | |
| was O | |
| started O | |
| on O | |
| aspirin O | |
| therapy O | |
| and O | |
| splenomegaly B-ety | |
| was O | |
| noted O | |
| on O | |
| abdomen O | |
| ultrasound O | |
| . O | |
| her O | |
| platelet O | |
| count O | |
| normalized O | |
| to O | |
| 334,000 O | |
| . O | |
| on O | |
| pathology O | |
| , O | |
| the O | |
| renal O | |
| mass O | |
| was O | |
| classified O | |
| as O | |
| a O | |
| papillary B-ety | |
| renal I-ety | |
| neoplasm I-ety | |
| consistent O | |
| with O | |
| a O | |
| translocation O | |
| carcinoma B-ety | |
| . O | |
| there O | |
| was O | |
| no O | |
| splenic O | |
| tissue O | |
| in O | |
| the O | |
| specimen O | |
| . O | |
| it O | |
| was O | |
| noted O | |
| that O | |
| the O | |
| complete O | |
| lack O | |
| of O | |
| staining O | |
| of O | |
| any O | |
| keratins O | |
| or O | |
| epithelial O | |
| membrane O | |
| antigens O | |
| was O | |
| not O | |
| consistent O | |
| with O | |
| a O | |
| usual O | |
| renal B-ety | |
| cell I-ety | |
| carcinoma I-ety | |
| and O | |
| hence O | |
| the O | |
| diagnosis O | |
| of O | |
| a O | |
| translocation O | |
| tumor B-ety | |
| was O | |
| made O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| lost O | |
| to O | |
| follow O | |
| up O | |
| presenting O | |
| 2 O | |
| years O | |
| later O | |
| and O | |
| a O | |
| follow-up O | |
| CT O | |
| scan O | |
| noted O | |
| marked O | |
| splenic B-ety | |
| atrophy I-ety | |
| with O | |
| several O | |
| splenules O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| completely O | |
| asymptomatic O | |
| and O | |
| at O | |
| the O | |
| time O | |
| received O | |
| all O | |
| the O | |
| post-splenectomy O | |
| vaccination O | |
| and O | |
| her O | |
| platelet O | |
| count O | |
| remained O | |
| within O | |
| normal O | |
| limits O | |
| . O | |
| A O | |
| 3 O | |
| years O | |
| old O | |
| boy O | |
| without O | |
| any O | |
| particular O | |
| diseases O | |
| history O | |
| , O | |
| admitted O | |
| to O | |
| the O | |
| emergency O | |
| room O | |
| for O | |
| a O | |
| bipolar O | |
| trauma B-ety | |
| with O | |
| a O | |
| left O | |
| hemicorporal O | |
| point O | |
| of O | |
| impact O | |
| following O | |
| a O | |
| domestic O | |
| accident O | |
| . O | |
| the O | |
| delay O | |
| to O | |
| consult O | |
| was O | |
| 5 O | |
| hours O | |
| after O | |
| the O | |
| incident O | |
| . O | |
| the O | |
| clinical O | |
| examination O | |
| at O | |
| admission O | |
| had O | |
| showed O | |
| a O | |
| deformed O | |
| left O | |
| superior O | |
| member O | |
| , O | |
| painful B-ety | |
| on O | |
| palpation O | |
| with O | |
| the O | |
| presence O | |
| of O | |
| the O | |
| humeral O | |
| pulse O | |
| and O | |
| a O | |
| right O | |
| inferior O | |
| member O | |
| shortened O | |
| and O | |
| flexed O | |
| , O | |
| the O | |
| thigh O | |
| slightly O | |
| in O | |
| adduction O | |
| , O | |
| internal O | |
| rotation O | |
| with O | |
| the O | |
| member O | |
| . O | |
| A O | |
| radiological O | |
| assessment O | |
| was O | |
| performed O | |
| immediately O | |
| ; O | |
| including O | |
| a O | |
| standard O | |
| x-ray O | |
| of O | |
| the O | |
| pelvis O | |
| which O | |
| showed O | |
| a O | |
| dislocated B-ety | |
| head I-ety | |
| of I-ety | |
| the I-ety | |
| right I-ety | |
| femur I-ety | |
| , O | |
| completed O | |
| secondarily O | |
| by O | |
| a O | |
| CT O | |
| scan O | |
| of O | |
| the O | |
| hip O | |
| confirming O | |
| the O | |
| posterior O | |
| type O | |
| of O | |
| the O | |
| dislocation O | |
| isolated O | |
| from O | |
| any O | |
| fractures B-ety | |
| of I-ety | |
| the I-ety | |
| head I-ety | |
| of I-ety | |
| the I-ety | |
| femur I-ety | |
| . O | |
| the O | |
| standard O | |
| radiography O | |
| of O | |
| the O | |
| left O | |
| shoulder O | |
| showed O | |
| a O | |
| salter O | |
| I O | |
| epiphyseal O | |
| separation O | |
| of O | |
| the O | |
| humerus O | |
| . O | |
| after O | |
| one O | |
| hour O | |
| , O | |
| we O | |
| performed O | |
| an O | |
| orthopedic O | |
| reduction O | |
| of O | |
| the O | |
| dislocated O | |
| hip O | |
| monitored O | |
| under O | |
| scope O | |
| , O | |
| with O | |
| placement O | |
| of O | |
| a O | |
| pelvic O | |
| splint O | |
| for O | |
| an O | |
| analgesic O | |
| aim O | |
| to O | |
| be O | |
| kept O | |
| during O | |
| three O | |
| weeks O | |
| . O | |
| the O | |
| radiological O | |
| results O | |
| were O | |
| satisfactory O | |
| with O | |
| a O | |
| restored O | |
| bilateral O | |
| symmetry O | |
| of O | |
| the O | |
| articular O | |
| anatomy O | |
| . O | |
| the O | |
| salter O | |
| I O | |
| detachment O | |
| of O | |
| the O | |
| humerus O | |
| was O | |
| orthopedically O | |
| reduced O | |
| then O | |
| immobilized O | |
| by O | |
| a O | |
| thoracoabdominal O | |
| plaster O | |
| be O | |
| kept O | |
| during O | |
| a O | |
| month O | |
| . O | |
| the O | |
| child O | |
| has O | |
| been O | |
| discharged O | |
| the O | |
| next O | |
| day O | |
| . O | |
| revised O | |
| after O | |
| a O | |
| month O | |
| , O | |
| showed O | |
| a O | |
| stable O | |
| left O | |
| hip O | |
| on O | |
| the O | |
| clinical O | |
| examination O | |
| . O | |
| in O | |
| the O | |
| decline O | |
| of O | |
| 2 O | |
| years O | |
| , O | |
| we O | |
| haven't O | |
| noticed O | |
| any O | |
| recidivism O | |
| and O | |
| the O | |
| functional O | |
| results O | |
| were O | |
| good O | |
| ; O | |
| on O | |
| the O | |
| radiography O | |
| we O | |
| do O | |
| not O | |
| have O | |
| any O | |
| signs O | |
| of O | |
| avascular B-ety | |
| necrosis I-ety | |
| no O | |
| changes O | |
| of O | |
| the O | |
| head O | |
| of O | |
| femur O | |
| , O | |
| of O | |
| the O | |
| acetabulum O | |
| or O | |
| the O | |
| joint O | |
| space O | |
| . O | |
| we O | |
| received O | |
| a O | |
| boy O | |
| 3 O | |
| - O | |
| year-old O | |
| boy O | |
| with O | |
| autistic B-ety | |
| disorder I-ety | |
| on O | |
| hospital O | |
| of O | |
| pediatric O | |
| ward O | |
| A O | |
| at O | |
| university O | |
| hospital O | |
| mohammed O | |
| VI O | |
| of O | |
| marrakesh O | |
| . O | |
| he O | |
| has O | |
| no O | |
| family O | |
| history O | |
| of O | |
| illness B-ety | |
| or O | |
| autistic O | |
| spectrum O | |
| disorder O | |
| . O | |
| the O | |
| history O | |
| revealed O | |
| that O | |
| at O | |
| 2 O | |
| years O | |
| of O | |
| age O | |
| . O | |
| the O | |
| child O | |
| was O | |
| diagnosed O | |
| with O | |
| a O | |
| ‘ O | |
| ‘ O | |
| severe O | |
| communication B-ety | |
| disorder I-ety | |
| , O | |
| ' O | |
| ' O | |
| with O | |
| social B-ety | |
| interaction I-ety | |
| difficulties I-ety | |
| and O | |
| sensory O | |
| processing O | |
| delay O | |
| . O | |
| A O | |
| composite O | |
| follow-up O | |
| of O | |
| all O | |
| previous O | |
| assessments O | |
| and O | |
| investigations O | |
| was O | |
| undertaken O | |
| . O | |
| blood O | |
| work O | |
| was O | |
| normal O | |
| ( O | |
| thyroid-stimulating O | |
| hormone O | |
| ( O | |
| TSH O | |
| ) O | |
| , O | |
| hemoglobin O | |
| , O | |
| mean O | |
| corpuscular O | |
| volume O | |
| ( O | |
| MCV O | |
| ) O | |
| , O | |
| and O | |
| ferritin O | |
| ) O | |
| . O | |
| genetic O | |
| testing O | |
| was O | |
| unremarkable O | |
| ( O | |
| normal O | |
| karyotype O | |
| , O | |
| negative O | |
| for O | |
| fragile O | |
| X O | |
| ) O | |
| and O | |
| the O | |
| magnetic O | |
| resonance O | |
| imaging O | |
| ( O | |
| MRI O | |
| ) O | |
| in O | |
| search O | |
| of O | |
| a O | |
| demyelinating O | |
| attack O | |
| of O | |
| the O | |
| white O | |
| matter O | |
| , O | |
| electroencephalography O | |
| ( O | |
| EEG O | |
| ) O | |
| , O | |
| optometry O | |
| assessment O | |
| were O | |
| also O | |
| normal O | |
| . O | |
| at O | |
| the O | |
| conclusion O | |
| of O | |
| this O | |
| composite O | |
| assessment O | |
| , O | |
| the O | |
| boy O | |
| was O | |
| given O | |
| a O | |
| primary O | |
| diagnosis O | |
| of O | |
| autistic B-ety | |
| spectrum I-ety | |
| disorder I-ety | |
| . O | |
| A O | |
| plan O | |
| was O | |
| instituted O | |
| including O | |
| speech-language O | |
| therapy O | |
| , O | |
| intensive O | |
| individualized O | |
| educational O | |
| programming O | |
| , O | |
| and O | |
| contact O | |
| was O | |
| encouraged O | |
| with O | |
| the O | |
| autism O | |
| society O | |
| . O | |
| for O | |
| that O | |
| purpose O | |
| , O | |
| the O | |
| parents O | |
| moved O | |
| to O | |
| morocco O | |
| to O | |
| be O | |
| surrounded O | |
| by O | |
| family O | |
| without O | |
| any O | |
| huge O | |
| improvement O | |
| . O | |
| upon O | |
| direct O | |
| questioning O | |
| at O | |
| initial O | |
| presentation O | |
| , O | |
| the O | |
| 3 O | |
| - O | |
| year-old O | |
| child O | |
| was O | |
| reported O | |
| by O | |
| the O | |
| parents O | |
| to O | |
| have O | |
| unexplained O | |
| fatigue B-ety | |
| , O | |
| gastrointestinal B-ety | |
| symptoms I-ety | |
| included O | |
| bloating B-ety | |
| , O | |
| constipation B-ety | |
| and O | |
| diarrhea B-ety | |
| . O | |
| psychiatric O | |
| symptoms O | |
| included O | |
| a O | |
| frequently O | |
| depressed B-ety | |
| mood I-ety | |
| , O | |
| disproportionate O | |
| anger O | |
| , O | |
| and O | |
| emotional B-ety | |
| lability I-ety | |
| . O | |
| on O | |
| exploring O | |
| his O | |
| history O | |
| , O | |
| the O | |
| child O | |
| was O | |
| born O | |
| from O | |
| yemenite O | |
| father O | |
| and O | |
| moroccan O | |
| mother O | |
| in O | |
| germany O | |
| at-term O | |
| weighing O | |
| 3500 O | |
| g O | |
| with O | |
| an O | |
| apgar O | |
| score O | |
| of O | |
| 9 O | |
| at O | |
| 1 O | |
| minute O | |
| and O | |
| 10 O | |
| at O | |
| 5 O | |
| minutes O | |
| after O | |
| an O | |
| uneventful O | |
| pregnancy O | |
| and O | |
| delivery O | |
| . O | |
| no O | |
| concerns O | |
| were O | |
| present O | |
| in O | |
| the O | |
| neonatal O | |
| period O | |
| . O | |
| development O | |
| in O | |
| the O | |
| first O | |
| 24 O | |
| months O | |
| of O | |
| life O | |
| appeared O | |
| fine O | |
| according O | |
| to O | |
| the O | |
| parents-his O | |
| motor O | |
| skills O | |
| seemed O | |
| to O | |
| progress O | |
| normally O | |
| and O | |
| he O | |
| achieved O | |
| expected O | |
| milestones O | |
| . O | |
| after O | |
| 2 O | |
| years O | |
| of O | |
| age O | |
| , O | |
| however O | |
| , O | |
| his O | |
| language O | |
| skills O | |
| slowly O | |
| began O | |
| to O | |
| regress O | |
| . O | |
| he O | |
| also O | |
| demonstrated O | |
| a O | |
| change O | |
| in O | |
| temperament O | |
| as O | |
| he O | |
| started O | |
| to O | |
| whine O | |
| repeatedly O | |
| and O | |
| to O | |
| scream O | |
| without O | |
| provocation O | |
| . O | |
| physical O | |
| examination O | |
| revealed O | |
| a O | |
| height O | |
| and O | |
| weight O | |
| normal O | |
| for O | |
| age O | |
| . O | |
| he O | |
| was O | |
| uncommunicative O | |
| , O | |
| restless O | |
| , O | |
| and O | |
| somewhat O | |
| agitated O | |
| . O | |
| general O | |
| examination O | |
| was O | |
| unremarkable O | |
| other O | |
| than O | |
| dark O | |
| rings O | |
| around O | |
| the O | |
| eyes O | |
| . O | |
| there O | |
| were O | |
| no O | |
| dysmorphic O | |
| features O | |
| evident O | |
| . O | |
| he O | |
| had O | |
| difficulty O | |
| maintaining O | |
| eye O | |
| contact O | |
| , O | |
| and O | |
| he O | |
| appeared O | |
| disinterested O | |
| in O | |
| what O | |
| was O | |
| taking O | |
| place O | |
| . O | |
| no O | |
| abnormality O | |
| was O | |
| found O | |
| on O | |
| abdominal O | |
| assessment O | |
| . O | |
| anti-tissue O | |
| transglutaminase O | |
| antibodies O | |
| levels O | |
| were O | |
| 76 O | |
| U O | |
| ( O | |
| normal O | |
| < O | |
| 10 O | |
| ) O | |
| . O | |
| the O | |
| patient O | |
| underwent O | |
| upper O | |
| endoscopy O | |
| as O | |
| duodenal O | |
| biopsy O | |
| to O | |
| confirm O | |
| a O | |
| celiac B-ety | |
| disease I-ety | |
| diagnosis O | |
| . O | |
| it O | |
| shows O | |
| a O | |
| total O | |
| villous B-ety | |
| atrophy I-ety | |
| corresponding O | |
| to O | |
| a O | |
| stage O | |
| 4 O | |
| of O | |
| marsh O | |
| classification O | |
| . O | |
| given O | |
| the O | |
| positive O | |
| screen O | |
| for O | |
| celiac B-ety | |
| disease I-ety | |
| ( O | |
| positive O | |
| anti-tissue O | |
| transglutaminase O | |
| antibodies O | |
| and O | |
| results O | |
| of O | |
| duodenal O | |
| biopsy O | |
| ) O | |
| , O | |
| dietary O | |
| intervention O | |
| was O | |
| immediately O | |
| commenced O | |
| . O | |
| all O | |
| gluten O | |
| was O | |
| eliminated O | |
| from O | |
| the O | |
| boy's O | |
| diet O | |
| . O | |
| within O | |
| 1 O | |
| month O | |
| , O | |
| the O | |
| boy's O | |
| gastrointestinal B-ety | |
| symptoms I-ety | |
| were O | |
| relieved O | |
| and O | |
| his O | |
| behavior O | |
| had O | |
| changed O | |
| . O | |
| the O | |
| mother O | |
| reported O | |
| that O | |
| her O | |
| boy O | |
| became O | |
| progressively O | |
| more O | |
| communicative O | |
| . O | |
| the O | |
| child O | |
| has O | |
| continued O | |
| on O | |
| the O | |
| gluten-free O | |
| diet O | |
| and O | |
| has O | |
| progressed O | |
| well O | |
| and O | |
| remained O | |
| healthy O | |
| over O | |
| the O | |
| following O | |
| 6 O | |
| months O | |
| . O | |
| A O | |
| seventy O | |
| two O | |
| years O | |
| old O | |
| male O | |
| presented O | |
| to O | |
| our O | |
| clinic O | |
| with O | |
| swelling B-ety | |
| , I-ety | |
| pain I-ety | |
| , I-ety | |
| and I-ety | |
| limitation I-ety | |
| of I-ety | |
| movement I-ety | |
| at I-ety | |
| knee I-ety | |
| joint I-ety | |
| . O | |
| the O | |
| patient's O | |
| history O | |
| revealed O | |
| swellings B-ety | |
| and I-ety | |
| pain I-ety | |
| at I-ety | |
| knee I-ety | |
| joint I-ety | |
| for O | |
| nearly O | |
| last O | |
| 20 O | |
| years O | |
| . O | |
| he O | |
| was O | |
| prescribed O | |
| nonsteroidal O | |
| anti-inflammatory O | |
| drugs O | |
| and O | |
| rest O | |
| . O | |
| but O | |
| pain B-ety | |
| didn't O | |
| relieve O | |
| and O | |
| limitations O | |
| in O | |
| range O | |
| of O | |
| motion O | |
| occurred O | |
| at O | |
| knee O | |
| joint O | |
| . O | |
| physical O | |
| examination O | |
| findings O | |
| included O | |
| a O | |
| solid O | |
| and O | |
| semi-mobile O | |
| mass O | |
| at O | |
| anterior O | |
| knee O | |
| region O | |
| . O | |
| knee O | |
| joint O | |
| range O | |
| of O | |
| motion O | |
| was O | |
| 80 O | |
| degrees O | |
| flexion O | |
| and O | |
| 0 O | |
| degrees O | |
| extension O | |
| . O | |
| there O | |
| wasn't O | |
| any O | |
| neurovascular B-ety | |
| pathology I-ety | |
| . O | |
| antero-posterior O | |
| and O | |
| lateral O | |
| knee O | |
| x-rays O | |
| showed O | |
| degenerative B-ety | |
| changes I-ety | |
| and O | |
| a O | |
| giant O | |
| , O | |
| irregular O | |
| , O | |
| calcific O | |
| mass O | |
| which O | |
| started O | |
| below O | |
| patella O | |
| and O | |
| extended O | |
| to O | |
| suprapatellar O | |
| area O | |
| . O | |
| knee O | |
| MRI O | |
| revealed O | |
| many O | |
| loose O | |
| bodies O | |
| ( O | |
| consistent O | |
| with O | |
| synovial B-ety | |
| chondromatosis I-ety | |
| ) O | |
| isointense O | |
| with O | |
| fatty O | |
| bone O | |
| marrow O | |
| at O | |
| all O | |
| sequences O | |
| at O | |
| the O | |
| level O | |
| of O | |
| right O | |
| knee O | |
| joint O | |
| . O | |
| scalloping O | |
| was O | |
| observed O | |
| at O | |
| tibial O | |
| and O | |
| femoral O | |
| surfaces O | |
| . O | |
| decision O | |
| for O | |
| a O | |
| surgical O | |
| intervention O | |
| was O | |
| made O | |
| and O | |
| after O | |
| informing O | |
| the O | |
| patient O | |
| , O | |
| consent O | |
| was O | |
| taken O | |
| . O | |
| under O | |
| spinal O | |
| anesthesia O | |
| , O | |
| a O | |
| tourniquet O | |
| was O | |
| applied O | |
| to O | |
| right O | |
| lower O | |
| extremity O | |
| . O | |
| right O | |
| knee O | |
| was O | |
| entered O | |
| with O | |
| an O | |
| anterior O | |
| longitudinal O | |
| incision O | |
| . O | |
| cutaneous O | |
| and O | |
| subcutaneous O | |
| tissues O | |
| were O | |
| passed O | |
| . O | |
| quadriceps O | |
| mechanism O | |
| was O | |
| opened O | |
| with O | |
| a O | |
| medial O | |
| parapatellar O | |
| incision O | |
| and O | |
| patella O | |
| was O | |
| toppled O | |
| to O | |
| left O | |
| side O | |
| . O | |
| intraarticular O | |
| mass O | |
| was O | |
| exposed O | |
| . O | |
| the O | |
| mass O | |
| was O | |
| released O | |
| from O | |
| surrounding O | |
| tissues O | |
| by O | |
| blunt O | |
| excision O | |
| and O | |
| excised O | |
| with O | |
| enucleation O | |
| . O | |
| then O | |
| synovial O | |
| tissue O | |
| was O | |
| excised O | |
| with O | |
| synoviectomy O | |
| . O | |
| surgical O | |
| area O | |
| was O | |
| irrigated O | |
| using O | |
| abundant O | |
| isotonic O | |
| solution O | |
| . O | |
| the O | |
| excised O | |
| mass O | |
| was O | |
| sent O | |
| to O | |
| pathology O | |
| laboratory O | |
| . O | |
| pathology O | |
| evaluation O | |
| showed O | |
| that O | |
| the O | |
| mass O | |
| was O | |
| consistent O | |
| with O | |
| synovial B-ety | |
| chondromatosis I-ety | |
| . O | |
| active O | |
| and O | |
| passive O | |
| exercises O | |
| were O | |
| started O | |
| at O | |
| an O | |
| early O | |
| period O | |
| after O | |
| surgery O | |
| . O | |
| recurrence O | |
| was O | |
| not O | |
| detected O | |
| at O | |
| his O | |
| last O | |
| control O | |
| visit O | |
| . O | |
| knee O | |
| movements O | |
| were O | |
| at O | |
| full O | |
| range O | |
| when O | |
| compared O | |
| with O | |
| the O | |
| other O | |
| knee O | |
| . O | |
| there O | |
| was O | |
| no O | |
| pain B-ety | |
| or O | |
| other O | |
| complaints O | |
| . O | |
| A O | |
| 35 O | |
| - O | |
| year-old O | |
| mentally O | |
| ill O | |
| man O | |
| was O | |
| transferred O | |
| from O | |
| a O | |
| local O | |
| psychiatric O | |
| hospital O | |
| after O | |
| attempted O | |
| suicide O | |
| by O | |
| fire O | |
| 3 O | |
| days O | |
| before O | |
| admission O | |
| . O | |
| he O | |
| acquired O | |
| full-and O | |
| partial-thickness O | |
| injury O | |
| in O | |
| approximately O | |
| 38% O | |
| of O | |
| his O | |
| TBSA O | |
| , O | |
| including O | |
| face O | |
| and O | |
| neck O | |
| ( O | |
| 5% O | |
| ) O | |
| , O | |
| both O | |
| upper O | |
| extremities O | |
| ( O | |
| 8% O | |
| ) O | |
| , O | |
| right O | |
| thigh O | |
| ( O | |
| 4% O | |
| ) O | |
| , O | |
| left O | |
| thigh O | |
| and O | |
| leg O | |
| ( O | |
| 3% O | |
| ) O | |
| , O | |
| and O | |
| most O | |
| of O | |
| his O | |
| anterior O | |
| and O | |
| posterior O | |
| trunk O | |
| ( O | |
| 16% O | |
| ) O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| hospitalized O | |
| for O | |
| 66 O | |
| days O | |
| and O | |
| underwent O | |
| five O | |
| debridement O | |
| surgeries O | |
| . O | |
| the O | |
| psychiatric O | |
| diagnosis O | |
| was O | |
| schizophrenia B-ety | |
| type O | |
| ICD O | |
| 10 O | |
| F20.3 O | |
| , O | |
| treated O | |
| with O | |
| haloperidol O | |
| 1.5 O | |
| mg O | |
| and O | |
| diazepam O | |
| 5 O | |
| mg O | |
| daily O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| occasionally O | |
| restrained O | |
| due O | |
| to O | |
| rebellious O | |
| and O | |
| self-destruction O | |
| behavior O | |
| . O | |
| the O | |
| nutrition O | |
| management O | |
| of O | |
| this O | |
| patient O | |
| was O | |
| started O | |
| after O | |
| a O | |
| week O | |
| of O | |
| hospitalization O | |
| , O | |
| which O | |
| is O | |
| considered O | |
| late O | |
| . O | |
| in O | |
| the O | |
| initial O | |
| nutrition O | |
| assessment O | |
| , O | |
| the O | |
| patient O | |
| was O | |
| 40 O | |
| kg O | |
| weight O | |
| and O | |
| 150 O | |
| cm O | |
| tall O | |
| thus O | |
| the O | |
| body O | |
| mass O | |
| index O | |
| ( O | |
| BMI O | |
| ) O | |
| was O | |
| 17,57 O | |
| kg O | |
| / O | |
| m O | |
| 2 O | |
| or O | |
| underweight O | |
| . O | |
| gastrointestinal O | |
| symptoms O | |
| and O | |
| signs O | |
| were O | |
| not O | |
| found O | |
| . O | |
| information O | |
| regarding O | |
| the O | |
| patient's O | |
| dietary O | |
| intake O | |
| in O | |
| the O | |
| last O | |
| two O | |
| weeks O | |
| and O | |
| weight O | |
| change O | |
| within O | |
| the O | |
| last O | |
| 6 O | |
| months O | |
| could O | |
| not O | |
| be O | |
| obtained O | |
| , O | |
| but O | |
| his O | |
| mother O | |
| claimed O | |
| that O | |
| the O | |
| patient O | |
| seemed O | |
| to O | |
| lose O | |
| weight O | |
| because O | |
| he O | |
| refused O | |
| any O | |
| food O | |
| that O | |
| had O | |
| been O | |
| offered O | |
| to O | |
| him O | |
| ; O | |
| he O | |
| only O | |
| smoked O | |
| and O | |
| drank O | |
| coffee O | |
| . O | |
| albumin O | |
| level O | |
| was O | |
| 3.6 O | |
| gr O | |
| / O | |
| L O | |
| with O | |
| imbalanced O | |
| electrolyte O | |
| levels O | |
| . O | |
| signs O | |
| of O | |
| fluid B-ety | |
| accumulation I-ety | |
| were O | |
| not O | |
| found O | |
| . O | |
| according O | |
| to O | |
| the O | |
| subjective O | |
| global O | |
| assessment O | |
| ( O | |
| SGA O | |
| ) O | |
| tool O | |
| , O | |
| the O | |
| patient O | |
| belonged O | |
| to O | |
| group O | |
| C O | |
| ( O | |
| severely O | |
| malnourished O | |
| ) O | |
| . O | |
| energy O | |
| and O | |
| protein O | |
| were O | |
| given O | |
| starting O | |
| from O | |
| 30 O | |
| kcal O | |
| / O | |
| kg O | |
| , O | |
| increasing O | |
| gradually O | |
| to O | |
| 50 O | |
| kcal O | |
| / O | |
| kg O | |
| , O | |
| and O | |
| 2 O | |
| gp O | |
| / O | |
| kg O | |
| divided O | |
| into O | |
| oral O | |
| nutrition O | |
| and O | |
| oral O | |
| nutrition O | |
| supplements O | |
| ( O | |
| ONS O | |
| ) O | |
| with O | |
| a O | |
| 50 O | |
| : O | |
| 50 O | |
| ratio O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| also O | |
| given O | |
| micronutrient O | |
| supplementations O | |
| , O | |
| specifically O | |
| vitamin O | |
| A O | |
| 100,000 O | |
| units O | |
| for O | |
| the O | |
| first O | |
| week O | |
| , O | |
| vitamin O | |
| C O | |
| 100 O | |
| mg O | |
| 3 O | |
| times O | |
| a O | |
| day O | |
| , O | |
| and O | |
| zinc O | |
| 20 O | |
| mg O | |
| once O | |
| a O | |
| day O | |
| . O | |
| during O | |
| the O | |
| early O | |
| weeks O | |
| of O | |
| hospitalization O | |
| , O | |
| the O | |
| patient's O | |
| weight O | |
| loss O | |
| continued O | |
| . O | |
| at O | |
| the O | |
| end O | |
| of O | |
| the O | |
| second O | |
| week O | |
| , O | |
| his O | |
| body O | |
| weight O | |
| was O | |
| 36 O | |
| kilograms O | |
| while O | |
| his O | |
| serum O | |
| albumin O | |
| level O | |
| was O | |
| 2.7 O | |
| gr O | |
| / O | |
| L O | |
| . O | |
| on O | |
| the O | |
| 28 O | |
| th O | |
| day O | |
| , O | |
| the O | |
| patient's O | |
| body O | |
| weight O | |
| was O | |
| 33 O | |
| kilograms O | |
| while O | |
| his O | |
| serum O | |
| albumin O | |
| level O | |
| was O | |
| 2.1 O | |
| gr O | |
| / O | |
| L O | |
| . O | |
| energy O | |
| and O | |
| protein O | |
| intake O | |
| was O | |
| maintained O | |
| , O | |
| but O | |
| the O | |
| ratio O | |
| of O | |
| oral O | |
| intake O | |
| and O | |
| ONS O | |
| was O | |
| modified O | |
| to O | |
| 70 O | |
| : O | |
| 30 O | |
| . O | |
| during O | |
| the O | |
| treatment O | |
| , O | |
| the O | |
| patient's O | |
| appetite O | |
| was O | |
| unstable O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| also O | |
| hardly O | |
| cooperative O | |
| with O | |
| enteral O | |
| access O | |
| . O | |
| the O | |
| patient O | |
| often O | |
| writhed O | |
| in O | |
| pain B-ety | |
| and O | |
| became O | |
| more O | |
| aggressive O | |
| . O | |
| the O | |
| patient O | |
| did O | |
| not O | |
| respond O | |
| well O | |
| to O | |
| analgesics O | |
| and O | |
| sedations O | |
| . O | |
| partially O | |
| parenteral O | |
| nutrition O | |
| ( O | |
| PN O | |
| ) O | |
| enriched O | |
| with O | |
| branched-chain O | |
| amino O | |
| acid O | |
| ( O | |
| BCAA O | |
| ) O | |
| was O | |
| administered O | |
| to O | |
| support O | |
| protein O | |
| needs O | |
| . O | |
| however O | |
| , O | |
| his O | |
| BMI O | |
| continued O | |
| to O | |
| decline O | |
| , O | |
| and O | |
| on O | |
| the O | |
| 42 O | |
| nd O | |
| day O | |
| , O | |
| his O | |
| body O | |
| weight O | |
| dropped O | |
| to O | |
| 32 O | |
| kilograms O | |
| with O | |
| a O | |
| serum O | |
| albumin O | |
| level O | |
| of O | |
| 2 O | |
| gr O | |
| / O | |
| L O | |
| . O | |
| on O | |
| the O | |
| 66 O | |
| th O | |
| day O | |
| , O | |
| granulation O | |
| tissues O | |
| appeared O | |
| on O | |
| the O | |
| wound O | |
| bed O | |
| . O | |
| considering O | |
| the O | |
| mental O | |
| and O | |
| nutrition O | |
| status O | |
| of O | |
| the O | |
| patient O | |
| , O | |
| it O | |
| was O | |
| decided O | |
| not O | |
| to O | |
| continue O | |
| with O | |
| the O | |
| skin O | |
| graft O | |
| surgery O | |
| . O | |
| the O | |
| patient O | |
| had O | |
| lost O | |
| 24% O | |
| of O | |
| body O | |
| weight O | |
| ( O | |
| BMI O | |
| 11.96 O | |
| kg O | |
| / O | |
| m O | |
| 2 O | |
| ) O | |
| and O | |
| the O | |
| serum O | |
| albumin O | |
| level O | |
| was O | |
| 2.5 O | |
| gr O | |
| / O | |
| L O | |
| . O | |
| the O | |
| patient O | |
| displayed O | |
| severe O | |
| muscle B-ety | |
| wasting I-ety | |
| and O | |
| subcutaneous B-ety | |
| fat I-ety | |
| loss I-ety | |
| . O | |
| however O | |
| , O | |
| the O | |
| general O | |
| and O | |
| mental O | |
| condition O | |
| was O | |
| relatively O | |
| better O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| discharged O | |
| from O | |
| the O | |
| hospital O | |
| . O | |
| mrs O | |
| B.S O | |
| . O | |
| 28 O | |
| years O | |
| old O | |
| multiparous O | |
| that O | |
| we O | |
| had O | |
| received O | |
| 02 O | |
| hours O | |
| after O | |
| a O | |
| vaginal O | |
| delivery O | |
| of O | |
| a O | |
| newborn O | |
| alive O | |
| weighing O | |
| 2750 O | |
| grams O | |
| in O | |
| a O | |
| peripheral O | |
| maternity O | |
| 3 O | |
| km O | |
| away O | |
| . O | |
| it O | |
| was O | |
| referred O | |
| for O | |
| postpartum B-ety | |
| hemorrhage I-ety | |
| . O | |
| his O | |
| medical O | |
| history O | |
| was O | |
| featureless O | |
| . O | |
| on O | |
| admission O | |
| , O | |
| she O | |
| presented O | |
| hypovolemic B-ety | |
| shock I-ety | |
| with O | |
| blood O | |
| pressure O | |
| 76 O | |
| / O | |
| 44 O | |
| mmhg O | |
| , O | |
| regular O | |
| tachycardia B-ety | |
| at O | |
| 136 O | |
| beats O | |
| per O | |
| minute O | |
| , O | |
| polypnea B-ety | |
| to O | |
| 39 O | |
| cycles O | |
| per O | |
| minute O | |
| . O | |
| the O | |
| obstetrical O | |
| examination O | |
| objectified O | |
| an O | |
| involuted B-ety | |
| uterus I-ety | |
| , O | |
| an O | |
| absence O | |
| of O | |
| vaginal O | |
| and O | |
| perineal O | |
| cervical O | |
| lesions O | |
| , O | |
| a O | |
| fluid O | |
| and O | |
| red O | |
| blood O | |
| originating O | |
| of O | |
| endouterine O | |
| . O | |
| furthermore O | |
| , O | |
| there O | |
| was O | |
| purpura B-ety | |
| . O | |
| we O | |
| therefore O | |
| concluded O | |
| a O | |
| significant O | |
| postpartum B-ety | |
| hemorrhage I-ety | |
| complicated O | |
| by O | |
| coagulopathy B-ety | |
| . O | |
| resuscitation O | |
| measures O | |
| were O | |
| taken O | |
| and O | |
| an O | |
| transfusion O | |
| 1120 O | |
| ml O | |
| whole O | |
| blood O | |
| , O | |
| red O | |
| cell O | |
| pellets O | |
| 350 O | |
| ml O | |
| and O | |
| 860 O | |
| ml O | |
| fresh O | |
| frozen O | |
| plasma O | |
| have O | |
| helped O | |
| to O | |
| management O | |
| coagulopathy B-ety | |
| and O | |
| anemia B-ety | |
| . O | |
| blood O | |
| count O | |
| at O | |
| admission O | |
| highlighted O | |
| severe B-ety | |
| thrombocytopenia I-ety | |
| 23 O | |
| 0000 O | |
| platelets O | |
| and O | |
| hemoglobin O | |
| levels O | |
| of O | |
| 3.9 O | |
| g O | |
| / O | |
| dl O | |
| . O | |
| the O | |
| post O | |
| natal O | |
| care O | |
| was O | |
| also O | |
| administered O | |
| . O | |
| after O | |
| seven O | |
| days O | |
| of O | |
| hospitalization O | |
| , O | |
| she O | |
| was O | |
| going O | |
| after O | |
| an O | |
| amendment O | |
| to O | |
| the O | |
| clinical O | |
| symptoms O | |
| and O | |
| normal O | |
| laboratory O | |
| tests O | |
| . O | |
| twenty O | |
| five O | |
| days O | |
| later O | |
| , O | |
| she O | |
| returned O | |
| to O | |
| obstetric O | |
| emergencies O | |
| for O | |
| significant O | |
| bleeding B-ety | |
| with O | |
| severe B-ety | |
| anemia I-ety | |
| with O | |
| hemoglobin O | |
| 9 O | |
| g O | |
| / O | |
| dl O | |
| without O | |
| signs O | |
| of O | |
| hypovolemic B-ety | |
| shock I-ety | |
| . O | |
| the O | |
| gynecological O | |
| examination O | |
| was O | |
| normal O | |
| . O | |
| the O | |
| balance O | |
| sheet O | |
| of O | |
| the O | |
| coagulation O | |
| was O | |
| normal O | |
| including O | |
| prothrombin O | |
| to O | |
| 92% O | |
| and O | |
| a O | |
| normal O | |
| activated O | |
| partial O | |
| thromboplastin O | |
| time O | |
| . O | |
| the O | |
| treatments O | |
| were O | |
| based O | |
| on O | |
| oxytocin O | |
| , O | |
| tranexamic O | |
| acid O | |
| , O | |
| etamsylate O | |
| and O | |
| strict O | |
| regular O | |
| monitoring O | |
| . O | |
| transvaginal O | |
| ultrasound O | |
| coupled O | |
| doppler O | |
| was O | |
| normal O | |
| . O | |
| in O | |
| the O | |
| absence O | |
| of O | |
| arterial O | |
| embolization O | |
| , O | |
| she O | |
| was O | |
| going O | |
| with O | |
| ambulatory O | |
| monitoring O | |
| . O | |
| two O | |
| weeks O | |
| later O | |
| she O | |
| presented O | |
| again O | |
| rebleeding B-ety | |
| requiring O | |
| hospitalization O | |
| resulting O | |
| in O | |
| a O | |
| total O | |
| hysterectomy O | |
| after O | |
| conditioning O | |
| of O | |
| the O | |
| patient O | |
| . O | |
| histological O | |
| examination O | |
| of O | |
| the O | |
| surgical O | |
| specimen O | |
| objectified O | |
| in O | |
| the O | |
| cervix O | |
| and O | |
| uterine O | |
| body O | |
| the O | |
| presence O | |
| of O | |
| arterial O | |
| vessels O | |
| proliferation O | |
| homes O | |
| large O | |
| and O | |
| small O | |
| caliber O | |
| associated O | |
| with O | |
| tissue O | |
| hemorrhage B-ety | |
| . O | |
| the O | |
| postoperative O | |
| course O | |
| was O | |
| simple O | |
| . O | |
| A O | |
| 20 O | |
| years O | |
| old O | |
| man O | |
| presented O | |
| with O | |
| fever B-ety | |
| , O | |
| myalgias B-ety | |
| , O | |
| arthralgias B-ety | |
| , O | |
| retro-orbital B-ety | |
| pain I-ety | |
| , O | |
| vomiting B-ety | |
| and O | |
| gum O | |
| bleeding O | |
| during O | |
| a O | |
| large O | |
| dengue O | |
| outbreak O | |
| in O | |
| lahore O | |
| , O | |
| pakistan O | |
| . O | |
| on O | |
| 7th O | |
| day O | |
| of O | |
| illness O | |
| patient O | |
| became O | |
| afebrile O | |
| , O | |
| but O | |
| he O | |
| developed O | |
| severe O | |
| headaches B-ety | |
| , O | |
| unconsciousness B-ety | |
| followed O | |
| by O | |
| altered B-ety | |
| behavior I-ety | |
| . O | |
| on O | |
| 9th O | |
| day O | |
| of O | |
| illness O | |
| patient O | |
| developed O | |
| painful O | |
| neck B-ety | |
| swelling I-ety | |
| accompanied O | |
| by O | |
| fever B-ety | |
| , O | |
| tremors B-ety | |
| , O | |
| palpitations B-ety | |
| , O | |
| hoarseness B-ety | |
| of I-ety | |
| voice I-ety | |
| and O | |
| odynophagia B-ety | |
| . O | |
| examination O | |
| revealed O | |
| acutely O | |
| swollen B-ety | |
| , O | |
| tender B-ety | |
| thyroid I-ety | |
| gland I-ety | |
| along O | |
| with O | |
| features O | |
| of O | |
| hyperthyroidism B-ety | |
| . O | |
| laboratory O | |
| evaluation O | |
| revealed O | |
| stable O | |
| hematocrit O | |
| , O | |
| thrombocytopenia B-ety | |
| and O | |
| leukopenia B-ety | |
| . O | |
| patient O | |
| had O | |
| seroconverted O | |
| for O | |
| anti-dengue O | |
| igm O | |
| antibodies O | |
| on O | |
| the O | |
| 10th O | |
| day O | |
| of O | |
| illness O | |
| . O | |
| A O | |
| non-contrast O | |
| computed O | |
| tomogram O | |
| ( O | |
| CT O | |
| ) O | |
| of O | |
| the O | |
| brain O | |
| showed O | |
| right O | |
| frontal O | |
| lobe O | |
| hematoma B-ety | |
| . O | |
| thyroid O | |
| profile O | |
| showed O | |
| increased O | |
| free O | |
| T3 O | |
| and O | |
| T4 O | |
| and O | |
| low O | |
| TSH O | |
| . O | |
| technetium O | |
| thyroid O | |
| scan O | |
| showed O | |
| reduced B-ety | |
| tracer I-ety | |
| uptake I-ety | |
| . O | |
| he O | |
| was O | |
| diagnosed O | |
| as O | |
| having O | |
| subacute B-ety | |
| thyroiditis I-ety | |
| and O | |
| treated O | |
| with O | |
| oral O | |
| prednisolone O | |
| and O | |
| propranolol O | |
| . O | |
| follow O | |
| up O | |
| CT O | |
| brain O | |
| showed O | |
| resolving O | |
| hematoma B-ety | |
| . O | |
| patient's O | |
| recovery O | |
| was O | |
| uneventful O | |
| . O | |
| A O | |
| 28 O | |
| - O | |
| year-old O | |
| female O | |
| patient O | |
| presented O | |
| to O | |
| outpatient O | |
| dental O | |
| clinics O | |
| for O | |
| full O | |
| mouth O | |
| rehabilitation O | |
| . O | |
| on O | |
| physical O | |
| examination O | |
| , O | |
| the O | |
| patient O | |
| was O | |
| awake O | |
| , O | |
| alert O | |
| , O | |
| oriented O | |
| , O | |
| and O | |
| her O | |
| blood O | |
| pressure O | |
| , O | |
| temperature O | |
| and O | |
| heart O | |
| rate O | |
| were O | |
| within O | |
| normal O | |
| limits O | |
| . O | |
| upon O | |
| taking O | |
| medical O | |
| history O | |
| the O | |
| patient O | |
| revealed O | |
| that O | |
| was O | |
| diagnosed O | |
| with O | |
| thymoma B-ety | |
| MG I-ety | |
| and O | |
| on O | |
| medication O | |
| including O | |
| pyridostigmine O | |
| bromide O | |
| 60 O | |
| mg O | |
| , O | |
| azathioprine O | |
| 50 O | |
| mg O | |
| and O | |
| prednisone O | |
| 20 O | |
| mg O | |
| . O | |
| intraoral O | |
| examination O | |
| showed O | |
| fair O | |
| oral O | |
| hygiene O | |
| multiple O | |
| fixed O | |
| prosthodontic O | |
| restorations O | |
| and O | |
| multiple O | |
| carious B-ety | |
| teeth I-ety | |
| , O | |
| multiple O | |
| remaining O | |
| roots O | |
| and O | |
| lipomatous O | |
| tongue B-ety | |
| atrophy I-ety | |
| . O | |
| the O | |
| patient O | |
| was O | |
| referred O | |
| to O | |
| her O | |
| neurologist O | |
| to O | |
| provide O | |
| a O | |
| detailed O | |
| history O | |
| about O | |
| her O | |
| medical O | |
| condition O | |
| and O | |
| to O | |
| coordinate O | |
| with O | |
| him O | |
| regarding O | |
| the O | |
| steroid O | |
| dose O | |
| take O | |
| to O | |
| avoid O | |
| any O | |
| complication O | |
| during O | |
| patient O | |
| management O | |
| . O | |
| A O | |
| consultation O | |
| letter O | |
| had O | |
| been O | |
| received O | |
| from O | |
| her O | |
| neurologist O | |
| explaining O | |
| the O | |
| patient O | |
| medical O | |
| condition O | |
| which O | |
| starts O | |
| with O | |
| difficulty B-ety | |
| in I-ety | |
| breathing I-ety | |
| , I-ety | |
| chewing I-ety | |
| and I-ety | |
| swallowing I-ety | |
| , O | |
| there O | |
| was O | |
| no O | |
| external O | |
| ocular O | |
| weakness O | |
| , O | |
| motor O | |
| weakness O | |
| , O | |
| sphincter O | |
| dysfunction O | |
| , O | |
| sensory B-ety | |
| deficits I-ety | |
| , O | |
| muscle B-ety | |
| wasting I-ety | |
| and O | |
| no O | |
| signs O | |
| of O | |
| diplopia B-ety | |
| , O | |
| dizziness B-ety | |
| , O | |
| double O | |
| vision O | |
| , O | |
| ptosis B-ety | |
| or O | |
| any O | |
| difficulty O | |
| in O | |
| maintaining O | |
| balance O | |
| . O | |
| patient O | |
| underwent O | |
| chest O | |
| CT O | |
| scan O | |
| with O | |
| contrast O | |
| which O | |
| show O | |
| evidence O | |
| of O | |
| thymoma B-ety | |
| benign I-ety | |
| tumor I-ety | |
| of O | |
| the O | |
| thymus O | |
| that O | |
| has O | |
| been O | |
| the O | |
| possible O | |
| causes O | |
| of O | |
| MG B-ety | |
| . O | |
| diagnosis O | |
| was O | |
| confirmed O | |
| with O | |
| measuring O | |
| serum O | |
| level O | |
| of O | |
| acetylcholine O | |
| receptor O | |
| antibodies O | |
| , O | |
| later O | |
| treatment O | |
| plan O | |
| had O | |
| been O | |
| formulated O | |
| including O | |
| drugs O | |
| to O | |
| control O | |
| the O | |
| condition O | |
| and O | |
| then O | |
| thymectomy O | |
| to O | |
| avoid O | |
| sever O | |
| complication O | |
| to O | |
| the O | |
| patient O | |
| . O | |
| before O | |
| proceeding O | |
| to O | |
| the O | |
| dental O | |
| management O | |
| of O | |
| the O | |
| case O | |
| ; O | |
| CBC O | |
| and O | |
| blood O | |
| chemistry O | |
| had O | |
| been O | |
| requested O | |
| form O | |
| the O | |
| patient O | |
| . O | |
| creatinine O | |
| level O | |
| was O | |
| below O | |
| normal O | |
| ( O | |
| 42.23 O | |
| umol O | |
| / O | |
| l O | |
| ) O | |
| , O | |
| with O | |
| normal O | |
| levels O | |
| of O | |
| albumin O | |
| , O | |
| urea O | |
| , O | |
| uric O | |
| acid O | |
| , O | |
| AST O | |
| , O | |
| ALT O | |
| , O | |
| cholesterol O | |
| , O | |
| triglycerides O | |
| and O | |
| bilirubin O | |
| . O | |
| patient O | |
| had O | |
| elevated O | |
| WBC O | |
| “ O | |
| 12.52 O | |
| x O | |
| 10 O | |
| 9 O | |
| / O | |
| L O | |
| ” O | |
| and O | |
| platelet O | |
| “ O | |
| 453 O | |
| x O | |
| 10 O | |
| 9 O | |
| / O | |
| L O | |
| ” O | |
| with O | |
| reduction O | |
| in O | |
| RBC O | |
| “ O | |
| 4.4 O | |
| x O | |
| 10 O | |
| 9 O | |
| / O | |
| L O | |
| ” O | |
| and O | |
| eosinophil O | |
| count O | |
| “ O | |
| 0.07 O | |
| ” O | |
| . O | |
| consultation O | |
| with O | |
| patient O | |
| neurologist O | |
| regarding O | |
| the O | |
| steroid O | |
| dose O | |
| to O | |
| reduce O | |
| the O | |
| susceptibility O | |
| of O | |
| developing O | |
| adrenal O | |
| crisis B-ety | |
| . O | |
| A O | |
| 13 O | |
| - O | |
| year-old O | |
| boy O | |
| diagnosed O | |
| with O | |
| WHO O | |
| diagnostic O | |
| criteria O | |
| of O | |
| probable O | |
| NS B-ety | |
| was O | |
| referred O | |
| from O | |
| atanga O | |
| HC O | |
| III O | |
| in O | |
| pader O | |
| district O | |
| where O | |
| he O | |
| was O | |
| enrolled O | |
| and O | |
| undergoing O | |
| care O | |
| at O | |
| the O | |
| nodding B-ety | |
| syndrome I-ety | |
| treatment O | |
| center O | |
| ; O | |
| he O | |
| came O | |
| with O | |
| a O | |
| history O | |
| of O | |
| progressive O | |
| swelling B-ety | |
| and I-ety | |
| pain I-ety | |
| in I-ety | |
| the I-ety | |
| right I-ety | |
| lumbar I-ety | |
| region I-ety | |
| . O | |
| the O | |
| swelling B-ety | |
| was O | |
| associated O | |
| with O | |
| a O | |
| high O | |
| grade O | |
| fever B-ety | |
| which O | |
| was O | |
| constant O | |
| and O | |
| only O | |
| partially O | |
| relieved O | |
| by O | |
| analgesics O | |
| . O | |
| these O | |
| symptoms O | |
| were O | |
| not O | |
| associated O | |
| with O | |
| vomiting B-ety | |
| , O | |
| constipation B-ety | |
| , O | |
| yellow B-ety | |
| eyes I-ety | |
| , O | |
| loss B-ety | |
| of I-ety | |
| appetite I-ety | |
| or O | |
| weight B-ety | |
| loss I-ety | |
| . O | |
| the O | |
| patient O | |
| reported O | |
| a O | |
| history O | |
| of O | |
| falling O | |
| from O | |
| a O | |
| tree O | |
| during O | |
| one O | |
| of O | |
| the O | |
| nodding B-ety | |
| episodes O | |
| in O | |
| october O | |
| 2012 O | |
| and O | |
| hit O | |
| his O | |
| abdomen O | |
| onto O | |
| a O | |
| tree O | |
| branch O | |
| . O | |
| on O | |
| further O | |
| probe O | |
| on O | |
| his O | |
| childhood O | |
| history O | |
| , O | |
| his O | |
| mother O | |
| reported O | |
| that O | |
| he O | |
| was O | |
| born O | |
| normally O | |
| at O | |
| home O | |
| by O | |
| a O | |
| traditional O | |
| birth O | |
| attendant O | |
| ( O | |
| TBA O | |
| ) O | |
| in O | |
| one O | |
| of O | |
| the O | |
| internally O | |
| displaced O | |
| peoples O | |
| ( O | |
| IDP O | |
| ) O | |
| camps O | |
| in O | |
| 2000 O | |
| . O | |
| she O | |
| reported O | |
| that O | |
| there O | |
| was O | |
| an O | |
| uneventful O | |
| pregnancy O | |
| which O | |
| was O | |
| carried O | |
| to O | |
| term O | |
| and O | |
| delivery O | |
| by O | |
| spontaneous O | |
| vaginal O | |
| delivery O | |
| ( O | |
| SVD O | |
| ) O | |
| . O | |
| she O | |
| reported O | |
| that O | |
| during O | |
| her O | |
| pregnancy O | |
| , O | |
| she O | |
| had O | |
| exclusive O | |
| feeding O | |
| on O | |
| the O | |
| relief O | |
| food O | |
| provided O | |
| by O | |
| WFP O | |
| ( O | |
| beans O | |
| , O | |
| yellow O | |
| posho O | |
| and O | |
| cooking O | |
| oil O | |
| ) O | |
| during O | |
| the O | |
| IDP O | |
| camps O | |
| and O | |
| denies O | |
| history O | |
| of O | |
| ingestion O | |
| of O | |
| herbs O | |
| or O | |
| medications O | |
| which O | |
| caused O | |
| adverse O | |
| events O | |
| during O | |
| and O | |
| after O | |
| the O | |
| pregnancy O | |
| . O | |
| she O | |
| reported O | |
| that O | |
| her O | |
| child O | |
| had O | |
| a O | |
| normal O | |
| physical O | |
| , O | |
| cognitive O | |
| and O | |
| social O | |
| childhood O | |
| development O | |
| before O | |
| the O | |
| onset O | |
| of O | |
| nodding B-ety | |
| which O | |
| began O | |
| in O | |
| may O | |
| 27th O | |
| 2011 O | |
| immediately O | |
| after O | |
| returning O | |
| home O | |
| from O | |
| IDP O | |
| camps O | |
| . O | |
| the O | |
| child O | |
| was O | |
| enrolled O | |
| in O | |
| atanga O | |
| treatment O | |
| centre O | |
| and O | |
| was O | |
| being O | |
| managed O | |
| with O | |
| carbamazepine O | |
| , O | |
| multivitamins O | |
| and O | |
| ivermectin O | |
| . O | |
| she O | |
| reported O | |
| that O | |
| in O | |
| spite O | |
| of O | |
| these O | |
| medications O | |
| the O | |
| child O | |
| continued O | |
| to O | |
| have O | |
| seizures B-ety | |
| and O | |
| nodding B-ety | |
| at O | |
| least O | |
| twice O | |
| a O | |
| day O | |
| and O | |
| had O | |
| since O | |
| dropped O | |
| out O | |
| of O | |
| school O | |
| . O | |
| on O | |
| general O | |
| examination O | |
| , O | |
| he O | |
| was O | |
| dehydrated B-ety | |
| , O | |
| febrile B-ety | |
| and O | |
| moderately O | |
| wasted O | |
| . O | |
| there O | |
| was O | |
| a O | |
| right O | |
| lumbar O | |
| region O | |
| mass O | |
| , O | |
| tender O | |
| , O | |
| indurated O | |
| and O | |
| non-fluctuant O | |
| . O | |
| the O | |
| spleen O | |
| and O | |
| liver O | |
| were O | |
| not O | |
| palpable O | |
| . O | |
| there O | |
| was O | |
| no O | |
| renal O | |
| or O | |
| supra-pubic O | |
| tenderness O | |
| . O | |
| the O | |
| rectum O | |
| was O | |
| full O | |
| of O | |
| faecal O | |
| material O | |
| which O | |
| was O | |
| of O | |
| normal O | |
| colour O | |
| and O | |
| consistency O | |
| . O | |
| the O | |
| anal O | |
| tone O | |
| was O | |
| normal O | |
| and O | |
| there O | |
| was O | |
| no O | |
| blood O | |
| on O | |
| examining O | |
| fingure O | |
| . O | |
| haematological O | |
| investigations O | |
| were O | |
| conducted O | |
| and O | |
| showed O | |
| neutrophilia B-ety | |
| , O | |
| lympocytosis B-ety | |
| , O | |
| monocytosis B-ety | |
| , O | |
| and O | |
| eosinophilia B-ety | |
| . O | |
| there O | |
| were O | |
| immature O | |
| granulocytes O | |
| and O | |
| atypical B-ety | |
| lymphocytes I-ety | |
| seen O | |
| on O | |
| the O | |
| peripheral O | |
| film O | |
| report O | |
| . O | |
| other O | |
| laboratory O | |
| results O | |
| including O | |
| liver O | |
| function O | |
| tests O | |
| ( O | |
| ALT O | |
| , O | |
| AST O | |
| ) O | |
| were O | |
| elevated O | |
| while O | |
| serum O | |
| protein O | |
| levels O | |
| were O | |
| low O | |
| ; O | |
| renal O | |
| functions O | |
| tests O | |
| ( O | |
| serum O | |
| creatinine O | |
| , O | |
| blood O | |
| urea O | |
| and O | |
| nitrogen O | |
| level O | |
| ) O | |
| , O | |
| and O | |
| serum O | |
| electrolytes O | |
| ( O | |
| K O | |
| + O | |
| , O | |
| na O | |
| + O | |
| , O | |
| cl O | |
| - O | |
| , O | |
| HC03 O | |
| - O | |
| ) O | |
| which O | |
| were O | |
| within O | |
| normal O | |
| ranges O | |
| . O | |
| abdominal O | |
| ultrasound O | |
| showed O | |
| inflamed O | |
| internal O | |
| and O | |
| external O | |
| oblique O | |
| muscles O | |
| of O | |
| the O | |
| anterior O | |
| abdominal O | |
| wall O | |
| . O | |
| the O | |
| patient O | |
| underwent O | |
| incision O | |
| and O | |
| drainage O | |
| at O | |
| gulu O | |
| hospital O | |
| and O | |
| wound O | |
| left O | |
| open O | |
| for O | |
| 14 O | |
| days O | |
| and O | |
| thereafter O | |
| secondary O | |
| wound O | |
| closure O | |
| was O | |
| conducted O | |
| . O | |
| he O | |
| received O | |
| supplementary O | |
| food O | |
| rehabilitation O | |
| and O | |
| his O | |
| seizure O | |
| medication O | |
| was O | |
| changed O | |
| to O | |
| sodium O | |
| valproate O | |
| 200mg O | |
| once O | |
| a O | |
| day O | |
| under O | |
| direct O | |
| observation O | |
| therapy O | |
| ( O | |
| DOTS O | |
| ) O | |
| and O | |
| close O | |
| monitoring O | |
| of O | |
| the O | |
| vital O | |
| signs O | |
| . O | |
| the O | |
| patient O | |
| continued O | |
| to O | |
| have O | |
| regular O | |
| follow O | |
| up O | |
| in O | |
| the O | |
| surgical O | |
| ward O | |
| ; O | |
| seizures B-ety | |
| and O | |
| nodding B-ety | |
| stopped O | |
| completely O | |
| from O | |
| the O | |
| time O | |
| of O | |
| intervention O | |
| in O | |
| the O | |
| hospital O | |
| . O | |
| with O | |
| these O | |
| interventions O | |
| for O | |
| over O | |
| one O | |
| month O | |
| the O | |
| child O | |
| had O | |
| no O | |
| seizures B-ety | |
| nor O | |
| nodding B-ety | |
| and O | |
| the O | |
| child O | |
| returned O | |
| to O | |
| normal O | |
| life O | |
| . O | |
| A O | |
| subsequent O | |
| review O | |
| of O | |
| the O | |
| haematological O | |
| and O | |
| clinical O | |
| chemistry O | |
| findings O | |
| 2 O | |
| weeks O | |
| later O | |
| showed O | |
| that O | |
| renal O | |
| function O | |
| tests O | |
| , O | |
| serum O | |
| electrolytes O | |
| were O | |
| normal O | |
| except O | |
| the O | |
| liver O | |
| enzymes O | |
| level O | |
| were O | |
| elevated O | |
| and O | |
| were O | |
| still O | |
| high O | |
| . O | |
| A O | |
| 3 O | |
| years O | |
| old O | |
| girl O | |
| born O | |
| from O | |
| non-consanguineous O | |
| parents O | |
| , O | |
| without O | |
| any O | |
| neonatal O | |
| suffering O | |
| ; O | |
| with O | |
| good O | |
| psychomotor O | |
| development O | |
| , O | |
| from O | |
| a O | |
| popular O | |
| district O | |
| in O | |
| one O | |
| of O | |
| our O | |
| cities O | |
| , O | |
| without O | |
| any O | |
| obvious O | |
| contact O | |
| with O | |
| dogs O | |
| ; O | |
| presented O | |
| with O | |
| exophthalmia B-ety | |
| associated O | |
| with O | |
| unilateral B-ety | |
| blindness I-ety | |
| evolving O | |
| rapidly O | |
| within O | |
| 3 O | |
| months O | |
| . O | |
| clinical O | |
| examination O | |
| showed O | |
| a O | |
| non-pulsatile O | |
| , O | |
| painless O | |
| , O | |
| axial O | |
| , O | |
| irreducible O | |
| exophthalmia B-ety | |
| with O | |
| no O | |
| sign O | |
| of O | |
| conjunctivitis B-ety | |
| or O | |
| keratitis B-ety | |
| , O | |
| and O | |
| right O | |
| monocular B-ety | |
| blindness I-ety | |
| , O | |
| right B-ety | |
| ptosis I-ety | |
| ; O | |
| and O | |
| fundal O | |
| examination O | |
| had O | |
| objectified O | |
| right O | |
| papillary O | |
| oedema O | |
| . O | |
| the O | |
| rest O | |
| of O | |
| the O | |
| clinical O | |
| examination O | |
| was O | |
| normal O | |
| . O | |
| brain O | |
| and O | |
| orbital O | |
| magnetic O | |
| resonance O | |
| imaging O | |
| ( O | |
| MRI O | |
| ) O | |
| revealed O | |
| an O | |
| extra-connal B-ety | |
| right I-ety | |
| orbital I-ety | |
| lesion I-ety | |
| near O | |
| the O | |
| orbital O | |
| apex O | |
| , O | |
| measuring O | |
| 28 O | |
| x O | |
| 18mm O | |
| , O | |
| of O | |
| oval O | |
| shape O | |
| , O | |
| it O | |
| appeared O | |
| hypo-signal O | |
| in O | |
| T1 O | |
| and O | |
| hyper-signal O | |
| in O | |
| T2 O | |
| , O | |
| limited O | |
| by O | |
| a O | |
| thin O | |
| wall O | |
| which O | |
| took O | |
| contrast O | |
| product O | |
| , O | |
| this O | |
| lesion B-ety | |
| compressed O | |
| the O | |
| optic O | |
| nerve O | |
| towards O | |
| the O | |
| nasal O | |
| region O | |
| . O | |
| chest O | |
| x-ray O | |
| and O | |
| abdominal O | |
| ultrasound O | |
| did O | |
| not O | |
| reveal O | |
| any O | |
| other O | |
| localization O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| operated O | |
| by O | |
| performing O | |
| a O | |
| right O | |
| extra-dural O | |
| frontal O | |
| approach O | |
| , O | |
| a O | |
| cyst O | |
| puncture O | |
| was O | |
| done O | |
| in O | |
| the O | |
| first O | |
| intention O | |
| because O | |
| the O | |
| cyst B-ety | |
| was O | |
| adherent O | |
| to O | |
| the O | |
| neighbouring O | |
| structures O | |
| making O | |
| its O | |
| complete O | |
| removal O | |
| impossible O | |
| , O | |
| then O | |
| a O | |
| microscopic O | |
| extirpation O | |
| of O | |
| the O | |
| cystic O | |
| membrane O | |
| , O | |
| combined O | |
| with O | |
| abundant O | |
| washing O | |
| by O | |
| hypertonic O | |
| serum O | |
| to O | |
| sterilize O | |
| the O | |
| cystic O | |
| sit O | |
| and O | |
| reduce O | |
| chances O | |
| of O | |
| dissemination O | |
| . O | |
| histological O | |
| examination O | |
| was O | |
| in O | |
| favour O | |
| of O | |
| intra-orbital O | |
| hydatidosis B-ety | |
| . O | |
| postoperatively O | |
| , O | |
| the O | |
| patient O | |
| was O | |
| given O | |
| an O | |
| antihelminthic O | |
| treatment O | |
| of O | |
| albendazole O | |
| at O | |
| a O | |
| dose O | |
| of O | |
| 10mg O | |
| per O | |
| kilogram O | |
| per O | |
| day O | |
| in O | |
| 3 O | |
| doses O | |
| separated O | |
| by O | |
| 2 O | |
| weeks O | |
| ; O | |
| the O | |
| evolution O | |
| was O | |
| marked O | |
| by O | |
| the O | |
| significant O | |
| regression O | |
| of O | |
| the O | |
| exophthalmia B-ety | |
| and O | |
| the O | |
| gradual O | |
| improvement O | |
| of O | |
| the O | |
| visual O | |
| acuity O | |
| . O | |
| the O | |
| patient O | |
| however O | |
| still O | |
| retains O | |
| a O | |
| right O | |
| unilateral O | |
| nasal O | |
| hemianopia B-ety | |
| after O | |
| two O | |
| years O | |
| of O | |
| follow-up O | |
| . O | |
| an O | |
| MRI O | |
| done O | |
| in O | |
| the O | |
| same O | |
| period O | |
| shows O | |
| a O | |
| cure O | |
| of O | |
| the O | |
| patient O | |
| by O | |
| a O | |
| complete O | |
| disappearance O | |
| of O | |
| the O | |
| cyst B-ety | |
| . O | |
| A O | |
| 21 O | |
| - O | |
| year-old O | |
| male O | |
| was O | |
| referred O | |
| to O | |
| the O | |
| gastroenterology O | |
| clinic O | |
| for O | |
| incidental O | |
| findings O | |
| of O | |
| severe O | |
| chronic B-ety | |
| pancreatitis I-ety | |
| on O | |
| cross-sectional O | |
| imaging O | |
| but O | |
| no O | |
| associated O | |
| symptoms O | |
| of O | |
| pancreatitis B-ety | |
| . O | |
| he O | |
| had O | |
| presented O | |
| to O | |
| the O | |
| emergency O | |
| department O | |
| for O | |
| abdominal B-ety | |
| pain I-ety | |
| consistent O | |
| with O | |
| prior O | |
| episodes O | |
| of O | |
| renal B-ety | |
| colic I-ety | |
| . O | |
| computed O | |
| tomography O | |
| scan O | |
| confirmed O | |
| the O | |
| presence O | |
| of O | |
| renal B-ety | |
| calculi I-ety | |
| that O | |
| passed O | |
| with O | |
| conservative O | |
| management O | |
| . O | |
| an O | |
| incidental O | |
| finding O | |
| on O | |
| the O | |
| imaging O | |
| showed O | |
| marked O | |
| pancreatic B-ety | |
| atrophy I-ety | |
| with O | |
| multiple O | |
| sub-centimeter O | |
| calcifications B-ety | |
| consistent O | |
| with O | |
| severe O | |
| chronic B-ety | |
| pancreatitis I-ety | |
| . O | |
| remarkably O | |
| , O | |
| he O | |
| did O | |
| not O | |
| report O | |
| having O | |
| any O | |
| symptoms O | |
| associated O | |
| with O | |
| pancreatic B-ety | |
| insufficiency I-ety | |
| including O | |
| epigastric B-ety | |
| pain I-ety | |
| , O | |
| vomiting B-ety | |
| , O | |
| steatorrhea B-ety | |
| and O | |
| weight O | |
| loss O | |
| . O | |
| he O | |
| denied O | |
| having O | |
| any O | |
| prior O | |
| episodes O | |
| of O | |
| acute B-ety | |
| pancreatitis I-ety | |
| and O | |
| had O | |
| no O | |
| history O | |
| of O | |
| alcohol O | |
| use O | |
| . O | |
| his O | |
| laboratory O | |
| tests O | |
| were O | |
| all O | |
| within O | |
| normal O | |
| range O | |
| , O | |
| including O | |
| complete O | |
| blood O | |
| count O | |
| , O | |
| liver O | |
| function O | |
| tests O | |
| , O | |
| amylase O | |
| and O | |
| lipase O | |
| . O | |
| his O | |
| family O | |
| history O | |
| was O | |
| significant O | |
| as O | |
| his O | |
| father O | |
| had O | |
| an O | |
| isolated O | |
| episode O | |
| of O | |
| pancreatitis B-ety | |
| which O | |
| required O | |
| abdominal O | |
| surgery O | |
| . O | |
| magnetic O | |
| resonance O | |
| cholangiopancreatography O | |
| ( O | |
| MRCP O | |
| ) O | |
| showed O | |
| severe O | |
| parenchymal B-ety | |
| atrophy I-ety | |
| and O | |
| pancreatic B-ety | |
| ductal I-ety | |
| stones I-ety | |
| with O | |
| ductal O | |
| dilation O | |
| to O | |
| 9mm O | |
| . O | |
| due O | |
| to O | |
| his O | |
| young O | |
| age O | |
| and O | |
| atypical O | |
| presentation O | |
| , O | |
| he O | |
| was O | |
| referred O | |
| for O | |
| genetic O | |
| testing O | |
| and O | |
| counselling O | |
| . O | |
| he O | |
| underwent O | |
| genetic O | |
| testing O | |
| for O | |
| various O | |
| genes O | |
| known O | |
| to O | |
| cause O | |
| hereditary B-ety | |
| pancreatitis I-ety | |
| : O | |
| CASR O | |
| , O | |
| CFTR O | |
| , O | |
| CTRC O | |
| , O | |
| PRSS1 O | |
| , O | |
| SPINK1 O | |
| . O | |
| he O | |
| tested O | |
| positive O | |
| for O | |
| homozygous O | |
| variant O | |
| of O | |
| SPINK1 O | |
| ( O | |
| N34S O | |
| ) O | |
| mutation O | |
| . O | |
| reflex O | |
| testing O | |
| of O | |
| at-risk O | |
| relatives O | |
| confirmed O | |
| that O | |
| both O | |
| of O | |
| his O | |
| parents O | |
| were O | |
| heterozygous O | |
| carriers O | |
| of O | |
| the O | |
| same O | |
| SPINK1 O | |
| ( O | |
| N34S O | |
| ) O | |
| mutation O | |
| and O | |
| a O | |
| review O | |
| of O | |
| their O | |
| extended O | |
| pedigree O | |
| revealed O | |
| that O | |
| they O | |
| were O | |
| distant O | |
| cousins O | |
| . O | |
| given O | |
| his O | |
| asymptomatic O | |
| clinical O | |
| course O | |
| , O | |
| he O | |
| remains O | |
| under O | |
| close O | |
| follow-up O | |
| without O | |
| requiring O | |
| any O | |
| specific O | |
| treatment O | |
| for O | |
| pancreatic B-ety | |
| insufficiency I-ety | |
| . O | |
| due O | |
| to O | |
| the O | |
| severity O | |
| of O | |
| pancreatitis B-ety | |
| noted O | |
| on O | |
| imaging O | |
| and O | |
| long O | |
| expected O | |
| lifespan O | |
| , O | |
| he O | |
| was O | |
| counselled O | |
| about O | |
| the O | |
| increased O | |
| risk O | |
| of O | |
| pancreatic B-ety | |
| malignancy I-ety | |
| and O | |
| is O | |
| undergoing O | |
| regular O | |
| cross-sectional O | |
| imaging O | |
| for O | |
| the O | |
| detection O | |
| and O | |
| prevention O | |
| of O | |
| cancer B-ety | |
| . O | |
| A O | |
| 21 O | |
| year O | |
| old O | |
| female O | |
| patient O | |
| with O | |
| the O | |
| diagnosis O | |
| of O | |
| SWS B-ety | |
| suffering O | |
| from O | |
| headaches B-ety | |
| admitted O | |
| to O | |
| our O | |
| clinic O | |
| . O | |
| she O | |
| had O | |
| a O | |
| 2 O | |
| year O | |
| history O | |
| of O | |
| frequent O | |
| non-pulsating O | |
| headaches B-ety | |
| . O | |
| her O | |
| headache B-ety | |
| was O | |
| relieving O | |
| with O | |
| non-steroidal O | |
| anti-inflammatory O | |
| drugs O | |
| and O | |
| was O | |
| not O | |
| worsening O | |
| with O | |
| physical O | |
| activity O | |
| . O | |
| there O | |
| was O | |
| no O | |
| nausea B-ety | |
| or O | |
| aura B-ety | |
| like O | |
| symptoms O | |
| accompanying O | |
| the O | |
| headache B-ety | |
| . O | |
| headaches B-ety | |
| were O | |
| lasting O | |
| for O | |
| hours O | |
| . O | |
| the O | |
| pain B-ety | |
| was O | |
| bilateral O | |
| , O | |
| generalized O | |
| and O | |
| pressing O | |
| in O | |
| quality O | |
| . O | |
| the O | |
| family O | |
| history O | |
| for O | |
| headache B-ety | |
| was O | |
| negative O | |
| . O | |
| she O | |
| had O | |
| a O | |
| history O | |
| of O | |
| seizures B-ety | |
| occurring O | |
| in O | |
| the O | |
| fifteenth O | |
| day O | |
| of O | |
| life O | |
| described O | |
| as O | |
| attacks O | |
| of O | |
| tonic O | |
| clonic O | |
| contractions O | |
| and O | |
| that's O | |
| when O | |
| she O | |
| was O | |
| diagnosed O | |
| with O | |
| SWS B-ety | |
| . O | |
| at O | |
| the O | |
| age O | |
| of O | |
| 6 O | |
| she O | |
| had O | |
| a O | |
| history O | |
| of O | |
| callosotomy O | |
| to O | |
| control O | |
| her O | |
| seizures B-ety | |
| . O | |
| at O | |
| the O | |
| age O | |
| of O | |
| 18 O | |
| during O | |
| a O | |
| laser O | |
| treatment O | |
| done O | |
| in O | |
| order O | |
| to O | |
| get O | |
| rid O | |
| of O | |
| her O | |
| port B-ety | |
| wine I-ety | |
| birthmark I-ety | |
| she O | |
| had O | |
| her O | |
| first O | |
| seizure B-ety | |
| since O | |
| callosotomy O | |
| . O | |
| after O | |
| that O | |
| she O | |
| was O | |
| prescribed O | |
| carbamazepine O | |
| 400 O | |
| mg O | |
| at O | |
| daily O | |
| dose O | |
| and O | |
| never O | |
| had O | |
| a O | |
| seizure B-ety | |
| since O | |
| then O | |
| . O | |
| according O | |
| to O | |
| the O | |
| story O | |
| taken O | |
| from O | |
| her O | |
| parents O | |
| even O | |
| though O | |
| she O | |
| had O | |
| a O | |
| normal O | |
| development O | |
| at O | |
| infancy O | |
| she O | |
| barely O | |
| graduated O | |
| from O | |
| elementary O | |
| school O | |
| and O | |
| she's O | |
| hardly O | |
| literate O | |
| . O | |
| there O | |
| was O | |
| nothing O | |
| significant O | |
| on O | |
| her O | |
| family O | |
| history O | |
| except O | |
| for O | |
| her O | |
| elder O | |
| sister's O | |
| port B-ety | |
| wine I-ety | |
| stain I-ety | |
| on O | |
| her O | |
| face O | |
| . O | |
| the O | |
| elder O | |
| sister O | |
| had O | |
| no O | |
| feature O | |
| of O | |
| SWS O | |
| and O | |
| no O | |
| researches O | |
| were O | |
| done O | |
| regarding O | |
| her O | |
| stain O | |
| . O | |
| she O | |
| was O | |
| inscribed O | |
| daily O | |
| doses O | |
| of O | |
| ketiapin O | |
| 25 O | |
| mg O | |
| for O | |
| anxiety B-ety | |
| disorder I-ety | |
| and O | |
| venlafaxine O | |
| 75 O | |
| mg O | |
| for O | |
| both O | |
| anxiety B-ety | |
| disorder I-ety | |
| and O | |
| the O | |
| chronic B-ety | |
| headaches I-ety | |
| . O | |
| she O | |
| was O | |
| also O | |
| inscribed O | |
| NSAID O | |
| drugs O | |
| . O | |
| after O | |
| the O | |
| first O | |
| week O | |
| of O | |
| this O | |
| treatment O | |
| her O | |
| headaches B-ety | |
| were O | |
| slightly O | |
| decreased O | |
| by O | |
| heaviness O | |
| but O | |
| the O | |
| frequency O | |
| was O | |
| the O | |
| same O | |
| . O | |
| at O | |
| her O | |
| physical O | |
| examination O | |
| a O | |
| facial B-ety | |
| nevus I-ety | |
| - O | |
| occurred O | |
| due O | |
| to O | |
| choroid O | |
| angioma-on B-ety | |
| the O | |
| right O | |
| forehead O | |
| , O | |
| right O | |
| eyelid O | |
| , O | |
| nasal O | |
| wing O | |
| and O | |
| the O | |
| cheek O | |
| was O | |
| observed O | |
| . O | |
| intra O | |
| oral O | |
| examination O | |
| showed O | |
| a O | |
| right O | |
| sided O | |
| overgrowth B-ety | |
| of I-ety | |
| gingiva I-ety | |
| . O | |
| gingival B-ety | |
| overgrowth I-ety | |
| was O | |
| bright O | |
| red O | |
| in O | |
| color O | |
| and O | |
| showed O | |
| blanching O | |
| on O | |
| applying O | |
| pressure O | |
| suggesting O | |
| angiomatous O | |
| enlargement O | |
| . O | |
| on O | |
| her O | |
| extremities O | |
| a O | |
| mild O | |
| asymmetry O | |
| was O | |
| visible O | |
| . O | |
| her O | |
| left O | |
| arm O | |
| and O | |
| leg O | |
| was O | |
| slightly O | |
| smaller O | |
| in O | |
| portions O | |
| and O | |
| showed O | |
| hemiparesis B-ety | |
| both O | |
| in O | |
| the O | |
| upper O | |
| and O | |
| lower O | |
| extremities O | |
| of O | |
| the O | |
| same O | |
| size O | |
| . O | |
| on O | |
| her O | |
| ophthalmological O | |
| evaluation O | |
| she O | |
| was O | |
| diagnosed O | |
| with O | |
| glaucoma B-ety | |
| of I-ety | |
| the I-ety | |
| right I-ety | |
| eye I-ety | |
| . O | |
| on O | |
| her O | |
| psychiatric O | |
| examination O | |
| she O | |
| showed O | |
| signs O | |
| of O | |
| anxiety B-ety | |
| disorder I-ety | |
| . O | |
| her O | |
| neurological O | |
| examination O | |
| was O | |
| not O | |
| remarkable O | |
| except O | |
| for O | |
| her O | |
| hemiparesis B-ety | |
| . O | |
| cranial O | |
| CT O | |
| scans O | |
| showed O | |
| diffuse B-ety | |
| atrophy I-ety | |
| in O | |
| the O | |
| right O | |
| hemisphere O | |
| and O | |
| irregular O | |
| double-contoured O | |
| gyriform O | |
| cortical B-ety | |
| calcifications I-ety | |
| in O | |
| the O | |
| right O | |
| occipital O | |
| area O | |
| . O | |
| gadolinium O | |
| enhanced O | |
| brain O | |
| MRI O | |
| revealed O | |
| multiple O | |
| dilated O | |
| pial O | |
| venous O | |
| vascular O | |
| structures O | |
| on O | |
| right O | |
| hemisphere O | |
| also O | |
| with O | |
| the O | |
| diffuse B-ety | |
| atrophy I-ety | |
| on O | |
| the O | |
| same O | |
| side O | |
| . O | |
| axial O | |
| T1 O | |
| weighted O | |
| cranial O | |
| MRI O | |
| shows O | |
| right O | |
| calvarial O | |
| thickness O | |
| compared O | |
| to O | |
| the O | |
| left O | |
| and O | |
| right O | |
| hemisphere O | |
| is O | |
| asymmetrically O | |
| smaller O | |
| than O | |
| the O | |
| left O | |
| . O | |
| in O | |
| addition O | |
| to O | |
| that O | |
| , O | |
| T2 O | |
| weighted O | |
| MRI O | |
| shows O | |
| extensive O | |
| venous O | |
| formations O | |
| around O | |
| corpus O | |
| of O | |
| right O | |
| lateral O | |
| ventricle O | |
| and O | |
| at O | |
| gallen O | |
| vein O | |
| localization O | |
| and O | |
| widespread O | |
| vascular O | |
| formations O | |
| are O | |
| seen O | |
| at O | |
| perivascular O | |
| space O | |
| , O | |
| anterior O | |
| to O | |
| third O | |
| ventricle O | |
| at O | |
| willis O | |
| polygon O | |
| localization O | |
| and O | |
| at O | |
| right O | |
| temporooccipital O | |
| area O | |
| at O | |
| quadrigeminal O | |
| cistern O | |
| localization O | |
| . O | |
| she O | |
| was O | |
| performed O | |
| a O | |
| proteus O | |
| intelligence O | |
| test O | |
| in O | |
| which O | |
| she O | |
| had O | |
| 75 O | |
| points O | |
| and O | |
| accepted O | |
| as O | |
| mildly B-ety | |
| mentally I-ety | |
| retarded I-ety | |
| . O | |
| proteus O | |
| intelligence O | |
| test O | |
| in O | |
| which O | |
| she O | |
| had O | |
| 75 O | |
| points O | |
| and O | |
| accepted O | |
| as O | |
| mildly O | |
| mentally O | |
| retarded O | |
| . O | |
| A O | |
| 33 O | |
| - O | |
| year O | |
| man O | |
| working O | |
| in O | |
| gulf O | |
| , O | |
| presented O | |
| with O | |
| hemetemesis B-ety | |
| 15 O | |
| days O | |
| ago O | |
| in O | |
| the O | |
| month O | |
| of O | |
| february O | |
| this O | |
| year O | |
| . O | |
| this O | |
| was O | |
| preceeded O | |
| by O | |
| low O | |
| grade O | |
| fever B-ety | |
| , O | |
| bone B-ety | |
| pain I-ety | |
| , O | |
| generalised B-ety | |
| bodyache I-ety | |
| , O | |
| low B-ety | |
| back I-ety | |
| ache I-ety | |
| and O | |
| generalised B-ety | |
| macular I-ety | |
| skin I-ety | |
| rashes I-ety | |
| . O | |
| there O | |
| was O | |
| no O | |
| history O | |
| of O | |
| abdominal B-ety | |
| pain I-ety | |
| , O | |
| jaundice B-ety | |
| or O | |
| features O | |
| of O | |
| chronic B-ety | |
| liver I-ety | |
| disease I-ety | |
| . O | |
| he O | |
| gave O | |
| history O | |
| of O | |
| intake O | |
| of O | |
| analgesics O | |
| for O | |
| backache B-ety | |
| . O | |
| after O | |
| symptomatic O | |
| treatment O | |
| he O | |
| returned O | |
| back O | |
| . O | |
| he O | |
| came O | |
| to O | |
| our O | |
| OPD O | |
| with O | |
| complete O | |
| blood O | |
| count O | |
| which O | |
| showed O | |
| a O | |
| haemoglobin O | |
| of O | |
| 8g O | |
| / O | |
| dl O | |
| , O | |
| total O | |
| count O | |
| 6700 O | |
| / O | |
| mm3 O | |
| platelet O | |
| count O | |
| 24000 O | |
| / O | |
| mm3 O | |
| and O | |
| ESR O | |
| 55mm O | |
| / O | |
| hr O | |
| . O | |
| on O | |
| examination O | |
| patient O | |
| was O | |
| pale O | |
| with O | |
| non O | |
| pruritic O | |
| macular B-ety | |
| rashes I-ety | |
| and O | |
| mild O | |
| splenomegaly B-ety | |
| . O | |
| residing O | |
| in O | |
| middle O | |
| east O | |
| with O | |
| background O | |
| history O | |
| of O | |
| fever B-ety | |
| , O | |
| backache B-ety | |
| , O | |
| skin B-ety | |
| rash I-ety | |
| , O | |
| splenomegaly B-ety | |
| and O | |
| a O | |
| low O | |
| platelet O | |
| count O | |
| possibility O | |
| of O | |
| atypical O | |
| infection B-ety | |
| like O | |
| brucellosis B-ety | |
| with O | |
| NSAID O | |
| induced O | |
| gi B-ety | |
| bleed I-ety | |
| was O | |
| considered O | |
| . O | |
| he O | |
| was O | |
| admitted O | |
| for O | |
| further O | |
| evaluation O | |
| and O | |
| endoscopy O | |
| done O | |
| showed O | |
| a O | |
| nodular B-ety | |
| ulcerative I-ety | |
| lesions I-ety | |
| in O | |
| the O | |
| antrum O | |
| of O | |
| stomach O | |
| and O | |
| histopathologic O | |
| examination O | |
| confirmed O | |
| adenocarcinoma B-ety | |
| of I-ety | |
| stomach I-ety | |
| . O | |
| liver O | |
| function O | |
| tests O | |
| showed O | |
| a O | |
| high O | |
| ALP O | |
| ( O | |
| 1536 O | |
| U O | |
| / O | |
| l O | |
| ) O | |
| , O | |
| elevated O | |
| INR O | |
| ( O | |
| 2.15 O | |
| ) O | |
| though O | |
| bilirubin O | |
| , O | |
| transaminases O | |
| and O | |
| serum O | |
| proteins O | |
| were O | |
| normal O | |
| . O | |
| brucella O | |
| agglutination O | |
| test O | |
| was O | |
| negative O | |
| . O | |
| xray O | |
| chest O | |
| was O | |
| normal O | |
| . O | |
| ultrasound O | |
| of O | |
| abdomen O | |
| showed O | |
| normal O | |
| echotexture O | |
| of O | |
| liver O | |
| , O | |
| no O | |
| SOL O | |
| , O | |
| normal O | |
| portal O | |
| vein O | |
| and O | |
| no O | |
| IHBRD O | |
| . O | |
| CT O | |
| scan O | |
| of O | |
| the O | |
| abdomen O | |
| revealed O | |
| gross O | |
| pylorus B-ety | |
| thickening I-ety | |
| with O | |
| regional O | |
| lymphadenopathy B-ety | |
| and O | |
| skeletal O | |
| metastasis B-ety | |
| with O | |
| sclerotic O | |
| foci O | |
| involving O | |
| vertebrae O | |
| and O | |
| pelvic O | |
| bones O | |
| and O | |
| lytic O | |
| areas O | |
| in O | |
| bilateral O | |
| iliac O | |
| blades O | |
| with O | |
| no O | |
| liver B-ety | |
| metastasis I-ety | |
| or O | |
| ascites B-ety | |
| . O | |
| A O | |
| skeletal O | |
| survey O | |
| was O | |
| done O | |
| which O | |
| showed O | |
| lytic B-ety | |
| lesions I-ety | |
| in O | |
| the O | |
| iliac O | |
| and O | |
| femoral O | |
| bones O | |
| . O | |
| bone O | |
| marrow O | |
| aspirate O | |
| showed O | |
| decreased O | |
| red O | |
| cells O | |
| and O | |
| platelets O | |
| and O | |
| marrow O | |
| biopsy O | |
| done O | |
| was O | |
| reported O | |
| as O | |
| metastasis B-ety | |
| from O | |
| adenocarcinoma B-ety | |
| . O | |
| coagulation O | |
| profile O | |
| done O | |
| was O | |
| suggestive O | |
| of O | |
| DIC B-ety | |
| due O | |
| to O | |
| the O | |
| raised O | |
| levels O | |
| of O | |
| FDP O | |
| ( O | |
| 5,170 O | |
| ng O | |
| / O | |
| dl O | |
| ) O | |
| and O | |
| a O | |
| low O | |
| fibrinogen O | |
| \ O | |
| ( O | |
| 152mg O | |
| / O | |
| dl O | |
| ) O | |
| . O | |
| he O | |
| was O | |
| transferred O | |
| to O | |
| medical O | |
| oncology O | |
| department O | |
| for O | |
| subsequent O | |
| management O | |
| and O | |
| was O | |
| treated O | |
| with O | |
| chemotherapy O | |
| . O | |
| he O | |
| succumbed O | |
| to O | |
| his O | |
| illness O | |
| within O | |
| 10 O | |
| months O | |
| of O | |
| diagnosis O | |
| . O | |
| our O | |
| patient O | |
| was O | |
| an O | |
| 87 O | |
| - O | |
| year-old O | |
| african-american O | |
| woman O | |
| who O | |
| was O | |
| a O | |
| nursing O | |
| home O | |
| resident O | |
| , O | |
| with O | |
| a O | |
| history O | |
| of O | |
| diabetes B-ety | |
| mellitus I-ety | |
| type I-ety | |
| 2 I-ety | |
| and O | |
| subarachnoid B-ety | |
| hemorrhage I-ety | |
| leading O | |
| to O | |
| aphasia B-ety | |
| , O | |
| hemiplegia B-ety | |
| , O | |
| seizures B-ety | |
| and O | |
| dysphagia B-ety | |
| requiring O | |
| percutaneous O | |
| gastric O | |
| feeds O | |
| . O | |
| while O | |
| at O | |
| the O | |
| nursing O | |
| home O | |
| , O | |
| she O | |
| had O | |
| recurrent O | |
| aspiration B-ety | |
| pneumonia I-ety | |
| and O | |
| large O | |
| tube-feed O | |
| residuals O | |
| consistent O | |
| with O | |
| a O | |
| diagnosis O | |
| of O | |
| underlying O | |
| gastroparesis B-ety | |
| . O | |
| her O | |
| management O | |
| included O | |
| metoclopramide O | |
| and O | |
| reduced O | |
| tube-feeding O | |
| rates O | |
| , O | |
| which O | |
| improved O | |
| her O | |
| symptoms O | |
| . O | |
| however O | |
| , O | |
| within O | |
| months O | |
| the O | |
| aspiration B-ety | |
| and O | |
| increased O | |
| residuals O | |
| returned O | |
| . O | |
| after O | |
| trials O | |
| of O | |
| different O | |
| medication O | |
| therapies O | |
| without O | |
| success O | |
| , O | |
| she O | |
| started O | |
| mirtazapine O | |
| and O | |
| her O | |
| residual O | |
| volume O | |
| and O | |
| aspirations B-ety | |
| decreased O | |
| with O | |
| a O | |
| dose O | |
| of O | |
| 15mg O | |
| nightly O | |
| . O | |
| A O | |
| 3 O | |
| - O | |
| day-old O | |
| boy O | |
| from O | |
| kosovo O | |
| with O | |
| dextro-transposition B-ety | |
| of I-ety | |
| the I-ety | |
| great I-ety | |
| arteries I-ety | |
| who O | |
| developed O | |
| progressive B-ety | |
| heart I-ety | |
| failure I-ety | |
| required O | |
| an O | |
| emergency O | |
| arterial O | |
| switch O | |
| operation O | |
| . O | |
| because O | |
| of O | |
| persistent O | |
| pulmonary B-ety | |
| edema I-ety | |
| after O | |
| completion O | |
| of O | |
| the O | |
| arterial O | |
| switch O | |
| operation O | |
| at O | |
| our O | |
| institution O | |
| , O | |
| the O | |
| patient O | |
| could O | |
| not O | |
| be O | |
| weaned O | |
| off O | |
| mechanical O | |
| ventilation O | |
| . O | |
| transthoracic O | |
| echocardiography O | |
| revealed O | |
| an O | |
| anomalous O | |
| accelerated O | |
| flow O | |
| , O | |
| indicating O | |
| an O | |
| anomalous O | |
| systemic O | |
| pulmonary O | |
| shunt O | |
| . O | |
| arterial O | |
| catheterization O | |
| revealed O | |
| an O | |
| abnormal B-ety | |
| bronchial I-ety | |
| artery I-ety | |
| originating O | |
| from O | |
| the O | |
| left O | |
| subclavian O | |
| artery O | |
| and O | |
| bifurcating O | |
| to O | |
| both O | |
| lungs O | |
| . O | |
| the O | |
| anomalous B-ety | |
| ectatic I-ety | |
| bronchial I-ety | |
| artery I-ety | |
| was O | |
| successfully O | |
| occluded O | |
| by O | |
| coil O | |
| embolization O | |
| . O | |
| the O | |
| improvement O | |
| of O | |
| the O | |
| patient's O | |
| hemodynamic O | |
| status O | |
| resulted O | |
| in O | |
| an O | |
| uneventful O | |
| post-operative O | |
| course O | |
| . O | |
| A O | |
| 43 O | |
| - O | |
| year-old O | |
| non-diabetic O | |
| indian O | |
| male O | |
| reported O | |
| to O | |
| our O | |
| outpatient O | |
| department O | |
| with O | |
| chief O | |
| complaints O | |
| of O | |
| cough B-ety | |
| with O | |
| expectoration O | |
| , O | |
| chest B-ety | |
| pain I-ety | |
| , O | |
| reduced B-ety | |
| appetite I-ety | |
| , O | |
| fever B-ety | |
| with I-ety | |
| chills I-ety | |
| , O | |
| and O | |
| night B-ety | |
| sweats I-ety | |
| for O | |
| two O | |
| weeks O | |
| . O | |
| he O | |
| also O | |
| complained O | |
| of O | |
| breathlessness B-ety | |
| on O | |
| exertion O | |
| and O | |
| had O | |
| two O | |
| episodes O | |
| of O | |
| blood B-ety | |
| in I-ety | |
| his I-ety | |
| sputum I-ety | |
| . O | |
| the O | |
| patient O | |
| explained O | |
| that O | |
| the O | |
| cough B-ety | |
| was O | |
| continuous O | |
| and O | |
| was O | |
| relieved O | |
| after O | |
| taking O | |
| cough O | |
| syrup O | |
| . O | |
| he O | |
| also O | |
| mentioned O | |
| that O | |
| the O | |
| episodes O | |
| of O | |
| fever B-ety | |
| were O | |
| initially O | |
| intermittent O | |
| and O | |
| then O | |
| daily O | |
| for O | |
| the O | |
| last O | |
| two O | |
| weeks O | |
| and O | |
| were O | |
| relieved O | |
| after O | |
| taking O | |
| paracetamol O | |
| . O | |
| the O | |
| chest B-ety | |
| pain I-ety | |
| was O | |
| localized O | |
| to O | |
| the O | |
| middle O | |
| of O | |
| the O | |
| chest O | |
| and O | |
| was O | |
| aggravated O | |
| on O | |
| exertion O | |
| . O | |
| he O | |
| was O | |
| a O | |
| businessman O | |
| by O | |
| profession O | |
| with O | |
| no O | |
| history O | |
| of O | |
| smoking O | |
| , O | |
| alcoholism O | |
| , O | |
| or O | |
| any O | |
| other O | |
| substance O | |
| abuse O | |
| . O | |
| also O | |
| , O | |
| there O | |
| was O | |
| no O | |
| history O | |
| of O | |
| any O | |
| contact O | |
| of O | |
| TB B-ety | |
| or O | |
| COVID B-ety | |
| - I-ety | |
| 19 I-ety | |
| in O | |
| the O | |
| family O | |
| or O | |
| close O | |
| contacts O | |
| . O | |
| and O | |
| there O | |
| was O | |
| no O | |
| history O | |
| of O | |
| foreign O | |
| travel O | |
| in O | |
| the O | |
| recent O | |
| past O | |
| . O | |
| but O | |
| he O | |
| had O | |
| reported O | |
| having O | |
| traveled O | |
| by O | |
| a O | |
| domestic O | |
| airline O | |
| about O | |
| twenty O | |
| days O | |
| back O | |
| . O | |
| there O | |
| was O | |
| no O | |
| history O | |
| of O | |
| weight O | |
| loss O | |
| or O | |
| any O | |
| other O | |
| major O | |
| illness O | |
| in O | |
| the O | |
| past O | |
| . O | |
| on O | |
| examination O | |
| his O | |
| vitals O | |
| were-pulse O | |
| - O | |
| 108 O | |
| / O | |
| minute O | |
| , O | |
| arterial O | |
| BP O | |
| - O | |
| 130 O | |
| / O | |
| 80 O | |
| mm O | |
| of O | |
| hg O | |
| , O | |
| respiratory O | |
| rate O | |
| of O | |
| 30 O | |
| breaths O | |
| / O | |
| minute O | |
| , O | |
| sp02 O | |
| - O | |
| 899% O | |
| on O | |
| room O | |
| air O | |
| , O | |
| temperature O | |
| - O | |
| 101 O | |
| - O | |
| degree O | |
| centigrade O | |
| . O | |
| his O | |
| sp02 O | |
| fell O | |
| by O | |
| 70% O | |
| on O | |
| room O | |
| air O | |
| after O | |
| waking O | |
| . O | |
| on O | |
| auscultation O | |
| , O | |
| there O | |
| was O | |
| crepitation B-ety | |
| on O | |
| the O | |
| bilateral O | |
| middle O | |
| lobes O | |
| of O | |
| the O | |
| lungs O | |
| . O | |
| also O | |
| , O | |
| dyspnea B-ety | |
| on O | |
| exertion O | |
| was O | |
| noted O | |
| . O | |
| the O | |
| rest O | |
| of O | |
| the O | |
| systemic O | |
| examination O | |
| was O | |
| within O | |
| normal O | |
| limits O | |
| . O | |
| considering O | |
| this O | |
| as O | |
| a O | |
| probable O | |
| case O | |
| of O | |
| TB B-ety | |
| with O | |
| COVID B-ety | |
| - I-ety | |
| 19 I-ety | |
| he O | |
| was O | |
| advised O | |
| a O | |
| chest O | |
| radiograph O | |
| with O | |
| sputum O | |
| microscopy O | |
| ( O | |
| ziehl O | |
| neelsen O | |
| ( O | |
| ZN O | |
| ) O | |
| staining O | |
| for O | |
| acid-fast O | |
| bacilli O | |
| ) O | |
| , O | |
| cartridge-based O | |
| nucleic O | |
| acid O | |
| amplification O | |
| test O | |
| ( O | |
| CBNAAT O | |
| ) O | |
| of O | |
| the O | |
| sputum O | |
| and O | |
| other O | |
| routine O | |
| investigations O | |
| . O | |
| to O | |
| check O | |
| for O | |
| the O | |
| COVID B-ety | |
| - I-ety | |
| 19 I-ety | |
| he O | |
| was O | |
| advised O | |
| qualitative O | |
| polymerase O | |
| chain O | |
| reaction O | |
| ( O | |
| PCR O | |
| ) O | |
| test O | |
| from O | |
| the O | |
| oropharyngeal O | |
| swab O | |
| . O | |
| the O | |
| results O | |
| were O | |
| surprising O | |
| with O | |
| mycobacterium B-ety | |
| tuberculosis I-ety | |
| detected O | |
| on O | |
| sputum O | |
| fluorescent O | |
| microscopy O | |
| and O | |
| were O | |
| also O | |
| confirmed O | |
| by O | |
| the O | |
| CBNAAT O | |
| . O | |
| however O | |
| , O | |
| there O | |
| was O | |
| no O | |
| resistance O | |
| to O | |
| rifampicin O | |
| . O | |
| the O | |
| results O | |
| of O | |
| the O | |
| PCR O | |
| were O | |
| positive O | |
| for O | |
| RNA O | |
| specific O | |
| to O | |
| sars-cov B-ety | |
| - I-ety | |
| 2 I-ety | |
| . O | |
| besides O | |
| , O | |
| the O | |
| chest O | |
| radiograph O | |
| pa-view O | |
| was O | |
| suggestive O | |
| of O | |
| bilateral O | |
| consolidations B-ety | |
| on I-ety | |
| the I-ety | |
| middle I-ety | |
| lobes I-ety | |
| of I-ety | |
| lungs I-ety | |
| with O | |
| ill-defined O | |
| borders O | |
| . O | |
| the O | |
| other O | |
| investigations O | |
| revealed O | |
| a O | |
| low B-ety | |
| lymphocyte I-ety | |
| count I-ety | |
| ( O | |
| 1x O | |
| 10 O | |
| 9 O | |
| / O | |
| L O | |
| ) O | |
| and O | |
| increased B-ety | |
| levels I-ety | |
| of I-ety | |
| c-reactive I-ety | |
| protein I-ety | |
| ( O | |
| CRP O | |
| ) O | |
| ( O | |
| 57 O | |
| mg O | |
| / O | |
| L O | |
| ) O | |
| , O | |
| lactate O | |
| dehydrogenase O | |
| ( O | |
| LDH O | |
| ) O | |
| ( O | |
| 580 O | |
| U O | |
| / O | |
| L O | |
| ) O | |
| , O | |
| and O | |
| erythrocyte O | |
| sedimentation O | |
| rate O | |
| ( O | |
| ESR O | |
| ) O | |
| ( O | |
| 70 O | |
| mm O | |
| in O | |
| the O | |
| 1 O | |
| st O | |
| hour O | |
| ) O | |
| . O | |
| also O | |
| , O | |
| a O | |
| sample O | |
| for O | |
| liquid O | |
| culture O | |
| ( O | |
| MGIT O | |
| BACTEC O | |
| ) O | |
| was O | |
| sent O | |
| to O | |
| the O | |
| intermediate O | |
| reference O | |
| laboratory O | |
| ( O | |
| IRL O | |
| ) O | |
| which O | |
| revealed O | |
| the O | |
| growth O | |
| of O | |
| mycobacterium B-ety | |
| tuberculosis I-ety | |
| . O | |
| computed O | |
| tomography O | |
| was O | |
| not O | |
| performed O | |
| as O | |
| the O | |
| diagnosis O | |
| was O | |
| established O | |
| by O | |
| other O | |
| cheaper O | |
| and O | |
| faster O | |
| methods O | |
| and O | |
| also O | |
| the O | |
| patient O | |
| was O | |
| unwilling O | |
| for O | |
| the O | |
| same O | |
| . O | |
| all O | |
| the O | |
| other O | |
| routine O | |
| investigations O | |
| were O | |
| within O | |
| normal O | |
| limits O | |
| . O | |
| he O | |
| was O | |
| referred O | |
| to O | |
| the O | |
| nearest O | |
| designated O | |
| COVID O | |
| - O | |
| 19 O | |
| management O | |
| center O | |
| , O | |
| where O | |
| he O | |
| was O | |
| managed O | |
| as O | |
| per O | |
| national O | |
| guidelines O | |
| . O | |
| besides O | |
| , O | |
| he O | |
| was O | |
| also O | |
| started O | |
| on O | |
| an O | |
| antitubercular O | |
| treatment O | |
| of O | |
| four O | |
| drugs O | |
| as O | |
| per O | |
| the O | |
| national O | |
| tuberculosis B-ety | |
| elimination O | |
| program O | |
| ( O | |
| NTEP O | |
| ) O | |
| guidelines O | |
| . O | |
| he O | |
| was O | |
| advised O | |
| follow-up O | |
| post O | |
| completion O | |
| of O | |
| his O | |
| stay O | |
| at O | |
| the O | |
| designated O | |
| COVID O | |
| - O | |
| 19 O | |
| center O | |
| , O | |
| but O | |
| he O | |
| has O | |
| not O | |
| yet O | |
| reported O | |
| back O | |
| for O | |
| follow-up O | |
| . O | |
| written O | |
| informed O | |
| consent O | |
| was O | |
| obtained O | |
| from O | |
| the O | |
| patient O | |
| for O | |
| using O | |
| clinical O | |
| data O | |
| and O | |
| images O | |
| for O | |
| publication O | |
| in O | |
| this O | |
| study O | |
| . O | |
| A O | |
| 23 O | |
| year O | |
| old O | |
| female O | |
| patient O | |
| ( O | |
| weight O | |
| 67kg O | |
| , O | |
| height O | |
| 171cm O | |
| , O | |
| BMI O | |
| 22.91kg O | |
| / O | |
| cm O | |
| 2 O | |
| ) O | |
| presented O | |
| to O | |
| emergency O | |
| department O | |
| with O | |
| fever B-ety | |
| ( O | |
| 39.4oc O | |
| ) O | |
| , O | |
| tachycardia B-ety | |
| ( O | |
| 116 O | |
| bpm O | |
| ) O | |
| , O | |
| hypotension B-ety | |
| ( O | |
| 95 O | |
| / O | |
| 45 O | |
| mmhg O | |
| ) O | |
| , O | |
| tachypnoea B-ety | |
| ( O | |
| 25 O | |
| breaths O | |
| / O | |
| min O | |
| ) O | |
| , O | |
| sore B-ety | |
| throat I-ety | |
| , O | |
| neck B-ety | |
| pain I-ety | |
| , O | |
| diffuse B-ety | |
| pain I-ety | |
| and O | |
| tissue O | |
| oedema B-ety | |
| in O | |
| the O | |
| right-side O | |
| gluteal O | |
| region O | |
| . O | |
| she O | |
| was O | |
| appointed O | |
| to O | |
| hospital O | |
| by O | |
| a O | |
| private O | |
| outpatient O | |
| surgical O | |
| center O | |
| where O | |
| she O | |
| had O | |
| undergone O | |
| perineal O | |
| abscess O | |
| drainage O | |
| a O | |
| week O | |
| before O | |
| . O | |
| recent O | |
| medical O | |
| history O | |
| included O | |
| also O | |
| endometrial O | |
| curettage O | |
| for O | |
| ERPC O | |
| a O | |
| month O | |
| before O | |
| and O | |
| conservative O | |
| therapy O | |
| for O | |
| hemorrhoids B-ety | |
| 15 O | |
| days O | |
| after O | |
| . O | |
| past O | |
| medical O | |
| history O | |
| included O | |
| henoch-schönlein B-ety | |
| purpura I-ety | |
| during O | |
| childhood O | |
| . O | |
| social O | |
| history O | |
| included O | |
| smoking O | |
| ( O | |
| 11 O | |
| pack-years O | |
| ) O | |
| , O | |
| family O | |
| history O | |
| was O | |
| non-contributory O | |
| . O | |
| she O | |
| had O | |
| no O | |
| known O | |
| drug O | |
| allergies O | |
| . O | |
| complete O | |
| blood O | |
| count O | |
| revealed O | |
| marked O | |
| neutrophilic B-ety | |
| leukocytosis I-ety | |
| ( O | |
| WBC O | |
| 23.400 O | |
| / O | |
| lt O | |
| ) O | |
| . O | |
| A O | |
| CT O | |
| scan O | |
| revealed O | |
| small O | |
| bilateral B-ety | |
| pleural I-ety | |
| effusions I-ety | |
| , O | |
| small O | |
| hepatic B-ety | |
| enlargement I-ety | |
| , O | |
| gerota's O | |
| fascia O | |
| thickening O | |
| , O | |
| perineal O | |
| soft O | |
| tissue O | |
| stranding O | |
| with O | |
| fascial O | |
| thickening O | |
| and O | |
| small O | |
| bubbles O | |
| of O | |
| air O | |
| . O | |
| fournier's B-ety | |
| gangrene I-ety | |
| was O | |
| set O | |
| as O | |
| working O | |
| diagnosis O | |
| ( O | |
| calculated O | |
| FGSI O | |
| 8 O | |
| , O | |
| UFGSI O | |
| 10 O | |
| and O | |
| LRINEC O | |
| 7 O | |
| ) O | |
| and O | |
| the O | |
| patient O | |
| was O | |
| transported O | |
| to O | |
| operation O | |
| room O | |
| for O | |
| immediate O | |
| radical O | |
| surgical O | |
| debridement O | |
| of O | |
| necrotic O | |
| tissue O | |
| . O | |
| blood O | |
| and O | |
| surgical O | |
| material O | |
| was O | |
| taken O | |
| for O | |
| microbiologic O | |
| analysis O | |
| . O | |
| due O | |
| to O | |
| the O | |
| extent O | |
| of O | |
| the O | |
| surgical O | |
| debridement O | |
| , O | |
| the O | |
| patient O | |
| was O | |
| admitted O | |
| postoperatively O | |
| to O | |
| the O | |
| ICU O | |
| ( O | |
| SOFA O | |
| score O | |
| 6 O | |
| , O | |
| APACHE O | |
| II O | |
| score O | |
| 12 O | |
| ) O | |
| ; O | |
| where O | |
| sedation O | |
| ( O | |
| midazolam O | |
| 30 O | |
| mcg O | |
| / O | |
| kg O | |
| / O | |
| hr O | |
| c.iv O | |
| ) O | |
| , O | |
| analgesia O | |
| ( O | |
| fentanyl O | |
| 3 O | |
| mcg O | |
| / O | |
| kg O | |
| / O | |
| min O | |
| c.iv O | |
| ) O | |
| , O | |
| triple O | |
| antibiotic O | |
| regimen O | |
| with O | |
| meropenem O | |
| 2gr O | |
| q8h O | |
| i.v O | |
| . O | |
| , O | |
| clindamycin O | |
| 600mg O | |
| q O | |
| 6h O | |
| i.v O | |
| . O | |
| and O | |
| daptomycin O | |
| 500mg O | |
| q.d O | |
| . O | |
| i.v O | |
| . O | |
| , O | |
| gastroprotective O | |
| and O | |
| antithrombotic O | |
| prophylaxis O | |
| were O | |
| initiated O | |
| . O | |
| during O | |
| the O | |
| next O | |
| 3 O | |
| days O | |
| a O | |
| second O | |
| CT O | |
| and O | |
| an O | |
| obstetrical O | |
| consultation O | |
| were O | |
| conducted O | |
| with O | |
| no O | |
| significant O | |
| findings O | |
| . O | |
| human B-ety | |
| immunodeficiency I-ety | |
| virus I-ety | |
| and O | |
| diabetic B-ety | |
| screen O | |
| were O | |
| also O | |
| negative O | |
| . O | |
| yet O | |
| , O | |
| the O | |
| patient O | |
| remained O | |
| febrile B-ety | |
| . O | |
| microbiology O | |
| cultures O | |
| from O | |
| material O | |
| taken O | |
| from O | |
| the O | |
| surgical O | |
| trauma O | |
| area O | |
| revealed O | |
| candida O | |
| albicans O | |
| , O | |
| staphylococcus O | |
| epidermidis O | |
| and O | |
| klebsiella O | |
| pneumonia O | |
| ; O | |
| hence O | |
| antibiotic O | |
| regimen O | |
| was O | |
| modified O | |
| and O | |
| antimycotic O | |
| treatment O | |
| ( O | |
| caspofungin O | |
| 100mg O | |
| q.d O | |
| . O | |
| i.v O | |
| . O | |
| ) O | |
| was O | |
| initiated O | |
| too O | |
| . O | |
| debridements O | |
| were O | |
| repeated O | |
| every O | |
| 24 O | |
| hours O | |
| but O | |
| due O | |
| to O | |
| the O | |
| extent O | |
| of O | |
| the O | |
| lesions B-ety | |
| , O | |
| on O | |
| the O | |
| 10 O | |
| th O | |
| day O | |
| , O | |
| the O | |
| patient O | |
| was O | |
| transported O | |
| to O | |
| operation O | |
| room O | |
| for O | |
| temporary O | |
| ileostomy O | |
| till O | |
| the O | |
| end O | |
| of O | |
| the O | |
| therapy O | |
| . O | |
| percutaneous O | |
| tracheotomy O | |
| was O | |
| also O | |
| performed O | |
| . O | |
| hyperbaric O | |
| oxygen O | |
| therapy O | |
| was O | |
| not O | |
| available O | |
| at O | |
| the O | |
| setting O | |
| . O | |
| one O | |
| day O | |
| after O | |
| the O | |
| second O | |
| surgery O | |
| , O | |
| patient's O | |
| condition O | |
| complicated O | |
| with O | |
| MRSA O | |
| ventilation B-ety | |
| associated I-ety | |
| pneumonia I-ety | |
| . O | |
| along O | |
| with O | |
| that O | |
| , O | |
| a O | |
| localized B-ety | |
| oedema I-ety | |
| appeared O | |
| in O | |
| her O | |
| left O | |
| upper O | |
| limb O | |
| . O | |
| A O | |
| palpable B-ety | |
| mass I-ety | |
| along O | |
| the O | |
| anterior O | |
| margin O | |
| of O | |
| the O | |
| sternocleidomastoid O | |
| muscle O | |
| was O | |
| also O | |
| noticed O | |
| . O | |
| vascular O | |
| ultrasound O | |
| examination O | |
| revealed O | |
| occlusion B-ety | |
| of I-ety | |
| left I-ety | |
| internal I-ety | |
| jugular I-ety | |
| vein I-ety | |
| . O | |
| transcranial O | |
| doppler O | |
| examination O | |
| was O | |
| normal O | |
| . O | |
| dental O | |
| consultation O | |
| and O | |
| examination O | |
| of O | |
| soft O | |
| palate O | |
| and O | |
| peritonsilar O | |
| tissues O | |
| showed O | |
| no O | |
| abnormalities O | |
| . O | |
| linezolide O | |
| 600 O | |
| mg O | |
| q12h O | |
| i.v O | |
| . O | |
| was O | |
| added O | |
| to O | |
| antibiotic O | |
| regimen O | |
| . O | |
| since O | |
| debridements O | |
| were O | |
| going O | |
| on O | |
| , O | |
| simultaneous O | |
| anticoagulation O | |
| therapy O | |
| was O | |
| started O | |
| with O | |
| only O | |
| bemiparine O | |
| 2500 O | |
| b.i.d O | |
| . O | |
| s.c O | |
| . O | |
| gradually O | |
| , O | |
| the O | |
| patient O | |
| became O | |
| afebrile O | |
| and O | |
| her O | |
| clinical O | |
| condition O | |
| improved O | |
| . O | |
| she O | |
| was O | |
| discharged O | |
| from O | |
| ICU O | |
| 13 O | |
| days O | |
| later O | |
| . O | |
| A O | |
| follow-up O | |
| CTA O | |
| confirmed O | |
| the O | |
| disappearance O | |
| of O | |
| the O | |
| left B-ety | |
| jugular I-ety | |
| vein I-ety | |
| thrombosis I-ety | |
| . O | |
| about O | |
| a O | |
| month O | |
| after O | |
| her O | |
| ICU O | |
| discharge O | |
| , O | |
| an O | |
| operation O | |
| was O | |
| performed O | |
| for O | |
| ileostomy O | |
| closure O | |
| and O | |
| reconstruction O | |
| of O | |
| the O | |
| right O | |
| gluteal O | |
| region O | |
| . O | |
| on O | |
| a O | |
| follow-up O | |
| examination O | |
| 6 O | |
| months O | |
| later O | |
| , O | |
| the O | |
| young O | |
| woman O | |
| had O | |
| returned O | |
| to O | |
| her O | |
| normal O | |
| everyday O | |
| life O | |
| . O | |
| A O | |
| 31 O | |
| - O | |
| year-old O | |
| woman O | |
| with O | |
| no O | |
| pathological O | |
| history O | |
| was O | |
| admitted O | |
| to O | |
| our O | |
| hospital O | |
| for O | |
| chest B-ety | |
| pain I-ety | |
| , O | |
| bone B-ety | |
| and I-ety | |
| joint I-ety | |
| pain I-ety | |
| , O | |
| hair B-ety | |
| loss I-ety | |
| and O | |
| asthenia B-ety | |
| for O | |
| the O | |
| last O | |
| 3 O | |
| months O | |
| . O | |
| on O | |
| physical O | |
| examination O | |
| , O | |
| we O | |
| found O | |
| fever B-ety | |
| at O | |
| 38 O | |
| ° O | |
| C O | |
| , O | |
| polypnea B-ety | |
| at O | |
| 32 O | |
| cycles O | |
| / O | |
| min O | |
| , O | |
| arterial O | |
| hypertension B-ety | |
| at O | |
| 160 O | |
| / O | |
| 90 O | |
| mmhg O | |
| , O | |
| malar O | |
| rash O | |
| , O | |
| synovitis B-ety | |
| of I-ety | |
| wrists I-ety | |
| , I-ety | |
| elbows I-ety | |
| and I-ety | |
| ankles I-ety | |
| , O | |
| and O | |
| edema B-ety | |
| on O | |
| both O | |
| legs O | |
| . O | |
| diagnostic O | |
| assessment O | |
| : O | |
| laboratory O | |
| tests O | |
| disclosed O | |
| the O | |
| following O | |
| values O | |
| : O | |
| increase O | |
| level O | |
| of O | |
| erythrocyte O | |
| sedimentation O | |
| rate O | |
| 120 O | |
| mm O | |
| / O | |
| 1 O | |
| st O | |
| hour O | |
| , O | |
| C O | |
| reactive O | |
| protein O | |
| was O | |
| 20 O | |
| mg O | |
| / O | |
| l O | |
| . O | |
| the O | |
| blood O | |
| count O | |
| showed O | |
| hemoglobin O | |
| at O | |
| 9g O | |
| / O | |
| dl O | |
| , O | |
| MCV O | |
| at O | |
| 85 O | |
| µ O | |
| 3 O | |
| , O | |
| lymphopenia O | |
| at O | |
| 400 O | |
| / O | |
| mm O | |
| 3 O | |
| , O | |
| while O | |
| platelets O | |
| were O | |
| normal O | |
| 450 O | |
| 000 O | |
| / O | |
| mm O | |
| 3 O | |
| . O | |
| direct O | |
| coombs O | |
| test O | |
| was O | |
| negative O | |
| . O | |
| serum O | |
| albumin O | |
| was O | |
| 25g O | |
| / O | |
| l O | |
| ; O | |
| proteins O | |
| level O | |
| was O | |
| low O | |
| at O | |
| 50g O | |
| / O | |
| l O | |
| and O | |
| proteinuria O | |
| at O | |
| 3.2g O | |
| / O | |
| day O | |
| . O | |
| creatinine O | |
| was O | |
| normal O | |
| . O | |
| anti-nuclear O | |
| antibody O | |
| ANA O | |
| were O | |
| positive O | |
| 1 O | |
| / O | |
| 320 O | |
| with O | |
| homogeneous O | |
| pattern O | |
| , O | |
| anti-dsdna O | |
| level O | |
| was O | |
| 160U O | |
| / O | |
| ml O | |
| . O | |
| anti-cardiolipin O | |
| igg O | |
| antibodies O | |
| were O | |
| positive O | |
| 25UGPL O | |
| . O | |
| rheumatoid O | |
| factor O | |
| was O | |
| negative O | |
| . O | |
| C3 O | |
| and O | |
| C4 O | |
| complement O | |
| fractions O | |
| were O | |
| low O | |
| ( O | |
| 0.2 O | |
| g O | |
| / O | |
| l O | |
| and O | |
| 0.05 O | |
| g O | |
| / O | |
| l O | |
| ) O | |
| . O | |
| chest O | |
| x-ray O | |
| , O | |
| electrocardiogram O | |
| and O | |
| echocardiography O | |
| were O | |
| normal O | |
| . O | |
| chest O | |
| computed O | |
| tomography O | |
| ( O | |
| CT O | |
| ) O | |
| scan O | |
| showed O | |
| proximal O | |
| pulmonary B-ety | |
| embolism I-ety | |
| . O | |
| renal O | |
| ultrasound O | |
| was O | |
| normal O | |
| . O | |
| renal O | |
| biopsy O | |
| reveals O | |
| immunocomplex O | |
| nephritis B-ety | |
| , O | |
| lupus B-ety | |
| nephritis I-ety | |
| , O | |
| segmental O | |
| mesangial B-ety | |
| proliferation I-ety | |
| , O | |
| mild O | |
| activity O | |
| lupus O | |
| nephritis O | |
| class O | |
| III O | |
| ( O | |
| A O | |
| / O | |
| C O | |
| ) O | |
| . O | |
| before O | |
| starting O | |
| corticosteroids O | |
| , O | |
| we O | |
| analyzed O | |
| electrolytes O | |
| . O | |
| serum O | |
| calcium O | |
| was O | |
| elevated O | |
| 132 O | |
| mg O | |
| / O | |
| l O | |
| with O | |
| hyper-calciuria B-ety | |
| 479 O | |
| mg O | |
| / O | |
| 24 O | |
| h O | |
| . O | |
| 25 O | |
| OHD O | |
| was O | |
| normal O | |
| . O | |
| alcaline O | |
| phosphatase O | |
| was O | |
| 420 O | |
| UI O | |
| / O | |
| l O | |
| . O | |
| the O | |
| patient O | |
| did O | |
| not O | |
| have O | |
| any O | |
| symptoms O | |
| of O | |
| hypercalcemia B-ety | |
| . O | |
| serum O | |
| protein O | |
| electrophoresis O | |
| showed O | |
| polyclonal B-ety | |
| hypergammaglobulinaemia I-ety | |
| . O | |
| serum O | |
| and O | |
| urine O | |
| immunofixation O | |
| as O | |
| well O | |
| as O | |
| bence-jones O | |
| proteinuria O | |
| were O | |
| negative O | |
| . O | |
| intact O | |
| parathyroid O | |
| hormone O | |
| ( O | |
| ipth O | |
| ) O | |
| was O | |
| high O | |
| 628 O | |
| pg O | |
| / O | |
| ml O | |
| . O | |
| CT O | |
| scan O | |
| and O | |
| ultrasound O | |
| of O | |
| parathyroid O | |
| imaging O | |
| revealed O | |
| a O | |
| lower O | |
| left O | |
| parathyroid O | |
| nodule B-ety | |
| measuring O | |
| 2cm O | |
| x O | |
| 1 O | |
| cm O | |
| . O | |
| femoral O | |
| and O | |
| lumbar O | |
| bone O | |
| mineral O | |
| density O | |
| ( O | |
| BMD O | |
| ) O | |
| showed O | |
| osteoporosis B-ety | |
| ( O | |
| t-score O | |
| : O | |
| - O | |
| 2.6 O | |
| ) O | |
| . O | |
| in O | |
| addition O | |
| , O | |
| we O | |
| found O | |
| multiple O | |
| pelvic O | |
| osteolytic B-ety | |
| lesions I-ety | |
| at O | |
| CT O | |
| scan O | |
| . O | |
| other O | |
| causes O | |
| of O | |
| hypercalcemia B-ety | |
| and O | |
| bone O | |
| lysis B-ety | |
| were O | |
| excluded O | |
| . O | |
| the O | |
| diagnosis O | |
| in O | |
| this O | |
| case O | |
| was O | |
| SLE B-ety | |
| with I-ety | |
| lupus I-ety | |
| nephritis I-ety | |
| class I-ety | |
| III I-ety | |
| and O | |
| anti-phospholipid B-ety | |
| syndrome I-ety | |
| , O | |
| complicated O | |
| by O | |
| pulmonary B-ety | |
| embolism I-ety | |
| associated O | |
| to O | |
| primary O | |
| hyperparathyroidism B-ety | |
| causing O | |
| severe O | |
| hypercalcemia B-ety | |
| , O | |
| osteoporosis B-ety | |
| . O | |
| therapeutic O | |
| intervention O | |
| : O | |
| the O | |
| patient O | |
| was O | |
| given O | |
| a O | |
| pulse O | |
| of O | |
| methyl-prednisolone O | |
| 15 O | |
| mg O | |
| / O | |
| kg O | |
| / O | |
| day O | |
| for O | |
| 3 O | |
| days O | |
| followed O | |
| by O | |
| oral O | |
| prednisone O | |
| 1 O | |
| mg O | |
| / O | |
| kg O | |
| / O | |
| day O | |
| , O | |
| associated O | |
| with O | |
| intravenous O | |
| cyclophosphamide O | |
| 750 O | |
| mg O | |
| / O | |
| m O | |
| 2 O | |
| / O | |
| month O | |
| for O | |
| 6 O | |
| months O | |
| . O | |
| mycophenolate O | |
| mofetil O | |
| 2 O | |
| g O | |
| / O | |
| day O | |
| was O | |
| prescribed O | |
| as O | |
| a O | |
| maintenance O | |
| therapy O | |
| of O | |
| lupus B-ety | |
| nephritis I-ety | |
| with O | |
| hydroxychloroquine O | |
| at O | |
| a O | |
| dose O | |
| of O | |
| 400 O | |
| mg O | |
| / O | |
| day O | |
| . O | |
| treatment O | |
| of O | |
| pulmonary B-ety | |
| embolism I-ety | |
| was O | |
| initiated O | |
| with O | |
| subcutaneous O | |
| low O | |
| molecular O | |
| weight O | |
| heparin O | |
| ( O | |
| enoxaparin O | |
| 0.1 O | |
| ml O | |
| / O | |
| 10 O | |
| kg O | |
| / O | |
| 12h O | |
| ) O | |
| followed O | |
| by O | |
| antivitamin O | |
| K O | |
| . O | |
| for O | |
| hypercalcemia B-ety | |
| , O | |
| patient O | |
| has O | |
| received O | |
| intravenous O | |
| fluid O | |
| with O | |
| furosemide O | |
| . O | |
| she O | |
| also O | |
| required O | |
| alendronate O | |
| 70 O | |
| mg O | |
| / O | |
| week O | |
| with O | |
| vitamin O | |
| D O | |
| 400u O | |
| / O | |
| day O | |
| for O | |
| osteoporosis B-ety | |
| . O | |
| the O | |
| left O | |
| parathyroid O | |
| gland O | |
| was O | |
| surgically O | |
| removed O | |
| . O | |
| histopathological O | |
| examination O | |
| revealed O | |
| parathyroid B-ety | |
| adenoma I-ety | |
| . O | |
| her O | |
| immediate O | |
| postoperative O | |
| parathyroid O | |
| hormone O | |
| level O | |
| was O | |
| 64 O | |
| pg O | |
| / O | |
| ml O | |
| with O | |
| a O | |
| calcium O | |
| level O | |
| of O | |
| 98 O | |
| mg O | |
| / O | |
| l O | |
| . O | |
| follow-up O | |
| and O | |
| outcomes O | |
| : O | |
| forty-eight O | |
| hours O | |
| after O | |
| the O | |
| surgery O | |
| she O | |
| developed O | |
| oral B-ety | |
| paresthesia I-ety | |
| . O | |
| she O | |
| had O | |
| hypocalcemia B-ety | |
| at O | |
| 72 O | |
| mg O | |
| / O | |
| l O | |
| . O | |
| she O | |
| required O | |
| oral O | |
| supplementation O | |
| for O | |
| few O | |
| months O | |
| . O | |
| additional O | |
| investigations O | |
| for O | |
| multiple B-ety | |
| endocrine I-ety | |
| neoplasia I-ety | |
| were O | |
| negative O | |
| . O | |
| the O | |
| patient O | |
| remained O | |
| asymptomatic O | |
| . O | |
| her O | |
| SLE B-ety | |
| was O | |
| calm O | |
| without O | |
| any O | |
| relapse O | |
| . O | |
| control O | |
| of O | |
| proteinuria B-ety | |
| was O | |
| negative O | |
| . O | |
| corticosteroids O | |
| was O | |
| dropped O | |
| . O | |
| the O | |
| follow-up O | |
| was O | |
| 4 O | |
| years O | |
| . O | |
| this O | |
| case O | |
| report O | |
| describes O | |
| the O | |
| condition O | |
| of O | |
| a O | |
| 30 O | |
| - O | |
| year-old O | |
| man O | |
| involved O | |
| in O | |
| a O | |
| motor O | |
| vehicle O | |
| collision O | |
| . O | |
| clinical O | |
| examination O | |
| , O | |
| x-rays O | |
| , O | |
| and O | |
| computed O | |
| tomography O | |
| scan O | |
| revealed O | |
| a O | |
| posterior B-ety | |
| hip I-ety | |
| dislocation I-ety | |
| with O | |
| an O | |
| ipsilateral O | |
| femoral B-ety | |
| head I-ety | |
| and I-ety | |
| mid-shaft I-ety | |
| fractures I-ety | |
| . O | |
| the O | |
| patient O | |
| was O | |
| treated O | |
| by O | |
| closed O | |
| reduction O | |
| of O | |
| hip B-ety | |
| dislocation I-ety | |
| using O | |
| a O | |
| temporarily O | |
| applied O | |
| external O | |
| fixator O | |
| followed O | |
| by O | |
| intramedullary O | |
| nailing O | |
| of O | |
| the O | |
| femoral O | |
| shaft O | |
| . O | |
| achieving O | |
| a O | |
| closed O | |
| reduction O | |
| is O | |
| a O | |
| challenge O | |
| with O | |
| ipsilateral O | |
| fractures O | |
| but O | |
| it O | |
| should O | |
| be O | |
| favored O | |
| over O | |
| open O | |
| reduction O | |
| due O | |
| to O | |
| a O | |
| lower O | |
| risk O | |
| of O | |
| complications O | |
| . O | |
| the O | |
| type O | |
| of O | |
| femoral O | |
| head O | |
| fracture O | |
| , O | |
| in O | |
| this O | |
| case O | |
| , O | |
| may O | |
| have O | |
| aided O | |
| in O | |
| an O | |
| easier O | |
| reduction O | |
| . O | |
| in O | |
| may O | |
| 2014 O | |
| a O | |
| 49 O | |
| year O | |
| gentleman O | |
| was O | |
| admitted O | |
| for O | |
| widespread O | |
| mucocutaneous O | |
| blistering O | |
| diagnosed O | |
| as O | |
| PV B-ety | |
| by O | |
| histology O | |
| and O | |
| immunofluorescence O | |
| . O | |
| after O | |
| 6 O | |
| weeks O | |
| of O | |
| treatment O | |
| with O | |
| systemic O | |
| steroids O | |
| and O | |
| azathioprine O | |
| the O | |
| patient O | |
| developed O | |
| pulmonary B-ety | |
| emboli I-ety | |
| and O | |
| started O | |
| oral O | |
| anticoagulation O | |
| with O | |
| warfarin O | |
| . O | |
| in O | |
| late O | |
| september O | |
| , O | |
| the O | |
| patient O | |
| re-presented O | |
| with O | |
| a O | |
| severe O | |
| flare O | |
| of O | |
| PV B-ety | |
| and O | |
| a O | |
| recurrent O | |
| deep B-ety | |
| vein I-ety | |
| thrombosis I-ety | |
| despite O | |
| oral O | |
| anticoagulation O | |
| within O | |
| therapeutic O | |
| range O | |
| . O | |
| warfarin O | |
| was O | |
| changed O | |
| to O | |
| subcutaneous O | |
| low O | |
| molecular O | |
| heparin O | |
| in O | |
| therapeutic O | |
| dose O | |
| while O | |
| treatment O | |
| for O | |
| pemphigus B-ety | |
| was O | |
| escalated O | |
| : O | |
| first O | |
| azathioprine O | |
| was O | |
| switched O | |
| to O | |
| mycophenolate O | |
| mofetil O | |
| and O | |
| the O | |
| steroids O | |
| dose O | |
| increased O | |
| ; O | |
| then O | |
| due O | |
| to O | |
| poor O | |
| response O | |
| , O | |
| intravenous O | |
| immunoglobulins O | |
| were O | |
| given O | |
| for O | |
| three O | |
| courses O | |
| and O | |
| finally O | |
| he O | |
| received O | |
| four O | |
| infusions O | |
| of O | |
| rituximab O | |
| that O | |
| induced O | |
| sustained O | |
| remission O | |
| . O | |
| in O | |
| april O | |
| 2015 O | |
| the O | |
| dose O | |
| of O | |
| mycophenolate O | |
| was O | |
| decreased O | |
| but O | |
| anticoagulation O | |
| was O | |
| continued O | |
| until O | |
| the O | |
| beginning O | |
| of O | |
| july O | |
| 2015 O | |
| to O | |
| ensure O | |
| that O | |
| decreasing O | |
| immune O | |
| suppression O | |
| did O | |
| not O | |
| allow O | |
| the O | |
| emergence O | |
| of O | |
| another O | |
| flare O | |
| with O | |
| attendant O | |
| thrombotic O | |
| risk O | |
| . O | |
| A O | |
| 77 O | |
| - O | |
| year-old O | |
| tunisian O | |
| woman O | |
| was O | |
| hospitalized O | |
| because O | |
| of O | |
| massive O | |
| painful O | |
| ascites B-ety | |
| . O | |
| her O | |
| family O | |
| history O | |
| did O | |
| not O | |
| include O | |
| any O | |
| autoimmune B-ety | |
| disease I-ety | |
| . O | |
| she O | |
| denied O | |
| a O | |
| history B-ety | |
| of I-ety | |
| hepatitis I-ety | |
| , I-ety | |
| jaundice I-ety | |
| or I-ety | |
| alcohol I-ety | |
| use I-ety | |
| . O | |
| she O | |
| had O | |
| a O | |
| history O | |
| of O | |
| diabetes B-ety | |
| , O | |
| hypertension B-ety | |
| treated O | |
| by O | |
| glinide O | |
| and O | |
| calcium O | |
| blocker O | |
| . O | |
| she O | |
| was O | |
| explored O | |
| 4 O | |
| years O | |
| prior O | |
| to O | |
| admission O | |
| for O | |
| exudative B-ety | |
| pleuritis I-ety | |
| of O | |
| the O | |
| right O | |
| lung O | |
| without O | |
| any O | |
| established O | |
| diagnosis O | |
| after O | |
| multiple O | |
| explorations O | |
| including O | |
| thoracoscopy O | |
| with O | |
| biopsies O | |
| . O | |
| on O | |
| admission O | |
| , O | |
| blood O | |
| pressure O | |
| was O | |
| 150 O | |
| / O | |
| 70 O | |
| mmhg O | |
| , O | |
| her O | |
| rate O | |
| was O | |
| 80 O | |
| / O | |
| mn O | |
| and O | |
| body O | |
| temperature O | |
| was O | |
| 37 O | |
| ° O | |
| C O | |
| . O | |
| the O | |
| physical O | |
| examination O | |
| showed O | |
| only O | |
| abdominal B-ety | |
| distension I-ety | |
| related O | |
| to O | |
| the O | |
| important O | |
| ascites B-ety | |
| without O | |
| collateral O | |
| venous O | |
| circulation O | |
| . O | |
| she O | |
| had O | |
| no O | |
| skin B-ety | |
| lesions I-ety | |
| , O | |
| lymphadenopathy B-ety | |
| , O | |
| or O | |
| hepatosplenomegaly B-ety | |
| and O | |
| lower O | |
| extremities O | |
| showed O | |
| no O | |
| edema O | |
| . O | |
| laboratory O | |
| investigations O | |
| showed O | |
| : O | |
| leucopenia B-ety | |
| with O | |
| white O | |
| blood O | |
| cell O | |
| count O | |
| = O | |
| 3100 O | |
| / O | |
| mm3 O | |
| , O | |
| lymphopenia B-ety | |
| = O | |
| 840 O | |
| / O | |
| mm3 O | |
| , O | |
| hemoglobin O | |
| = O | |
| 10.5g O | |
| / O | |
| dl O | |
| ; O | |
| low O | |
| serum O | |
| albumin O | |
| level O | |
| = O | |
| 29g O | |
| / O | |
| L O | |
| , O | |
| 47 O | |
| ; O | |
| - O | |
| globulin O | |
| = O | |
| 19g O | |
| / O | |
| L O | |
| . O | |
| blood O | |
| glucose O | |
| levels O | |
| = O | |
| 180 O | |
| mg O | |
| / O | |
| dl O | |
| and O | |
| hemoglobin O | |
| a1c O | |
| = O | |
| 8.6 O | |
| % O | |
| . O | |
| urine O | |
| analysis O | |
| showed O | |
| trace O | |
| protein O | |
| ( O | |
| 0.03g O | |
| / O | |
| 24h O | |
| ) O | |
| . O | |
| platelet O | |
| count O | |
| , O | |
| activated O | |
| partial O | |
| thromboplastin O | |
| time O | |
| , O | |
| liver O | |
| function O | |
| tests O | |
| , O | |
| blood O | |
| urea O | |
| nitrogen O | |
| , O | |
| serum O | |
| creatinine O | |
| , O | |
| erythrocyte O | |
| sediment O | |
| rate O | |
| and O | |
| total O | |
| cholesterol O | |
| were O | |
| within O | |
| normal O | |
| limits O | |
| . O | |
| tests O | |
| for O | |
| hbsag O | |
| and O | |
| HCV O | |
| were O | |
| negative O | |
| . O | |
| abdominal O | |
| ultrasonography O | |
| showed O | |
| ascitic O | |
| fluid O | |
| without O | |
| any O | |
| sign O | |
| of O | |
| bowel O | |
| loop O | |
| thickening O | |
| or O | |
| enteritis B-ety | |
| . O | |
| neither O | |
| lymphadenopathy B-ety | |
| nor O | |
| liver B-ety | |
| abnormality I-ety | |
| was O | |
| present O | |
| . O | |
| A O | |
| chest O | |
| x-ray O | |
| film O | |
| disclosed O | |
| bilateral B-ety | |
| pleural I-ety | |
| effusion I-ety | |
| . O | |
| ascitic O | |
| obtained O | |
| by O | |
| aspiration O | |
| contained O | |
| 170 O | |
| cells O | |
| mm3 O | |
| ( O | |
| 67% O | |
| lymphocytes O | |
| ) O | |
| , O | |
| 46g O | |
| / O | |
| L O | |
| protein O | |
| , O | |
| but O | |
| no O | |
| malignant O | |
| cells O | |
| . O | |
| cultures O | |
| for O | |
| bacteria O | |
| and O | |
| mycobacteria O | |
| gave O | |
| no O | |
| growth O | |
| . O | |
| tuberculosis O | |
| investigation O | |
| including O | |
| initial O | |
| tuberculin O | |
| skin O | |
| test O | |
| and O | |
| the O | |
| research O | |
| of O | |
| koch O | |
| bacilli O | |
| in O | |
| sputum O | |
| and O | |
| urine O | |
| were O | |
| negative O | |
| . O | |
| echocardiogram O | |
| and O | |
| electrocardiogram O | |
| were O | |
| normal O | |
| . O | |
| computed O | |
| tomographic O | |
| scan O | |
| showed O | |
| massive O | |
| ascites B-ety | |
| , O | |
| no O | |
| dysmorphic O | |
| liver O | |
| , O | |
| and O | |
| a O | |
| mild O | |
| bilateral B-ety | |
| pleural I-ety | |
| effusion I-ety | |
| . O | |
| pelvic O | |
| examination O | |
| was O | |
| normal O | |
| . O | |
| oesogastroduodenoscopy O | |
| showed O | |
| hiatal B-ety | |
| hernia I-ety | |
| without O | |
| oesophageal O | |
| varices O | |
| . O | |
| an O | |
| exploratory O | |
| laparoscopy O | |
| was O | |
| performed O | |
| , O | |
| revealing O | |
| a O | |
| large O | |
| amount O | |
| of O | |
| ascite B-ety | |
| , O | |
| a O | |
| normal O | |
| liver O | |
| appearance O | |
| , O | |
| and O | |
| no O | |
| granulations O | |
| suggesting O | |
| tuberculosis B-ety | |
| or O | |
| peritoneal O | |
| carcinosis B-ety | |
| . O | |
| histological O | |
| examination O | |
| of O | |
| the O | |
| peritoneum O | |
| showed O | |
| non O | |
| specific O | |
| chronic B-ety | |
| inflammation I-ety | |
| . O | |
| systemic B-ety | |
| lupus I-ety | |
| erythematosus I-ety | |
| was O | |
| suspected O | |
| based O | |
| on O | |
| pleuritis B-ety | |
| , O | |
| lymphopenia B-ety | |
| and O | |
| leucopenia B-ety | |
| . O | |
| an O | |
| additional O | |
| serologic O | |
| survey O | |
| revealed O | |
| markedly O | |
| elevated O | |
| anti-nuclear O | |
| antibody O | |
| ( O | |
| ANA O | |
| ) O | |
| titer O | |
| of O | |
| 1 O | |
| / O | |
| 1600 O | |
| and O | |
| a O | |
| significantly O | |
| elevated O | |
| titer O | |
| of O | |
| antibody O | |
| to O | |
| double-stranded O | |
| DNA O | |
| ( O | |
| 83 O | |
| IU O | |
| / O | |
| ml O | |
| ; O | |
| normal O | |
| < O | |
| 30 O | |
| IU O | |
| / O | |
| ml O | |
| ) O | |
| . O | |
| she O | |
| had O | |
| also O | |
| positive O | |
| serum O | |
| antibody O | |
| against O | |
| the O | |
| smith O | |
| antigen O | |
| and O | |
| low O | |
| serum O | |
| level O | |
| of O | |
| C3 O | |
| complement O | |
| component O | |
| : O | |
| 67 O | |
| mg O | |
| / O | |
| dl O | |
| ( O | |
| serum O | |
| normal O | |
| range O | |
| : O | |
| 84 O | |
| – O | |
| 151 O | |
| ) O | |
| . O | |
| relying O | |
| on O | |
| these O | |
| findings O | |
| , O | |
| the O | |
| patient O | |
| was O | |
| diagnosed O | |
| with O | |
| SLE B-ety | |
| since O | |
| 4 O | |
| of O | |
| the O | |
| 11 O | |
| diagnostic O | |
| criteria O | |
| of O | |
| the O | |
| american O | |
| college O | |
| of O | |
| rheumatology O | |
| were O | |
| met O | |
| . O | |
| the O | |
| SLEDAI O | |
| score O | |
| according O | |
| to O | |
| systemic O | |
| lupus O | |
| erythematosus O | |
| disease O | |
| activity O | |
| index O | |
| was O | |
| estimated O | |
| to O | |
| be O | |
| 7 O | |
| on O | |
| admission O | |
| . O | |
| hydroxychloroquine O | |
| 200 O | |
| mg O | |
| daily O | |
| in O | |
| combination O | |
| with O | |
| diuretics O | |
| was O | |
| initiated O | |
| . O | |
| one O | |
| month O | |
| later O | |
| , O | |
| there O | |
| was O | |
| no O | |
| detectable O | |
| ascitic O | |
| fluid O | |
| and O | |
| no O | |
| pleural B-ety | |
| effusions I-ety | |
| . O | |
| five O | |
| months O | |
| later O | |
| she O | |
| remained O | |
| free O | |
| from O | |
| symptoms O | |
| while O | |
| continuing O | |
| to O | |
| take O | |
| hydroxychloroquine O | |
| A O | |
| 24 O | |
| - O | |
| year-old O | |
| african-american O | |
| man O | |
| presented O | |
| to O | |
| our O | |
| emergency O | |
| department O | |
| with O | |
| a O | |
| one-week O | |
| history O | |
| of O | |
| fever B-ety | |
| , O | |
| dyspnea B-ety | |
| , O | |
| cough B-ety | |
| , O | |
| and O | |
| abdominal B-ety | |
| pain I-ety | |
| . O | |
| A O | |
| computed O | |
| tomography O | |
| scan O | |
| of O | |
| his O | |
| chest O | |
| and O | |
| abdomen O | |
| revealed O | |
| bilateral B-ety | |
| lower I-ety | |
| lobe I-ety | |
| pneumonia I-ety | |
| and O | |
| two O | |
| retained O | |
| jackson-pratt O | |
| drains O | |
| in O | |
| the O | |
| right O | |
| upper O | |
| quadrant O | |
| . O | |
| he O | |
| was O | |
| taken O | |
| to O | |
| the O | |
| operating O | |
| room O | |
| for O | |
| drain O | |
| removal O | |
| , O | |
| a O | |
| right O | |
| hemicolectomy O | |
| , O | |
| debridement O | |
| of O | |
| a O | |
| duodenal O | |
| injury O | |
| , O | |
| a O | |
| roux-en-y O | |
| duodenojejunostomy O | |
| , O | |
| and O | |
| an O | |
| end O | |
| ileostomy O | |
| . O | |
| he O | |
| subsequently O | |
| became O | |
| increasing O | |
| hypoxemic B-ety | |
| in O | |
| the O | |
| intensive O | |
| care O | |
| unit O | |
| and O | |
| a O | |
| bronchoperitoneal O | |
| fistula B-ety | |
| was O | |
| diagnosed O | |
| . O | |
| he O | |
| required O | |
| high-frequency O | |
| oscillatory O | |
| ventilation O | |
| followed O | |
| by O | |
| lung O | |
| isolation O | |
| , O | |
| and O | |
| was O | |
| successfully O | |
| resuscitated O | |
| using O | |
| these O | |
| techniques O | |
| . O | |
| A O | |
| 33 O | |
| - O | |
| year-old O | |
| woman O | |
| came O | |
| to O | |
| department O | |
| of O | |
| fertility O | |
| , O | |
| endocrinology O | |
| and O | |
| reproduction O | |
| at O | |
| saiful O | |
| anwar O | |
| public O | |
| hospital O | |
| and O | |
| consulted O | |
| that O | |
| she O | |
| has O | |
| not B-ety | |
| menstruated I-ety | |
| since O | |
| 5 O | |
| years O | |
| ago O | |
| ( O | |
| 28 O | |
| years O | |
| old O | |
| ) O | |
| . O | |
| her O | |
| initial O | |
| menarche O | |
| was O | |
| at O | |
| the O | |
| age O | |
| of O | |
| 14 O | |
| years O | |
| and O | |
| it O | |
| is O | |
| in O | |
| accordance O | |
| with O | |
| the O | |
| normal O | |
| growth O | |
| of O | |
| a O | |
| child O | |
| at O | |
| her O | |
| age O | |
| . O | |
| the O | |
| patient O | |
| had O | |
| a O | |
| regular O | |
| menstrual O | |
| period O | |
| of O | |
| 5 O | |
| - O | |
| 7 O | |
| days O | |
| , O | |
| she O | |
| replaced O | |
| the O | |
| pads O | |
| for O | |
| 2 O | |
| - O | |
| 3 O | |
| times O | |
| / O | |
| day O | |
| , O | |
| and O | |
| had O | |
| no O | |
| menstrual B-ety | |
| pain I-ety | |
| . O | |
| the O | |
| patient O | |
| has O | |
| a O | |
| history O | |
| of O | |
| injective O | |
| contraceptive O | |
| that O | |
| was O | |
| done O | |
| every O | |
| once O | |
| a O | |
| month O | |
| in O | |
| 2010 O | |
| , O | |
| and O | |
| after O | |
| the O | |
| injection O | |
| , O | |
| she O | |
| menstruated O | |
| for O | |
| two O | |
| months O | |
| and O | |
| then O | |
| it O | |
| stopped O | |
| . O | |
| based O | |
| on O | |
| clinical O | |
| examination O | |
| and O | |
| a O | |
| physical O | |
| examination O | |
| , O | |
| the O | |
| patient O | |
| was O | |
| diagnosed O | |
| with O | |
| secondary B-ety | |
| amenorrhea I-ety | |
| . O | |
| investigations O | |
| that O | |
| were O | |
| used O | |
| are O | |
| ultrasonography O | |
| , O | |
| thorax O | |
| x-ray O | |
| and O | |
| CT O | |
| scan O | |
| head O | |
| . O | |
| ultrasonography O | |
| and O | |
| thorax O | |
| x-ray O | |
| showed O | |
| that O | |
| patient O | |
| is O | |
| suspected O | |
| to O | |
| have O | |
| right B-ety | |
| pleural I-ety | |
| effusion I-ety | |
| . O | |
| ct-scan O | |
| examination O | |
| showed O | |
| that O | |
| bilateral O | |
| ethmoidal B-ety | |
| sinusitis I-ety | |
| and O | |
| pituitary O | |
| gland O | |
| was O | |
| within O | |
| normal O | |
| limits O | |
| . O | |
| the O | |
| treatment O | |
| plan O | |
| in O | |
| this O | |
| patient O | |
| is O | |
| P O | |
| test O | |
| therapy O | |
| with O | |
| prothyra O | |
| 1x10 O | |
| mg O | |
| for O | |
| 7 O | |
| days O | |
| , O | |
| with O | |
| control O | |
| on O | |
| 2 O | |
| weeks O | |
| after O | |
| the O | |
| use O | |
| . O | |
| P O | |
| test O | |
| showed O | |
| a O | |
| negative O | |
| result O | |
| , O | |
| because O | |
| after O | |
| 14 O | |
| days O | |
| of O | |
| progesterone O | |
| consumption O | |
| the O | |
| prothyra O | |
| is O | |
| not O | |
| bleeding O | |
| . O | |
| the O | |
| treatment O | |
| is O | |
| followed O | |
| by O | |
| a O | |
| E O | |
| + O | |
| P O | |
| test O | |
| ( O | |
| estrogen O | |
| + O | |
| progesterone O | |
| ) O | |
| with O | |
| estrogen O | |
| 1x0.625 O | |
| mg O | |
| for O | |
| 21 O | |
| days O | |
| and O | |
| an O | |
| addition O | |
| of O | |
| progesterone O | |
| 1x10 O | |
| mg O | |
| on O | |
| 12th O | |
| - O | |
| 21st O | |
| days O | |
| , O | |
| while O | |
| the O | |
| control O | |
| was O | |
| performed O | |
| one O | |
| week O | |
| after O | |
| the O | |
| drug O | |
| runs O | |
| out O | |
| . O | |
| based O | |
| on O | |
| the O | |
| E O | |
| + O | |
| P O | |
| test O | |
| , O | |
| the O | |
| obtained O | |
| results O | |
| were O | |
| FSH O | |
| : O | |
| 8.71 O | |
| MIU O | |
| / O | |
| ml O | |
| , O | |
| LH O | |
| : O | |
| 3.1 O | |
| IU O | |
| / O | |
| L O | |
| , O | |
| prolactin O | |
| : O | |
| 319.4 O | |
| ng O | |
| / O | |
| ml O | |
| . O | |
| the O | |
| E O | |
| + O | |
| P O | |
| test O | |
| showed O | |
| a O | |
| negative O | |
| result O | |
| , O | |
| so O | |
| it O | |
| was O | |
| necessary O | |
| to O | |
| do O | |
| hysteroscopy O | |
| and O | |
| curettage O | |
| for O | |
| the O | |
| uterus O | |
| evaluation O | |
| . O | |
| hysteroscopy O | |
| results O | |
| showed O | |
| that O | |
| there O | |
| were O | |
| grade O | |
| 4 O | |
| adhesions B-ety | |
| in I-ety | |
| the I-ety | |
| uterine I-ety | |
| cavum I-ety | |
| , O | |
| with O | |
| a O | |
| pale O | |
| colored O | |
| connective O | |
| tissue O | |
| in O | |
| the O | |
| uterine O | |
| cavum O | |
| , O | |
| which O | |
| refers O | |
| to O | |
| the O | |
| diagnosis O | |
| of O | |
| secondary B-ety | |
| amenorrhea I-ety | |
| suspect O | |
| tuberculosis B-ety | |
| endometritis I-ety | |
| , O | |
| while O | |
| the O | |
| result O | |
| of O | |
| tissue O | |
| curettage O | |
| was O | |
| examined O | |
| on O | |
| the O | |
| anatomical O | |
| pathology O | |
| department O | |
| . O | |
| results O | |
| of O | |
| anatomical O | |
| pathology O | |
| hysteroscopy O | |
| showed O | |
| endometrial O | |
| tissue O | |
| with O | |
| stromal O | |
| looks O | |
| granulomas O | |
| with O | |
| lymphocytes O | |
| , O | |
| histiocytes O | |
| , O | |
| epithelioid O | |
| and O | |
| langhans O | |
| multinucleated O | |
| giant O | |
| cells O | |
| and O | |
| no O | |
| malignancy O | |
| was O | |
| found O | |
| in O | |
| this O | |
| preparation O | |
| , O | |
| which O | |
| showed O | |
| that O | |
| patient's O | |
| diagnosis O | |
| is O | |
| secondary B-ety | |
| amenorrhea I-ety | |
| suspected O | |
| tuberculosis B-ety | |
| endometritis I-ety | |
| . O | |
| based O | |
| on O | |
| the O | |
| anatomical O | |
| pathology O | |
| hysteroscopy O | |
| result O | |
| , O | |
| treatment O | |
| was O | |
| done O | |
| by O | |
| using O | |
| anti-tuberculosis O | |
| drug O | |
| category O | |
| I O | |
| ( O | |
| FDC O | |
| 1X3 O | |
| tab O | |
| ) O | |
| for O | |
| 6 O | |
| months O | |
| . O | |
| anatomical O | |
| pathology O | |
| result O | |
| through O | |
| macroscopic O | |
| observation O | |
| showed O | |
| visible O | |
| network O | |
| of O | |
| approximately O | |
| 0.3 O | |
| cm O | |
| and O | |
| 0.4 O | |
| cm O | |
| in O | |
| diameter O | |
| with O | |
| a O | |
| grayish-white O | |
| color O | |
| , O | |
| while O | |
| the O | |
| microscopic O | |
| observations O | |
| showed O | |
| fibromuscular O | |
| tissue O | |
| at O | |
| high O | |
| cylindrical O | |
| epithelium O | |
| with O | |
| polyps O | |
| shaped O | |
| vacuolar O | |
| , O | |
| and O | |
| inflammatory O | |
| granulomatic O | |
| and O | |
| aplastic O | |
| cells O | |
| were O | |
| not O | |
| found O | |
| . O | |
| mr O | |
| F.B O | |
| a O | |
| 70 O | |
| - O | |
| year-old O | |
| male O | |
| patient O | |
| presented O | |
| in O | |
| our O | |
| institution O | |
| because O | |
| of O | |
| the O | |
| occurrence O | |
| of O | |
| a O | |
| right O | |
| epistaxis O | |
| . O | |
| first O | |
| of O | |
| all O | |
| , O | |
| the O | |
| patient O | |
| is O | |
| not O | |
| smoking O | |
| and O | |
| reported O | |
| an O | |
| aneurysm B-ety | |
| of I-ety | |
| the I-ety | |
| abdominal I-ety | |
| aorta I-ety | |
| surgically O | |
| treated O | |
| by O | |
| prosthesis O | |
| under O | |
| plavix O | |
| . O | |
| the O | |
| beginning O | |
| of O | |
| the O | |
| symptomatology O | |
| goes O | |
| back O | |
| to O | |
| 2 O | |
| months O | |
| before O | |
| with O | |
| right B-ety | |
| nasal I-ety | |
| obstruction I-ety | |
| of O | |
| progressive O | |
| onset O | |
| , O | |
| associated O | |
| with O | |
| right B-ety | |
| epistaxis I-ety | |
| and O | |
| bloody B-ety | |
| rhinorrhea I-ety | |
| with O | |
| right O | |
| chronic O | |
| eye B-ety | |
| watering I-ety | |
| . O | |
| nasal O | |
| endoscopy O | |
| examination O | |
| revealed O | |
| a O | |
| pinnkish O | |
| burgeoning O | |
| mass O | |
| bleeding O | |
| on O | |
| contact O | |
| and O | |
| filling O | |
| the O | |
| right O | |
| nostril O | |
| vestibule O | |
| . O | |
| the O | |
| patient O | |
| didn't O | |
| presents O | |
| neurological B-ety | |
| signs I-ety | |
| nor O | |
| cervical O | |
| lymph O | |
| nods O | |
| . O | |
| otherwise O | |
| , O | |
| ophthalmologic O | |
| examination O | |
| found O | |
| normal O | |
| visual O | |
| acuity O | |
| and O | |
| ocular O | |
| mobility O | |
| on O | |
| both O | |
| sides O | |
| . O | |
| sinonasal O | |
| computed O | |
| tomography O | |
| ( O | |
| CT O | |
| ) O | |
| found O | |
| a O | |
| right O | |
| nasal O | |
| process O | |
| enhanced O | |
| after O | |
| injection O | |
| of O | |
| contrast O | |
| product O | |
| with O | |
| relatively O | |
| little O | |
| washing O | |
| at O | |
| the O | |
| late O | |
| time O | |
| . O | |
| otherwise O | |
| , O | |
| there O | |
| is O | |
| no O | |
| extension O | |
| involvement O | |
| at O | |
| the O | |
| level O | |
| of O | |
| the O | |
| cavum O | |
| and O | |
| the O | |
| pterygo O | |
| palate O | |
| fossa O | |
| . O | |
| this O | |
| finding O | |
| found O | |
| also O | |
| a O | |
| crenate O | |
| appearance O | |
| of O | |
| the O | |
| posterior O | |
| nasal O | |
| mucosa O | |
| especially O | |
| of O | |
| the O | |
| middle O | |
| turbinates O | |
| and O | |
| contralateral O | |
| inferior O | |
| turbinate O | |
| with O | |
| a O | |
| left B-ety | |
| deviation I-ety | |
| of I-ety | |
| the I-ety | |
| nasal I-ety | |
| septum I-ety | |
| with O | |
| nasal O | |
| spur O | |
| . O | |
| nasosinusal O | |
| MRI O | |
| shows O | |
| a O | |
| progressive O | |
| increase O | |
| in O | |
| size O | |
| of O | |
| the O | |
| tissue B-ety | |
| mass I-ety | |
| compared O | |
| to O | |
| the O | |
| previously O | |
| CT O | |
| occupying O | |
| the O | |
| right O | |
| nasal O | |
| fossa O | |
| on O | |
| almost O | |
| all O | |
| of O | |
| its O | |
| height O | |
| , O | |
| measuring O | |
| 4 O | |
| × O | |
| 2.8 O | |
| × O | |
| 3.5cm O | |
| without O | |
| extension O | |
| within O | |
| the O | |
| cavum O | |
| with O | |
| probable O | |
| invasion O | |
| of O | |
| the O | |
| lower O | |
| part O | |
| of O | |
| the O | |
| nasolacrimal O | |
| duct O | |
| and O | |
| mass O | |
| effect O | |
| on O | |
| both O | |
| the O | |
| sinusonasal O | |
| bone O | |
| septum O | |
| and O | |
| the O | |
| intersinusonasal O | |
| septum O | |
| . O | |
| this O | |
| finding O | |
| shows O | |
| ethmoidal B-ety | |
| sinus I-ety | |
| fluid I-ety | |
| retention I-ety | |
| . O | |
| the O | |
| appearance O | |
| , O | |
| even O | |
| if O | |
| it O | |
| remains O | |
| unspecific O | |
| , O | |
| is O | |
| compatible O | |
| with O | |
| inverted B-ety | |
| papilloma I-ety | |
| . O | |
| the O | |
| patient O | |
| underwent O | |
| complete O | |
| endoscopic O | |
| removal O | |
| of O | |
| the O | |
| tumor B-ety | |
| with O | |
| ethmoidectomy O | |
| and O | |
| right O | |
| maxillary O | |
| antrostomy O | |
| . O | |
| the O | |
| extemporaneous O | |
| examination O | |
| is O | |
| in O | |
| favor O | |
| of O | |
| a O | |
| malignant B-ety | |
| tumor I-ety | |
| lesion I-ety | |
| . O | |
| histopathologic O | |
| analysis O | |
| shows O | |
| a O | |
| tumor B-ety | |
| proliferation I-ety | |
| made O | |
| of O | |
| polymorphic O | |
| cells O | |
| with O | |
| major O | |
| anisocytosis O | |
| , O | |
| most O | |
| often O | |
| located O | |
| in O | |
| lobules O | |
| . O | |
| there O | |
| is O | |
| sometimes O | |
| a O | |
| somewhat O | |
| palisadic O | |
| seat O | |
| on O | |
| the O | |
| periphery O | |
| of O | |
| the O | |
| tumor B-ety | |
| mass I-ety | |
| . O | |
| the O | |
| mitotic O | |
| index O | |
| is O | |
| 10 O | |
| mitoses O | |
| per O | |
| 10 O | |
| high O | |
| power O | |
| fields O | |
| . O | |
| the O | |
| immunohistochemical O | |
| study O | |
| of O | |
| the O | |
| tumor B-ety | |
| found O | |
| that O | |
| the O | |
| cytokeratin O | |
| KL1 O | |
| and O | |
| CK7 O | |
| and O | |
| the O | |
| neuroendocrine O | |
| marker O | |
| chromogranin O | |
| A O | |
| , O | |
| synaptophysin O | |
| and O | |
| CD56 O | |
| are O | |
| positive O | |
| . O | |
| proliferation O | |
| index O | |
| ki67 O | |
| is O | |
| of O | |
| the O | |
| order O | |
| of O | |
| 80% O | |
| . O | |
| otherwise O | |
| there O | |
| is O | |
| an O | |
| absence O | |
| of O | |
| expression O | |
| of O | |
| PS100 O | |
| , O | |
| melana O | |
| , O | |
| HMB45 O | |
| , O | |
| desmin O | |
| , O | |
| p40 O | |
| , O | |
| CD45 O | |
| and O | |
| EBV O | |
| . O | |
| the O | |
| clear O | |
| positivity O | |
| of O | |
| cytokeratins O | |
| formally O | |
| excludes O | |
| the O | |
| diagnosis O | |
| of O | |
| olfactory B-ety | |
| neuroblastoma I-ety | |
| and O | |
| leads O | |
| to O | |
| neuroendocrine B-ety | |
| carcinoma I-ety | |
| . O | |
| given O | |
| the O | |
| atypia O | |
| , O | |
| the O | |
| mitotic O | |
| index O | |
| , O | |
| and O | |
| the O | |
| ki67 O | |
| proliferation O | |
| index O | |
| , O | |
| it O | |
| is O | |
| a O | |
| high-grade O | |
| large-cell B-ety | |
| neuroendocrine I-ety | |
| carcinoma I-ety | |
| . O | |
| extension O | |
| assessment O | |
| , O | |
| comprising O | |
| a O | |
| PET O | |
| SCAN O | |
| , O | |
| was O | |
| negative O | |
| . O | |
| postoperative O | |
| treatment O | |
| consisted O | |
| in O | |
| adjuvant O | |
| polychemotherapy O | |
| , O | |
| with O | |
| six O | |
| cycles O | |
| ( O | |
| cisplatin O | |
| and O | |
| etoposide O | |
| ) O | |
| , O | |
| followed O | |
| by O | |
| loco O | |
| regional O | |
| external O | |
| radiotherapy O | |
| . O | |
| after O | |
| 6 O | |
| month O | |
| follow-up O | |
| , O | |
| the O | |
| patient O | |
| was O | |
| in B-ety | |
| complete I-ety | |
| clinical I-ety | |
| and I-ety | |
| radiological I-ety | |
| remission I-ety | |
| . O | |
| A O | |
| 46 O | |
| - O | |
| year-old O | |
| man O | |
| with O | |
| hypertension B-ety | |
| and O | |
| dyslipidemia B-ety | |
| diagnosed O | |
| 4 O | |
| - O | |
| months O | |
| before O | |
| , O | |
| as O | |
| well O | |
| as O | |
| new-onset B-ety | |
| diabetes I-ety | |
| mellitus I-ety | |
| unveiled O | |
| 1 O | |
| - O | |
| month O | |
| earlier O | |
| , O | |
| was O | |
| referred O | |
| to O | |
| emergency O | |
| department O | |
| for O | |
| hypokalemia B-ety | |
| . O | |
| hormonal O | |
| study O | |
| and O | |
| dynamic O | |
| biochemical O | |
| tests O | |
| performed O | |
| indicated O | |
| ECS O | |
| . O | |
| imaging O | |
| and O | |
| cytological O | |
| findings O | |
| pointed O | |
| toward O | |
| a O | |
| likely O | |
| primary B-ety | |
| right I-ety | |
| parotid I-ety | |
| malignancy I-ety | |
| with O | |
| liver B-ety | |
| metastases I-ety | |
| . O | |
| somatostatin O | |
| receptor O | |
| scintigraphy O | |
| has O | |
| shown O | |
| an O | |
| increased O | |
| uptake O | |
| in O | |
| the O | |
| parotid O | |
| gland O | |
| and O | |
| mild O | |
| expression O | |
| in O | |
| liver B-ety | |
| metastasis I-ety | |
| . O | |
| the O | |
| patient O | |
| underwent O | |
| right O | |
| parotidectomy O | |
| , O | |
| and O | |
| histopathologic O | |
| examination O | |
| confirmed O | |
| ACC B-ety | |
| . O | |
| meanwhile O | |
| , O | |
| hypercortisolism B-ety | |
| was O | |
| managed O | |
| with O | |
| metyrapone O | |
| , O | |
| ketoconazole O | |
| , O | |
| and O | |
| lanreotide O | |
| . O | |
| despite O | |
| chemotherapy O | |
| onset O | |
| , O | |
| a O | |
| rapid O | |
| disease B-ety | |
| progression I-ety | |
| and O | |
| clinical O | |
| course O | |
| deterioration O | |
| was O | |
| observed O | |
| . O | |
| forty O | |
| year O | |
| old O | |
| male O | |
| presented O | |
| with O | |
| a O | |
| huge O | |
| mass O | |
| in O | |
| this O | |
| left O | |
| arm O | |
| . O | |
| the O | |
| same O | |
| patient O | |
| apparently O | |
| was O | |
| admitted O | |
| three O | |
| years O | |
| back O | |
| for O | |
| excision O | |
| of O | |
| the O | |
| arm B-ety | |
| swelling I-ety | |
| which O | |
| was O | |
| relatively O | |
| small O | |
| that O | |
| time O | |
| . O | |
| however O | |
| the O | |
| patient O | |
| did O | |
| not O | |
| undergo O | |
| surgery O | |
| and O | |
| was O | |
| takin O | |
| treatment O | |
| from O | |
| local O | |
| bone O | |
| setters O | |
| during O | |
| the O | |
| last O | |
| three O | |
| years O | |
| and O | |
| tumor B-ety | |
| grew O | |
| to O | |
| a O | |
| larger O | |
| size O | |
| during O | |
| this O | |
| period O | |
| . O | |
| the O | |
| current O | |
| dimensions O | |
| of O | |
| tumor B-ety | |
| was O | |
| 32x28 O | |
| cms O | |
| with O | |
| circumference O | |
| of O | |
| 87 O | |
| cms O | |
| . O | |
| x-ray O | |
| showed O | |
| complete O | |
| destruction B-ety | |
| of I-ety | |
| the I-ety | |
| upper I-ety | |
| humerus I-ety | |
| with O | |
| central O | |
| calcification B-ety | |
| . O | |
| biopsy O | |
| releveled O | |
| a O | |
| chondrosarcoma B-ety | |
| . O | |
| skeletal O | |
| survey O | |
| and O | |
| bone O | |
| scan O | |
| did O | |
| not O | |
| reveal O | |
| any O | |
| other O | |
| lesion B-ety | |
| in O | |
| the O | |
| body O | |
| . O | |
| A O | |
| forequarter O | |
| amputation O | |
| was O | |
| done O | |
| and O | |
| a O | |
| 16 O | |
| kg O | |
| tumor B-ety | |
| mass I-ety | |
| was O | |
| excised O | |
| . O | |
| at O | |
| three O | |
| years O | |
| follow O | |
| up O | |
| , O | |
| the O | |
| patient O | |
| has O | |
| no O | |
| complains O | |
| with O | |
| no O | |
| recurrence O | |
| of O | |
| the O | |
| tumor B-ety | |
| . O | |
| A O | |
| 20 O | |
| - O | |
| year-old O | |
| right-handed O | |
| female O | |
| factory O | |
| worker O | |
| with O | |
| no O | |
| medical O | |
| history O | |
| is O | |
| consulting O | |
| in O | |
| the O | |
| emergency O | |
| ward O | |
| with O | |
| an O | |
| open O | |
| trauma B-ety | |
| of O | |
| the O | |
| left O | |
| hand O | |
| resulting O | |
| from O | |
| an O | |
| occupational O | |
| accident O | |
| . O | |
| her O | |
| hand O | |
| was O | |
| crushed O | |
| under O | |
| a O | |
| heavy O | |
| object O | |
| . O | |
| physical O | |
| examination O | |
| found O | |
| an O | |
| important O | |
| swelling B-ety | |
| and O | |
| obvious O | |
| distortion O | |
| at O | |
| the O | |
| dorsum O | |
| of O | |
| the O | |
| hand O | |
| associated O | |
| with O | |
| wounds O | |
| of O | |
| the O | |
| ulnar O | |
| and O | |
| radial O | |
| edges O | |
| of O | |
| the O | |
| left O | |
| hand O | |
| . O | |
| the O | |
| neurovascular O | |
| examination O | |
| was O | |
| normal O | |
| ; O | |
| in O | |
| particular O | |
| no O | |
| sensitive O | |
| deficit O | |
| in O | |
| the O | |
| median O | |
| nerve O | |
| area O | |
| was O | |
| noted O | |
| . O | |
| plain O | |
| radiographs O | |
| with O | |
| front O | |
| and O | |
| lateral O | |
| views O | |
| showed O | |
| a O | |
| dislocation B-ety | |
| of I-ety | |
| the I-ety | |
| three I-ety | |
| lesser I-ety | |
| fingers I-ety | |
| associated O | |
| with O | |
| fractures B-ety | |
| of I-ety | |
| the I-ety | |
| hamatum I-ety | |
| and I-ety | |
| the I-ety | |
| second I-ety | |
| metacarpal I-ety | |
| . O | |
| the O | |
| three O | |
| lesser O | |
| metacarpals O | |
| and O | |
| the O | |
| distal O | |
| fragment O | |
| of O | |
| the O | |
| hamatum O | |
| were O | |
| medially O | |
| displaced O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| immediately O | |
| brought O | |
| to O | |
| the O | |
| operating O | |
| theatre O | |
| . O | |
| the O | |
| treatment O | |
| consisted O | |
| of O | |
| a O | |
| reduction O | |
| and O | |
| stabilisation O | |
| using O | |
| a O | |
| multiple O | |
| carpo-metacarpal O | |
| and O | |
| cross O | |
| inter-metacarpal O | |
| pinning O | |
| . O | |
| the O | |
| wound O | |
| was O | |
| cleaned O | |
| up O | |
| trimmed O | |
| and O | |
| sutured O | |
| . O | |
| the O | |
| had O | |
| and O | |
| the O | |
| wrist O | |
| were O | |
| immobilized O | |
| with O | |
| a O | |
| splint O | |
| for O | |
| six O | |
| weeks O | |
| . O | |
| the O | |
| patient O | |
| had O | |
| an O | |
| intense O | |
| and O | |
| regular O | |
| rehabilitation O | |
| program O | |
| . O | |
| at O | |
| one O | |
| year O | |
| follow-up O | |
| , O | |
| the O | |
| outcome O | |
| is O | |
| good O | |
| : O | |
| the O | |
| patient O | |
| is O | |
| painless O | |
| with O | |
| good O | |
| bone O | |
| consolidation O | |
| in O | |
| right O | |
| position O | |
| , O | |
| strictly O | |
| normal O | |
| range O | |
| of O | |
| motion O | |
| ( O | |
| metacarpophalangeal O | |
| 90 O | |
| ° O | |
| , O | |
| proximal O | |
| interphalagienne O | |
| 100 O | |
| ° O | |
| and O | |
| distal O | |
| interphalageal O | |
| 90 O | |
| ° O | |
| ) O | |
| and O | |
| a O | |
| 80% O | |
| grip O | |
| strength O | |
| compared O | |
| to O | |
| the O | |
| right O | |
| side O | |
| . O | |
| A O | |
| 16 O | |
| - O | |
| year-old O | |
| indian O | |
| boy O | |
| presented O | |
| to O | |
| our O | |
| hospital O | |
| with O | |
| a O | |
| history O | |
| of O | |
| a O | |
| lump B-ety | |
| in O | |
| the O | |
| lower O | |
| back O | |
| region O | |
| since O | |
| birth O | |
| . O | |
| initially O | |
| , O | |
| it O | |
| was O | |
| small O | |
| , O | |
| but O | |
| its O | |
| size O | |
| increased O | |
| gradually O | |
| over O | |
| time O | |
| to O | |
| a O | |
| size O | |
| of O | |
| 15 O | |
| cm O | |
| × O | |
| 15 O | |
| cm O | |
| at O | |
| presentation O | |
| . O | |
| there O | |
| were O | |
| no O | |
| other O | |
| associated O | |
| abnormalities O | |
| . O | |
| investigations O | |
| revealed O | |
| the O | |
| lump B-ety | |
| to O | |
| be O | |
| a O | |
| benign B-ety | |
| cystic I-ety | |
| teratoma I-ety | |
| . O | |
| the O | |
| patient O | |
| underwent O | |
| surgery O | |
| , O | |
| and O | |
| the O | |
| whole O | |
| tumor B-ety | |
| , O | |
| from O | |
| its O | |
| base O | |
| to O | |
| the O | |
| vertebrae O | |
| , O | |
| was O | |
| excised O | |
| . O | |
| bisection O | |
| of O | |
| the O | |
| tumor B-ety | |
| revealed O | |
| that O | |
| it O | |
| contained O | |
| hair O | |
| and O | |
| pultaceous O | |
| material O | |
| consistent O | |
| with O | |
| a O | |
| teratoma B-ety | |
| , O | |
| which O | |
| was O | |
| later O | |
| confirmed O | |
| by O | |
| histopathologic O | |
| examination O | |
| . O | |
| A O | |
| 70yrs O | |
| old O | |
| female O | |
| was O | |
| admitted O | |
| in O | |
| our O | |
| institution O | |
| diagnosed O | |
| with O | |
| severe O | |
| bilateral B-ety | |
| osteoarthritis I-ety | |
| . O | |
| the O | |
| x-rays O | |
| showed O | |
| bone O | |
| on O | |
| bone O | |
| tricompartment O | |
| OA B-ety | |
| knee I-ety | |
| with I-ety | |
| varus I-ety | |
| malalignment I-ety | |
| . O | |
| she O | |
| was O | |
| posted O | |
| for O | |
| single O | |
| stage O | |
| bilateral O | |
| total O | |
| knee O | |
| replacement O | |
| and O | |
| as O | |
| planned O | |
| the O | |
| left O | |
| knee O | |
| was O | |
| operated O | |
| first O | |
| . O | |
| after O | |
| exposure O | |
| , O | |
| proximal O | |
| tibial O | |
| , O | |
| distal O | |
| femoral O | |
| cuts O | |
| and O | |
| measurement O | |
| of O | |
| extension O | |
| gaps O | |
| the O | |
| synovium O | |
| from O | |
| the O | |
| anterior O | |
| femur O | |
| was O | |
| removed O | |
| and O | |
| sizing O | |
| was O | |
| done O | |
| . O | |
| the O | |
| AP O | |
| cut O | |
| was O | |
| then O | |
| proceeded O | |
| with O | |
| . O | |
| we O | |
| spotted O | |
| a O | |
| small O | |
| osteochondral O | |
| cyst B-ety | |
| in O | |
| the O | |
| anterior O | |
| femur O | |
| which O | |
| was O | |
| curretted O | |
| to O | |
| remove O | |
| the O | |
| cystic O | |
| material O | |
| , O | |
| which O | |
| is O | |
| when O | |
| we O | |
| realised O | |
| that O | |
| the O | |
| cyst B-ety | |
| was O | |
| large O | |
| and O | |
| communicating O | |
| with O | |
| the O | |
| medulary O | |
| canal O | |
| . O | |
| the O | |
| remaining O | |
| femoral O | |
| preparations O | |
| was O | |
| done O | |
| keeping O | |
| in O | |
| mind O | |
| the O | |
| risk O | |
| of O | |
| iatrogenic O | |
| fracture B-ety | |
| and O | |
| extension O | |
| stem O | |
| was O | |
| used O | |
| in O | |
| the O | |
| femur O | |
| . O | |
| the O | |
| defect O | |
| was O | |
| then O | |
| packed O | |
| cancellous O | |
| bone O | |
| graft O | |
| . O | |
| it O | |
| is O | |
| the O | |
| case O | |
| of O | |
| a O | |
| 29 O | |
| years O | |
| old O | |
| woman O | |
| , O | |
| G2P1001 O | |
| , O | |
| married O | |
| , O | |
| at O | |
| 9 O | |
| weeks O | |
| of O | |
| pregnancy O | |
| . O | |
| she O | |
| consulted O | |
| at O | |
| our O | |
| emergency O | |
| service O | |
| for O | |
| the O | |
| exacerbation O | |
| of O | |
| a O | |
| left O | |
| pelvic B-ety | |
| pain I-ety | |
| that O | |
| has O | |
| been O | |
| evolving O | |
| for O | |
| two O | |
| weeks O | |
| prior O | |
| to O | |
| admission O | |
| . O | |
| A O | |
| transient O | |
| lull O | |
| was O | |
| observed O | |
| following O | |
| a O | |
| treatment O | |
| with O | |
| a O | |
| progesteron O | |
| ( O | |
| hydroxyprogesterone O | |
| caproate O | |
| ) O | |
| and O | |
| an O | |
| antispasmodic O | |
| ( O | |
| tiemonium O | |
| methylsulfate O | |
| ) O | |
| in O | |
| a O | |
| community O | |
| clinic O | |
| . O | |
| the O | |
| resurgence O | |
| of O | |
| that O | |
| lancinating O | |
| and O | |
| permanent O | |
| pain B-ety | |
| irradiating O | |
| to O | |
| the O | |
| loins O | |
| and O | |
| associated O | |
| with O | |
| slight O | |
| vaginal B-ety | |
| bleeding I-ety | |
| prompted O | |
| consultation O | |
| . O | |
| she O | |
| had O | |
| first O | |
| menses O | |
| at O | |
| 14 O | |
| and O | |
| her O | |
| menstrual O | |
| cycle O | |
| is O | |
| regular O | |
| with O | |
| a O | |
| length O | |
| of O | |
| 30 O | |
| days O | |
| . O | |
| she O | |
| has O | |
| never O | |
| practiced O | |
| contraception O | |
| . O | |
| she O | |
| has O | |
| been O | |
| adequately O | |
| treated O | |
| for O | |
| acute B-ety | |
| pelvic I-ety | |
| inflammatory I-ety | |
| disease I-ety | |
| five O | |
| years O | |
| earlier O | |
| . O | |
| her O | |
| only O | |
| child O | |
| is O | |
| a O | |
| girl O | |
| born O | |
| vaginally O | |
| seven O | |
| years O | |
| ago O | |
| . O | |
| her O | |
| blood O | |
| group O | |
| is O | |
| B O | |
| rhesus O | |
| positive O | |
| and O | |
| she O | |
| has O | |
| never O | |
| undergone O | |
| surgery O | |
| . O | |
| she O | |
| presented O | |
| with O | |
| sympathetic O | |
| signs B-ety | |
| of I-ety | |
| pregnancy I-ety | |
| and O | |
| the O | |
| urinary O | |
| pregnancy O | |
| test O | |
| was O | |
| positive O | |
| but O | |
| echography O | |
| was O | |
| not O | |
| yet O | |
| done O | |
| . O | |
| on O | |
| admission O | |
| , O | |
| besides O | |
| the O | |
| main O | |
| complain O | |
| , O | |
| the O | |
| patient O | |
| had O | |
| vaginal B-ety | |
| bleeding I-ety | |
| and O | |
| nausea B-ety | |
| but O | |
| neither O | |
| fever B-ety | |
| , O | |
| nor O | |
| vomiting B-ety | |
| . O | |
| on O | |
| physical O | |
| examination O | |
| her O | |
| general O | |
| condition O | |
| was O | |
| good O | |
| and O | |
| the O | |
| blood O | |
| pressure O | |
| was O | |
| 110 O | |
| / O | |
| 70 O | |
| millimeters O | |
| of O | |
| mercury O | |
| , O | |
| the O | |
| respiratory O | |
| rate O | |
| : O | |
| 20 O | |
| cycles O | |
| / O | |
| minute O | |
| ; O | |
| the O | |
| pulse O | |
| rate O | |
| : O | |
| 70 O | |
| pulsations O | |
| / O | |
| minute O | |
| and O | |
| the O | |
| temperature O | |
| : O | |
| 37.3 O | |
| degree O | |
| celsius O | |
| . O | |
| the O | |
| conjunctivae O | |
| were O | |
| pink O | |
| and O | |
| the O | |
| tongue O | |
| was O | |
| clean O | |
| and O | |
| moist O | |
| . O | |
| there O | |
| were O | |
| no O | |
| cervical O | |
| adenopathies O | |
| . O | |
| the O | |
| breast O | |
| and O | |
| cardiopulmonary O | |
| examination O | |
| revealed O | |
| no O | |
| abnormalities O | |
| . O | |
| the O | |
| abdomen O | |
| was O | |
| flat O | |
| , O | |
| and O | |
| mobile O | |
| with O | |
| respiration O | |
| . O | |
| on O | |
| palpation O | |
| there O | |
| was O | |
| just O | |
| a O | |
| tenderness B-ety | |
| of I-ety | |
| the I-ety | |
| left I-ety | |
| iliac I-ety | |
| fossa I-ety | |
| and O | |
| the O | |
| bowel O | |
| sounds O | |
| were O | |
| normal O | |
| on O | |
| auscultation O | |
| . O | |
| inspection O | |
| under O | |
| speculum O | |
| revealed O | |
| normal O | |
| gravid O | |
| external O | |
| cervical O | |
| os O | |
| and O | |
| there O | |
| was O | |
| no O | |
| vaginal O | |
| discharge O | |
| . O | |
| on O | |
| digital O | |
| exploration O | |
| , O | |
| the O | |
| cervix O | |
| was O | |
| posterior O | |
| long O | |
| and O | |
| closed O | |
| , O | |
| the O | |
| uterus O | |
| was O | |
| globular O | |
| , O | |
| increased O | |
| in O | |
| size O | |
| and O | |
| compatible O | |
| with O | |
| an O | |
| eight O | |
| weeks O | |
| pregnancy O | |
| . O | |
| the O | |
| left O | |
| adnexae O | |
| presented O | |
| with O | |
| a O | |
| tender O | |
| , O | |
| smooth O | |
| and O | |
| mobile O | |
| mass O | |
| of O | |
| seven O | |
| centimeters O | |
| diameter O | |
| but O | |
| the O | |
| right O | |
| one O | |
| were O | |
| normal O | |
| . O | |
| the O | |
| posterior O | |
| cervico-vaginal O | |
| fornix O | |
| was O | |
| neither O | |
| tender O | |
| nor O | |
| bulging O | |
| . O | |
| we O | |
| suspected O | |
| a O | |
| non O | |
| ruptured O | |
| extra-uterine B-ety | |
| pregnancy I-ety | |
| with O | |
| the O | |
| following O | |
| differentials O | |
| : O | |
| heterotopic B-ety | |
| pregnancy I-ety | |
| , O | |
| torsion B-ety | |
| of I-ety | |
| ovarian I-ety | |
| cyst I-ety | |
| in O | |
| pregnancy O | |
| , O | |
| and O | |
| intra-cystic O | |
| ovarian B-ety | |
| bleeding I-ety | |
| in O | |
| pregnancy O | |
| . O | |
| paraclinical O | |
| investigations O | |
| revealed O | |
| : O | |
| beta O | |
| human O | |
| chorionic O | |
| gonadotropin O | |
| ( O | |
| β O | |
| hcg O | |
| ) O | |
| level O | |
| of O | |
| 96 O | |
| 702 O | |
| milli O | |
| international O | |
| units O | |
| per O | |
| milliliter O | |
| of O | |
| plasma O | |
| ( O | |
| miu O | |
| / O | |
| ml O | |
| ) O | |
| . O | |
| ultrasonography O | |
| revealed O | |
| a O | |
| heterogenous O | |
| left B-ety | |
| ovarian I-ety | |
| mass I-ety | |
| of O | |
| 82 O | |
| millimeters O | |
| in O | |
| diameter O | |
| , O | |
| an O | |
| empty O | |
| uterus O | |
| and O | |
| no O | |
| peritoneal B-ety | |
| effusion I-ety | |
| . O | |
| this O | |
| comforted O | |
| our O | |
| first O | |
| diagnosis O | |
| . O | |
| after O | |
| a O | |
| normal O | |
| pre-operative O | |
| work O | |
| up O | |
| , O | |
| an O | |
| emergency O | |
| laparotomy O | |
| was O | |
| done O | |
| under O | |
| general O | |
| anesthesia O | |
| . O | |
| the O | |
| findings O | |
| were O | |
| : O | |
| left O | |
| ovary O | |
| containing O | |
| a O | |
| gestational O | |
| sac O | |
| and O | |
| the O | |
| corpus O | |
| luteum O | |
| , O | |
| normal O | |
| right O | |
| adnexae O | |
| , O | |
| normal O | |
| left O | |
| tube O | |
| and O | |
| normal O | |
| uterus O | |
| . O | |
| there O | |
| was O | |
| no O | |
| hemoperitoneum O | |
| . O | |
| we O | |
| dissected O | |
| the O | |
| ovarian O | |
| capsule O | |
| and O | |
| carried O | |
| out O | |
| ablation O | |
| of O | |
| the O | |
| gestational O | |
| sac O | |
| , O | |
| then O | |
| we O | |
| did O | |
| hemostasis O | |
| . O | |
| the O | |
| specimen O | |
| was O | |
| analysed O | |
| by O | |
| the O | |
| pathologist O | |
| who O | |
| found O | |
| decidual O | |
| cells O | |
| and O | |
| trophoblastic O | |
| tissue O | |
| within O | |
| the O | |
| ovarian O | |
| capsule O | |
| and O | |
| thus O | |
| confirmed O | |
| the O | |
| ovarian B-ety | |
| pregnancy I-ety | |
| . O | |
| post O | |
| operative O | |
| course O | |
| was O | |
| uneventful O | |
| and O | |
| the O | |
| patient O | |
| was O | |
| discharged O | |
| six O | |
| days O | |
| after O | |
| surgery O | |
| . O | |
| the O | |
| ? O | |
| hcg O | |
| level O | |
| decreased O | |
| and O | |
| disappeared O | |
| 25 O | |
| days O | |
| after O | |
| surgery O | |
| . O | |
| A O | |
| 26 O | |
| - O | |
| year-old O | |
| pregnant O | |
| patient O | |
| with O | |
| a O | |
| history O | |
| of O | |
| two O | |
| previous O | |
| cesarean O | |
| deliveries O | |
| was O | |
| referred O | |
| to O | |
| our O | |
| tertiary O | |
| clinic O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| having O | |
| severe O | |
| right B-ety | |
| sided I-ety | |
| abdominal I-ety | |
| pain I-ety | |
| with O | |
| sudden O | |
| onset O | |
| . O | |
| she O | |
| was O | |
| in O | |
| the O | |
| 18 O | |
| th O | |
| week O | |
| of O | |
| her O | |
| pregnancy O | |
| based O | |
| on O | |
| last O | |
| menstrual O | |
| period O | |
| . O | |
| obstetric O | |
| ultrasound O | |
| measurements O | |
| revealed O | |
| a O | |
| live O | |
| pregnancy O | |
| compatible O | |
| with O | |
| 18 O | |
| weeks O | |
| gestation O | |
| without O | |
| any O | |
| abnormality O | |
| . O | |
| however O | |
| , O | |
| a O | |
| 15x12cm O | |
| in O | |
| size O | |
| edematous O | |
| multicystic O | |
| adnexal B-ety | |
| mass I-ety | |
| occupying O | |
| the O | |
| mid O | |
| and O | |
| upper O | |
| right O | |
| abdomen O | |
| without O | |
| vascularity O | |
| was O | |
| identified O | |
| . O | |
| the O | |
| mass O | |
| was O | |
| suspected O | |
| to O | |
| originate O | |
| from O | |
| right O | |
| ovary O | |
| . O | |
| it O | |
| was O | |
| pushing O | |
| the O | |
| pregnant O | |
| uterus O | |
| into O | |
| the O | |
| left O | |
| and O | |
| anterior O | |
| direction O | |
| . O | |
| there O | |
| was O | |
| no O | |
| ultrasonographic O | |
| evidence O | |
| of O | |
| malignancy B-ety | |
| . O | |
| considering O | |
| the O | |
| severe O | |
| sudden O | |
| pain B-ety | |
| complaint O | |
| and O | |
| adnexal B-ety | |
| mass I-ety | |
| finding O | |
| , O | |
| explorative O | |
| laparotomy O | |
| was O | |
| planned O | |
| for O | |
| the O | |
| suspected O | |
| diagnosis O | |
| of O | |
| adnexal B-ety | |
| torsion I-ety | |
| . O | |
| A O | |
| mediolateral O | |
| ( O | |
| near O | |
| vertical O | |
| ) O | |
| skin O | |
| incision O | |
| was O | |
| made O | |
| originated O | |
| from O | |
| infra-umbilical O | |
| level O | |
| on O | |
| the O | |
| lateral O | |
| side O | |
| of O | |
| right O | |
| rectus O | |
| muscle O | |
| . O | |
| specifically O | |
| , O | |
| the O | |
| starting O | |
| point O | |
| for O | |
| this O | |
| slightly O | |
| oblique O | |
| incision O | |
| was O | |
| at O | |
| 3cm O | |
| lateral O | |
| to O | |
| the O | |
| midline O | |
| and O | |
| near O | |
| to O | |
| lateral O | |
| one O | |
| third O | |
| of O | |
| the O | |
| rectus O | |
| muscle O | |
| . O | |
| the O | |
| skin O | |
| and O | |
| fascia O | |
| incisions O | |
| were O | |
| approximately O | |
| 4cm O | |
| and O | |
| 2.5cm O | |
| in O | |
| length O | |
| , O | |
| respectively O | |
| and O | |
| this O | |
| difference O | |
| was O | |
| due O | |
| to O | |
| the O | |
| thick O | |
| subcutaneous O | |
| fat O | |
| tissue O | |
| . O | |
| the O | |
| oblique O | |
| paramedian O | |
| incision O | |
| of O | |
| the O | |
| anterior O | |
| rectus O | |
| sheath O | |
| was O | |
| approximately O | |
| 2cm O | |
| medial O | |
| to O | |
| the O | |
| lateral O | |
| border O | |
| of O | |
| the O | |
| rectus O | |
| muscle O | |
| and O | |
| it O | |
| was O | |
| extended O | |
| to O | |
| caudal-lateral O | |
| direction O | |
| , O | |
| down O | |
| to O | |
| 1 O | |
| / O | |
| 2cm O | |
| to O | |
| the O | |
| lateral O | |
| border O | |
| of O | |
| rectus O | |
| muscle O | |
| . O | |
| the O | |
| lateral O | |
| edge O | |
| of O | |
| anterior O | |
| rectus O | |
| sheath O | |
| incision O | |
| was O | |
| dissected O | |
| off O | |
| from O | |
| the O | |
| rectus O | |
| muscle O | |
| laterally O | |
| up O | |
| to O | |
| semilunar O | |
| line O | |
| of O | |
| rectus O | |
| muscle O | |
| in O | |
| 1cm O | |
| width O | |
| . O | |
| then O | |
| , O | |
| the O | |
| rectus O | |
| muscle O | |
| was O | |
| retracted O | |
| medially O | |
| to O | |
| expose O | |
| the O | |
| posterior O | |
| sheath O | |
| of O | |
| rectus O | |
| ( O | |
| below O | |
| the O | |
| arcuate O | |
| line O | |
| , O | |
| only O | |
| the O | |
| transversalis O | |
| fascia O | |
| and O | |
| parietal O | |
| peritoneum O | |
| are O | |
| exposed O | |
| ) O | |
| . O | |
| an O | |
| oblique O | |
| incision O | |
| was O | |
| made O | |
| on O | |
| the O | |
| posterior O | |
| sheath O | |
| of O | |
| rectus O | |
| and O | |
| peritoneum O | |
| behind O | |
| the O | |
| rectus O | |
| muscle O | |
| , O | |
| in O | |
| a O | |
| projection O | |
| of O | |
| the O | |
| anterior O | |
| sheath O | |
| incision O | |
| . O | |
| in O | |
| this O | |
| manner O | |
| , O | |
| the O | |
| abdominal O | |
| wall O | |
| incisions O | |
| were O | |
| located O | |
| at O | |
| anterior O | |
| and O | |
| posterior O | |
| sheaths O | |
| of O | |
| rectus O | |
| muscle O | |
| at O | |
| least O | |
| 1 O | |
| / O | |
| 2cm O | |
| medial O | |
| to O | |
| the O | |
| semilunar O | |
| line O | |
| and O | |
| to O | |
| the O | |
| lateral O | |
| border O | |
| of O | |
| rectus O | |
| . O | |
| in O | |
| other O | |
| words O | |
| , O | |
| incision O | |
| was O | |
| not O | |
| made O | |
| from O | |
| fascial O | |
| layers O | |
| ' O | |
| merging O | |
| point O | |
| or O | |
| by O | |
| muscle O | |
| splitting O | |
| dissection O | |
| . O | |
| therefore O | |
| , O | |
| traction O | |
| forces O | |
| from O | |
| enlarging O | |
| uterus O | |
| in O | |
| advancing O | |
| pregnant O | |
| abdomen O | |
| could O | |
| be O | |
| minimized O | |
| . O | |
| A O | |
| large O | |
| edematous B-ety | |
| , O | |
| necrotic B-ety | |
| and O | |
| dark O | |
| purple O | |
| torsion B-ety | |
| of I-ety | |
| a I-ety | |
| right I-ety | |
| adnexal I-ety | |
| mass I-ety | |
| was O | |
| observed O | |
| . O | |
| it O | |
| was O | |
| pulled O | |
| out O | |
| and O | |
| was O | |
| partially O | |
| dissected O | |
| from O | |
| its O | |
| surface O | |
| layer O | |
| following O | |
| a O | |
| 2cm O | |
| incision O | |
| . O | |
| the O | |
| cystic O | |
| structure O | |
| was O | |
| aspirated O | |
| and O | |
| right O | |
| salpingo-ooferectomy O | |
| was O | |
| performed O | |
| . O | |
| the O | |
| operation O | |
| was O | |
| completed O | |
| by O | |
| avoiding O | |
| the O | |
| manipulation O | |
| of O | |
| the O | |
| pregnant O | |
| uterus O | |
| . O | |
| frozen O | |
| section O | |
| pathology O | |
| of O | |
| the O | |
| removed O | |
| specimen O | |
| was O | |
| reported O | |
| as O | |
| benign O | |
| ( O | |
| necrotic O | |
| tissues O | |
| , O | |
| teratoma O | |
| ) O | |
| and O | |
| final O | |
| pathology O | |
| was O | |
| mucinous B-ety | |
| cystadenoma I-ety | |
| . O | |
| follow O | |
| up O | |
| on O | |
| the O | |
| pregnant O | |
| patient O | |
| was O | |
| uneventful O | |
| a O | |
| month O | |
| later O | |
| . O | |
| we O | |
| report O | |
| the O | |
| case O | |
| of O | |
| a O | |
| 15 O | |
| - O | |
| year-old O | |
| caucasian O | |
| girl O | |
| who O | |
| was O | |
| diagnosed O | |
| with O | |
| silver-russell B-ety | |
| syndrome I-ety | |
| at O | |
| the O | |
| age O | |
| of O | |
| four O | |
| and O | |
| a O | |
| half O | |
| years O | |
| . O | |
| recombinant O | |
| growth O | |
| hormone O | |
| was O | |
| administered O | |
| for O | |
| 18 O | |
| months O | |
| without O | |
| an O | |
| appropriate O | |
| increase O | |
| in O | |
| growth O | |
| velocity O | |
| . O | |
| at O | |
| the O | |
| age O | |
| of O | |
| seven O | |
| years O | |
| , O | |
| her O | |
| serum O | |
| growth O | |
| hormone O | |
| levels O | |
| were O | |
| high O | |
| , O | |
| and O | |
| an O | |
| insulin-like O | |
| growth O | |
| factor O | |
| 1 O | |
| generation O | |
| test O | |
| did O | |
| not O | |
| increase O | |
| insulin-like O | |
| growth O | |
| factor O | |
| 1 O | |
| levels O | |
| ( O | |
| baseline O | |
| insulin-like O | |
| growth O | |
| factor O | |
| 1 O | |
| levels O | |
| , O | |
| 52 O | |
| μg O | |
| / O | |
| L O | |
| ; O | |
| reference O | |
| range O | |
| , O | |
| 75 O | |
| μg O | |
| / O | |
| L O | |
| to O | |
| 365 O | |
| μg O | |
| / O | |
| L O | |
| ; O | |
| and O | |
| peak O | |
| , O | |
| 76 O | |
| μg O | |
| / O | |
| L O | |
| and O | |
| 50 O | |
| μg O | |
| / O | |
| L O | |
| after O | |
| 12 O | |
| and O | |
| 84 O | |
| hours O | |
| , O | |
| respectively O | |
| , O | |
| from O | |
| baseline O | |
| ) O | |
| . O | |
| the O | |
| genetic O | |
| analysis O | |
| showed O | |
| that O | |
| the O | |
| patient O | |
| was O | |
| homozygous O | |
| for O | |
| the O | |
| R217X O | |
| mutation O | |
| in O | |
| the O | |
| growth O | |
| hormone O | |
| receptor O | |
| gene O | |
| , O | |
| which O | |
| is O | |
| characteristic O | |
| of O | |
| laron B-ety | |
| syndrome I-ety | |
| . O | |
| on O | |
| the O | |
| basis O | |
| of O | |
| these O | |
| results O | |
| , O | |
| the O | |
| diagnosis O | |
| of O | |
| primary O | |
| growth B-ety | |
| hormone I-ety | |
| insensitivity I-ety | |
| syndrome I-ety | |
| was O | |
| made O | |
| , O | |
| and O | |
| recombinant O | |
| insulin-like O | |
| growth O | |
| factor O | |
| 1 O | |
| therapy O | |
| was O | |
| initiated O | |
| . O | |
| the O | |
| patient's O | |
| treatment O | |
| was O | |
| well O | |
| tolerated O | |
| , O | |
| but O | |
| unexplained O | |
| central O | |
| hypothyroidism O | |
| occurred O | |
| at O | |
| the O | |
| age O | |
| of O | |
| 12.9 O | |
| years O | |
| . O | |
| at O | |
| the O | |
| age O | |
| of O | |
| 15 O | |
| years O | |
| , O | |
| when O | |
| the O | |
| patient's O | |
| sexual O | |
| development O | |
| was O | |
| almost O | |
| completed O | |
| and O | |
| her O | |
| menstrual O | |
| cycle O | |
| occurred O | |
| irregularly O | |
| , O | |
| her O | |
| height O | |
| was O | |
| 129.8 O | |
| cm O | |
| , O | |
| which O | |
| is O | |
| 4.71 O | |
| standard O | |
| deviations O | |
| below O | |
| the O | |
| median O | |
| for O | |
| normal O | |
| girls O | |
| her O | |
| age O | |
| . O | |
| male O | |
| infant O | |
| 9.5 O | |
| month O | |
| old O | |
| was O | |
| examined O | |
| in O | |
| the O | |
| emergency O | |
| department O | |
| of O | |
| our O | |
| hospital O | |
| because O | |
| of O | |
| an O | |
| empty B-ety | |
| scrotum I-ety | |
| and O | |
| the O | |
| ipsilateral O | |
| testis O | |
| lying O | |
| in O | |
| a O | |
| high O | |
| iliac O | |
| crest O | |
| position O | |
| . O | |
| with O | |
| the O | |
| increase O | |
| in O | |
| intrabdominal O | |
| pressure O | |
| [ O | |
| crying O | |
| etc O | |
| . O | |
| ] O | |
| there O | |
| was O | |
| an O | |
| ever-increasing O | |
| swelling B-ety | |
| with O | |
| spiral O | |
| course O | |
| from O | |
| the O | |
| groin O | |
| to O | |
| ipsilateral O | |
| iliac O | |
| crest O | |
| . O | |
| on O | |
| clinical O | |
| examination O | |
| , O | |
| a O | |
| reducible O | |
| mass O | |
| was O | |
| present O | |
| in O | |
| the O | |
| right O | |
| ileac O | |
| crest O | |
| . O | |
| the O | |
| swelling B-ety | |
| looked O | |
| like O | |
| a O | |
| spigelian B-ety | |
| hernia I-ety | |
| [ O | |
| 4 O | |
| ] O | |
| . O | |
| however O | |
| no O | |
| abdominal B-ety | |
| wall I-ety | |
| defect I-ety | |
| could O | |
| be O | |
| palpated O | |
| at O | |
| that O | |
| area O | |
| . O | |
| moreover O | |
| the O | |
| ipsilateral O | |
| scrotum O | |
| was O | |
| empty O | |
| and O | |
| the O | |
| testis O | |
| could O | |
| be O | |
| palpated O | |
| with O | |
| difficulty O | |
| lying O | |
| in O | |
| a O | |
| high O | |
| inguinal O | |
| position O | |
| . O | |
| ultrasonography O | |
| showed O | |
| a O | |
| loop O | |
| of O | |
| herniated O | |
| small O | |
| bowel O | |
| and O | |
| an O | |
| undescended B-ety | |
| testis I-ety | |
| on I-ety | |
| the I-ety | |
| right I-ety | |
| . O | |
| at O | |
| operation O | |
| , O | |
| under O | |
| general O | |
| anesthesia O | |
| , O | |
| an O | |
| extended O | |
| transverse O | |
| inguinal O | |
| incision O | |
| was O | |
| made O | |
| . O | |
| upon O | |
| entering O | |
| the O | |
| inguinal O | |
| canal O | |
| a O | |
| large O | |
| hernia B-ety | |
| sac I-ety | |
| was O | |
| identified O | |
| . O | |
| this O | |
| followed O | |
| a O | |
| course O | |
| through O | |
| the O | |
| superficial O | |
| inguinal O | |
| ring O | |
| , O | |
| extended O | |
| upwards O | |
| to O | |
| the O | |
| anterior O | |
| abdomninal O | |
| wall O | |
| below O | |
| the O | |
| subcutaneous O | |
| plane O | |
| and O | |
| was O | |
| fixed O | |
| in O | |
| the O | |
| area O | |
| of O | |
| the O | |
| right O | |
| iliac O | |
| crest O | |
| . O | |
| we O | |
| noticed O | |
| that O | |
| the O | |
| hernia B-ety | |
| orifice O | |
| was O | |
| in O | |
| a O | |
| higher O | |
| than O | |
| normal O | |
| position O | |
| 5 O | |
| cm O | |
| from O | |
| the O | |
| pubic O | |
| bone O | |
| . O | |
| this O | |
| bulk O | |
| was O | |
| easily O | |
| reduced O | |
| back O | |
| to O | |
| the O | |
| abdomen O | |
| along O | |
| with O | |
| an O | |
| ipsilateral O | |
| mobile O | |
| intravaginal O | |
| testis O | |
| . O | |
| after O | |
| careful O | |
| isolation O | |
| of O | |
| the O | |
| sac O | |
| at O | |
| a O | |
| length O | |
| of O | |
| 3 O | |
| cm O | |
| the O | |
| ipsilateral O | |
| testis O | |
| was O | |
| isolated O | |
| . O | |
| the O | |
| vas O | |
| and O | |
| the O | |
| vessels O | |
| were O | |
| intravaginal O | |
| , O | |
| the O | |
| gubernaculum O | |
| was O | |
| fixed O | |
| in O | |
| an O | |
| ectopic O | |
| position O | |
| and O | |
| the O | |
| dorsal O | |
| inguinal O | |
| wall O | |
| was O | |
| lax O | |
| . O | |
| we O | |
| removed O | |
| the O | |
| large O | |
| sac O | |
| after O | |
| separating O | |
| the O | |
| vas O | |
| and O | |
| vessels O | |
| and O | |
| the O | |
| testis O | |
| . O | |
| moreover O | |
| we O | |
| strengthened O | |
| the O | |
| dorsal O | |
| inguinal O | |
| wall O | |
| , O | |
| fixated O | |
| the O | |
| testis O | |
| in O | |
| a O | |
| subdartos O | |
| pouch O | |
| and O | |
| closed O | |
| the O | |
| wound O | |
| . O | |
| patient O | |
| stayed O | |
| for O | |
| a O | |
| day O | |
| in O | |
| the O | |
| hospital O | |
| . O | |
| no O | |
| postoperative O | |
| complications O | |
| happened O | |
| . O | |
| three O | |
| years O | |
| later O | |
| the O | |
| boy O | |
| was O | |
| operated O | |
| for O | |
| left B-ety | |
| hydrocele I-ety | |
| . O | |
| the O | |
| boy O | |
| remains O | |
| in O | |
| perfect O | |
| health O | |
| now O | |
| five O | |
| years O | |
| after O | |
| the O | |
| initial O | |
| operation O | |
| . O | |
| A O | |
| 32 O | |
| - O | |
| year-old O | |
| female O | |
| patient O | |
| with O | |
| kniest B-ety | |
| syndrome I-ety | |
| presented O | |
| at O | |
| our O | |
| department O | |
| with O | |
| a O | |
| painful O | |
| pseudarthrosis B-ety | |
| after O | |
| femoral O | |
| valgisation O | |
| osteotomy O | |
| 8 O | |
| years O | |
| ago O | |
| . O | |
| A O | |
| wagner O | |
| cone O | |
| stem O | |
| and O | |
| acetabular O | |
| roof O | |
| cup O | |
| with O | |
| a O | |
| cemented O | |
| ecofit O | |
| cup O | |
| 2M O | |
| ( O | |
| dual-articulation O | |
| acetabular O | |
| cup O | |
| system O | |
| ) O | |
| were O | |
| implanted O | |
| due O | |
| to O | |
| a O | |
| dysplastic B-ety | |
| femur I-ety | |
| with O | |
| a O | |
| small O | |
| medullary O | |
| space O | |
| . O | |
| the O | |
| ecofit O | |
| cup O | |
| itself O | |
| is O | |
| associated O | |
| with O | |
| a O | |
| reduced O | |
| risk O | |
| of O | |
| dislocation O | |
| . O | |
| the O | |
| patient O | |
| was O | |
| satisfied O | |
| with O | |
| the O | |
| range O | |
| of O | |
| motion O | |
| after O | |
| hip O | |
| endoprosthesis O | |
| and O | |
| reported O | |
| a O | |
| significant O | |
| increase O | |
| in O | |
| quality O | |
| of O | |
| life O | |
| . O | |
| the O | |
| patient O | |
| is O | |
| still O | |
| comfortable O | |
| with O | |
| the O | |
| hip O | |
| prosthesis O | |
| at O | |
| the O | |
| most O | |
| recent O | |
| follow-up O | |
| 4 O | |
| years O | |
| after O | |
| implantation O | |
| . O | |
| follow-up O | |
| radiographs O | |
| over O | |
| 4 O | |
| years O | |
| have O | |
| not O | |
| revealed O | |
| any O | |
| signs O | |
| of O | |
| loosening O | |
| or O | |
| migration O | |
| , O | |
| and O | |
| no O | |
| trendelenburg B-ety | |
| sign I-ety | |
| was O | |
| reported O | |
| for O | |
| the O | |
| affected O | |
| side O | |
| . O |